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EXAMINING THE RELATIONSHIP BETWEEN LEISURE-TIME PHYSICAL 
ACTIVITY AND THE RISK OF COLON AND BREAST CANCER: A 








Co-Chairs: Dee W. Edington and Kathleen B. Welch 
 
Purpose:  The objective of this study was to review the methodology and analyze the 
existing data examining the relationship between leisure-time physical activity and the 
risk of colon and breast cancer.  Methods:  Methodological differences (participant 
characteristics, length of time physical activity was measured, categorizations of 
quantified physical activity, and assessment instrumentation used to record activity) 
among studies of activity and cancer risk were reviewed and potential confounding was 
estimated by calculating the percent difference between multivariate-adjusted effect 
measures and unadjusted effect measures.  A series of meta-analyses were completed.  
Studies quantifying activity using the Compendium of Physical Activities were included 
in the primary meta-analyses of colon and breast cancer risk.  Subjects from all studies 
were combined and categorized into low, moderate, and high amounts of weekly activity.  
Moderate and high groups were compared to the low reference group.  Results:  Percent 
differences between adjusted and unadjusted effect measures ranged from 0-31% across 
all physical activity categories for colon cancer studies and 0-21% for breast cancer 
studies, with one study reporting a larger difference for each set of analyses (Tang et al., 




high versus low activity ranged from 0.524 (95% CI = 0.348-0.788; p = 0.002; Males) to 
0.673 (95% CI = 0.474-0.956; p = 0.027; females) for colon cancer risk.  For breast 
cancer risk, effect measures for high versus low activity were 0.832 (95% CI = 0.747-
0.926; p = 0.001) for pre- and postmenopausal females combined, 0.820 (95% CI = 
0.584-1.151; p = 0.251) for premenopausal females, and 0.868 (95% CI = 0.754-0.999) 
for postmenopausal females. Conclusions:  Higher amounts of leisure-time physical 
activity were associated with a reduced risk of male and female colon cancer and 
postmenopausal breast cancer.  Future studies of the relationship between physical 
activity and cancer risk should adhere to a standardized questionnaire for assessing types 
of activity, standard time frame for measuring activity, and quantification of the amount 
of activity likely to be protective, to develop a better understanding of the effects of 




















Chapter I  
Introduction 
 
 Cancer is defined as a group of diseases that generate from most cell types in the 
body.  It is characterized by uncontrolled cellular proliferation and unregulated cell 
growth, as well as the spread of abnormal cells, leading to invasiveness of normal body 
tissue [1]. Malignant tumors differ from their benign counterparts, as malignancies are 
more invasive, have a faster growth rate, are undifferentiated, and often metastasize. 
Solid, malignant tumors known as carcinomas are responsible for the majority of cancers 
originating in body tissues, including the colon and breast.  Carcinomas often originate 
from hyperplasia, which is defined as increased local tissue size due to abnormal cellular 
proliferation, which often leads to unregulated cell growth.   
   Three classes of genes are involved in cancer initiation and progression: DNA 
repair genes, tumor-suppressor genes, and proto-oncogenes [2]. DNA repair genes are not 
directly involved with cellular replication and growth, but proto-oncogenes are non-
mutated alleles of genes associated with normal cellular replication and growth, while 
tumor-suppressor genes prevent abnormal cellular growth.  A mutation of DNA repair 
genes leads to additional mutations of tumor-suppressor genes and proto-oncogenes, 
resulting in the initiation and progression of cancer [3]. Specifically, the p53 gene is an 





50% of all human cancers, including colon and breast [4]. Both two acquired mutations 
or one inherited and one acquired mutation of DNA repair gene or tumor-suppressor gene 
alleles can inactivate the mechanisms that inhibit abnormal cell growth.  This is known as 
the “two-hit theory of carcinogenesis” [5, 6].  Typically, mutations of proto-oncogenes 
into oncogenes combined with the deactivation or deletion of tumor-suppressor genes 
leads to an unregulated growth of cancerous cells.  The progression of cancer is usually 
described according to the tumor-node-metastasis (TNM) system, which accounts for the 
size of the primary tumor, surrounding lymph node involvement, and presence of 
metastasis [7]. Most cancers are classified in stages I through IV – tumor limited to tissue 
of origin, spread of tumor into local surrounding tissue, invasive legion with lymph node 
involvement, and metastasis, respectively. 
 Cancer recently surpassed heart disease as the leading cause of death among 
Americans under age 85 since 1999, as 556,902 Americans died of cancer in 2003 and 
over 564,000 individuals are projected to die from cancer in 2006 [8]. In the United 
States (U.S.), the total economic burden of cancer is nearly $190 billion, including 
approximately $65 billion in direct health care expenditures and over $100 billion in 
indirect costs due to lost productivity (2003 U.S. dollars) [9]. According to the American 
Cancer Society, the lifetime probability of developing cancer is approximately 46% for 
males and 38% for females in the U.S.  Furthermore, the incidence rate for cancer of all 
sites was 553.3 per 100,000 males and 413.5 per 100,000 females between 1998 and 
2002, and over 1.4 million new cancer diagnoses are expected for 2006.  For the first 





deaths from cancer decreased (-369 deaths), although this was reported only in males (-
778), as cancer-related female deaths continued to increase (409).    
In addition to the sex differences in cancer related mortality in the United States, 
there are incidence and mortality differences among races.  African American males have 
a 23% higher incidence rate and 40% higher mortality rate for all cancer sites compared 
to their White counterparts.  Although African American females have a 7% lower 
incidence rate for all cancer sites, their mortality rate is still 18% higher compared to U.S. 
White females.  Such disparities in survival rates may be related to inequitable access to 
quality health care, and biological factors such as the development of different cancer-
related comorbidities, but the precise impact of these factors remains unclear [10]. 
However, it appears that access to quality health care may be the most important factor in 
survival, as recent research reported African Americans have similar survival rates as 
Whites when similar cancer treatment and care is received [11]. Specifically, access to 
early detection through appropriate screenings is essential for survival.  In addition to the 
lower survival rate among nearly all U.S. minorities, these populations are also more 
likely be diagnosed at a later stage than U.S. Whites [12].   
In summary, cancer consists of a sequence of events that eventually lead to 
abnormal cellular growth.  It is a leading cause of death in the U.S. and further 
exploration of risk factors associated with the prevention of cancer is necessary as the 
relationship between lifestyle risk factors such as physical activity and cancer risk 
remains largely unclear.  Two cancers that are among the most prevalent and fatal are 
breast cancer and colorectal cancer, and physical activity is thought to provide some 






 A multi-step carcinogenesis model is a widely accepted model for colorectal 
cancer progression [13]. Adenomatous polyps, which are usually adenocarcinomas, are 
an established precursor of colon cancer, often becoming colon tumors.  Within a normal 
epithelium, there is initial DNA damage in the form of an APC gene mutation, which 
leads to a hyper-proliferative epithelium, an early adenoma and eventually an 
intermediate adenoma after further genetic mutations.  At the point of the intermediate 
adenoma, a mutation of the K-RAS oncogene, a gene responsible for cellular proliferation 
and the regulation of cellular growth becomes mutated.  Eventually, the presence of a late 
adenoma occurs, which causes a loss of the p53 tumor suppressor gene.  The loss of p53 
allows for oncogenic growth and for the late adenoma to develop into a carcinoma, which 
has the potential to metastasize with other alterations. 
    Currently, colorectal cancer is the second most prevalent cancer among both sexes 
combined, and the third most prevalent cancer for each sex, as over 72,000 male cases 
and 75,000 female cases are predicted for 2006.  This is equivalent to 10% and 11% of all 
cancer cases, respectively [8]. Colorectal cancer is the second most fatal cancer among 
males, and 27,870 deaths are predicted for 2006, which is equivalent to 10% of all cancer 
deaths in males - slightly more than the predicted deaths due to prostate cancer.  
Colorectal cancer is responsible for 10% of all cancer deaths in females, and only lung 
and breast cancer cause more deaths.  The mortality rate for colorectal cancer (death rate 
per 100,000 population) remained relatively stable between 1950 and 2002, but has 
decreased to below 30% in the past ten years.  Meanwhile, the mortality rate among 





20% [8]. Recent trends (1998-2002) indicated a decrease in the incidence rate of 
colorectal cancer by 1.8% (both sexes), 2.5% (males), and 1.5% (females) per year.  
Additionally, annual trends during the same time period show a decrease in deaths 
attributable to colon cancer by 2.0% for males [14]. African-American males and females 
have higher colorectal cancer incidence and mortality rates compared to U.S. Whites.  
Higher mortality rates among African Americans may be due to later screening and 
diagnosis in this population [12]. Additionally, there may be biological disparities such as 
different comorbidities and higher presence of various risk factors between the two 
populations. 
 While no association between physical activity and rectal cancer has been 
reported, the association between physical activity and colon cancer risk reduction is very 
consistent among epidemiologic studies for occupational, leisure-time, and total activity. 
Prior studies have reported a dose-response effect of physical activity on colon cancer 
risk at higher exercise levels [15-19]. The biological plausibility of the positive effect of 
physical activity on colon cancer development consists of several primary mechanisms 
including a reduction in body fat [20], improved gastrointestinal transit time [21], and a 
reduction in circulating hormone levels, including estrogen [22].  
Prior research has shown little alteration in the relationship between physical 
activity and colon cancer after adjustment for other potential confounders.  Confounding 
factors are variables other than the exposure (in this case physical activity) that can 
potentially impact the association between the exposure (physical activity) and colon 
cancer risk [18, 19, 23-25]. However, some effect modification, defined as the “variation 





in the form of higher fiber intake [24].  Fiber intake has a similar impact on the 
gastrointestinal transit rate, as well as BMI, which can also affect colon cancer risk, 
regardless of physical activity level [18]. 
In addition to physical inactivity, primary risk factors for colon cancer include a 
diet that is low in fiber and vegetables while high in meat intake, obesity, and tobacco 
smoking.  Such lifestyle factors may provide some explanatory evidence for why the U.S. 
and other western countries having some of the highest colorectal cancer incidence rates 
in the world [26]. Consumption of specific foods and nutrients may play a role in the 
development of colon cancer.  The “western diet”, which is high in saturated fats 
including red meat while low in fiber, fruits, and vegetables has long been suspected to 
be a risk factor for colon cancer [27]. While the data remain inconsistent, research reports 
a modestly lower risk for colon cancer with a higher consumption of vegetables and fruits 
[16, 28].  The precise relationship between fiber and colon cancer risk also remains 
unclear. However, prior research indicated a colon cancer risk reduction with a higher 
intake of dietary fiber [29, 30].  Additionally, folic acid, Vitamin E, calcium, and overall 
multivitamin supplementation have been associated with a reduction of colorectal cancer 
or adenomas [31-33].  Mounting evidence suggests an elevated risk of colon cancer with 
meat eating, but the findings remain inconsistent [17, 34].  
 Most epidemiologic studies report that obesity increases the risk of colon cancer, 
especially in males.  Males in the highest quintile for body size have a doubled risk of 
colon cancer [16]. Most studies report a positive linear relationship between body mass 
index (BMI) and colon cancer [28]. Females who were in the highest BMI quintile had a 





this relationship is not as clear in older females.  However, for most males and females, a 
strong linear relationship is typically reported in the obese (BMI > 30 kg/m2) [28].  
Recent studies have reported that an early onset and long history of cigarette smoking 
may be a risk factor for colon cancer because tobacco is a major source of carcinogens, 
including heterocyclic amines, which cause tumor-suppressor gene mutations in rats [35, 
36].  Prior research also reported an elevated risk between smoking and colorectal 
adenomas [35].   
Colon cancer becomes symptomatic with the obstruction and bleeding of the 
bowel.  Changes in bowel habits, blood in the stool, and anemia are typical symptoms. As 
the cancer progresses, fatigue, anorexia, pain, weight loss, and jaundice can occur.  
Compared with cancers at other sites, screening is relatively effective at detecting colon 
cancer at earlier stages through stool testing for blood, sigmoidoscopies, and 
colonoscopies.  The American Cancer Society recommends a colonoscopy or flexible 
sigmoidoscopy every five years in addition to an annual fecal occult blood test (FOBT), 
and over half of all individuals aged 50 years and older have had a FOBT, colonoscopy, 
or sigmoidoscopy [37]. Detection of colon cancer is usually through one of the 
aforementioned screening tests along with a biopsy, and treatment is usually through 
radical surgical removal of the primary lesion whenever possible.  Treatment often only 
includes removal of the tumor but may include chemotherapy and/or radiotherapy.  At the 
present time, chemotherapy following surgery has been established only as an effective 
treatment in stage III colon cancer, and current evidence suggests this therapy can prevent 





Physical activity appears to provide a protective effect on colon cancer among 
males and females.  Relative to other risk factors, the relationship between physical 
inactivity and the development of colon cancer is understood because physical activity 
appears to specifically have a positive impact on the colon through various mechanisms 
including an improved gastrointestinal transit rate, positive hormonal alterations, and a 
reduction in body fat.  The relationship between physical activity and colon cancer risk is 
discussed in greater detail later in this chapter. 
 
Breast Cancer 
 Breast cancer is the most prevalent form of cancer in females, affecting more 
females than the next two most prevalent cancers (lung and colorectal) combined [8]. 
Over 175,000 new cases of invasive breast cancer were expected in 2007, which is 
approximately 31% of all new female cancer cases.  Additionally over 40,000 female 
breast cancer deaths are expected this year.  This is equivalent to approximately 15% of 
all cancer deaths in females, second only to lung cancer.  Since 1980, breast cancer 
incidence has been steadily climbing, albeit more slowly in the past few years [8].  This 
could be because more females are surviving breast cancer through early detection and 
use of mammograms, however, an increased obesity among U.S. females, and use of 
postmenopausal hormone therapy are also possible reasons for the increase in breast 
cancer [8, 38]. Between 1930 and 1990, the mortality rate for breast cancer (per 100,000 
population) remained slightly above 30%.  Since 1990, the mortality rate has begun to 
slowly decrease [8]. The incidence rate for female breast cancer is much higher among 





respectively).  This is likely due to a later age at first birth and increased use of 
mammograms and hormone replacement therapy among White females [10]. 
Additionally, African American females are less likely to be screened and diagnosed with 
breast cancer at an early stage compared to White females [12]. 
Both genetic and environmental factors influencing the development of breast 
cancer have been extensively studied in epidemiologic research [39]. Approximately 5% 
to 10% of all breast cancer cases and over 30% of cases among females under age 30 
years can be attributed to direct germline mutations [40]. Specific genes that have been 
linked to the presence of breast cancer include the Breast Cancer Genes 1 and 2 (BRCA1 
and BRCA2, respectively).  While the exact function of these genes is not known, it 
appears that these two genes act as tumor-suppressors [41]. Mutations of these suspected 
tumor-suppressor genes are responsible for an estimated 2% to 5% of breast cancer cases 
and are more strongly associated with breast cancer incidence among younger females.  
Individuals under age 40 years with BRCA1 are approximately 20 times more likely to 
develop breast cancer and have a lifetime risk of 60% to 85%, and this gene is more 
commonly found in Ashkenazi Jewish females [41, 42]. Another tumor-suppressor gene 
associated with the development of breast cancer is the p53 gene, which also is associated 
with colorectal and many other forms of cancer.  Germline mutations of p53 can occur in 
females with rare familial cancer, but this is quite infrequent in the population [41, 42]. 
More commonly, p53 mutations may also be associated with breast tumor progression 
[42]. 
 Many risk factors, including family history in a first degree relative, later 





hormone use, early age of menarche (<12 years), later age of first birth (> 30 years), 
nulliparity, and obesity have an established relationship with breast cancer [39]. 
Additionally, oral contraceptive use probably is associated with the disease, but the 
relationship is not as strong [43].  It is generally reported that physical activity decreases 
the risk of breast cancer [44], however, the precise protective effect of physical activity in 
pre- and post-menopausal females remains unclear and is discussed in further detail later 
in this chapter.   
 Prior research reports a consistent relationship between age at menopause and 
breast cancer risk later in life [45]. Specifically, breast cancer risk increases 
approximately 3% per year of delayed menopause [45]. The increased risk associated 
with a delayed onset of menopause likely is due to a prolonged circulation of steroid 
hormones [45].  Specifically, elevated levels of estradiol, a type of active endogenous 
estrogen is associated with increased breast cancer risk, and adipose tissue is the major 
source of estrogen following menopause, making obese postmenopausal females with 
higher levels of endogenous estrogen at an especially higher risk for breast cancer [46]. 
The relationship between estradiol levels and breast cancer risk among postmenopausal 
females is among the most consistent in epidemiologic literature [47]. Furthermore, many 
studies reported postmenopausal estrogen hormone use was associated with an elevated 
breast cancer risk, and a positive linear association existed between duration of use and 
level of risk [48].  
 Other reproductive factors are associated with breast cancer risk.  Age at 
menarche is somewhat associated with both pre- and post-menopausal breast cancer risk, 





likely due to the “cyclic hormonal changes that result in ovulation, menstruation, and 
cellular proliferation in the breast” that commence with menarche [39]. Nulliparous 
females typically have a higher risk for breast cancer compared to parous females. 
However, the relationship varies over time and depends on the number of childbirths 
[45]. For the first 10 to 20 years after delivery, the woman’s breast cancer risk is higher 
compared to a nulliparous woman of a similar age [49]. However, parous females have 
long-term reduction in risk later in life compared to their nulliparous counterparts, and 
multiparous females have an even greater risk reduction [50]. The earlier risk among 
parous females is likely due to the relationship between elevated hormone levels and a 
pre-existing malignant condition, while the later protective effect from one or more 
childbirths is likely due to various positive changes including differentiation of the 
epithelium and ductal system of the breast [51]. Additionally, females who are younger at 
the time of their first childbirth experience a protective effect independent of parity, as 
fewer breast cells have been initiated prior to the aforementioned differentiation in the 
breast epithelium [45]. Prior research only reports a slight increase in breast cancer risk 
associated with long-term oral contraceptive use, and this relationship generally appears 
to be stronger among females under the age of 35 years.  A slightly higher risk for breast 
cancer may exist among current and recent users of oral contraceptives, but this risk 
appears to be attenuated over time after stopping the use of oral contraceptives [52]. 
 The relationship between body mass index (BMI) and breast cancer risk is 
dependant on the female’s menopausal status and use of postmenopausal hormones.  A 
higher BMI typically is not a risk factor for premenopausal females, but is positively, 





Following menopause, adipose tissue becomes the primary source of plasma estrogens, 
creating a positive relationship between estrogen levels and BMI among these females, 
and making it difficult to determine a strong relationship between BMI and breast cancer 
risk.  Because higher levels of estrogen also are associated with postmenopausal hormone 
use, determining the relationship between BMI and breast cancer risk among 
postmenopausal females using hormone replacement therapy is difficult.  While a 
positive relationship between BMI and breast cancer risk was not reported among 
females with past or current hormone use, a positive relationship between BMI and breast 
cancer risk was observed among postmenopausal females who did not utilize hormone 
replacement therapy [54]. 
 Epidemiologic evidence consistently reports some degree of association between 
physical activity and breast cancer risk [55]. However, this relationship remains relatively 
unclear compared to the association between physical activity and colon cancer because 
the biological associations between physical activity and breast cancer are more complex, 
making it difficult to assess the biologic and epidemiologic evidence [44]. Also, much of 
the breast cancer risk is influenced by reproductive factors throughout the woman’s 
lifespan that are not easily altered, which makes it difficult to assess the relationship 
between breast cancer risk and a lifestyle risk factor such as physical activity [56]. A 
variety of biologic mechanisms have been hypothesized to link breast cancer with 
physical activity [57]. However, while such underlying mechanisms remain unclear, it is 
widely accepted that moderate to vigorous physical activity is reportedly associated with 






Research has primarily focused on the role of hormonal mechanisms, energy 
balance, and the relationship between the two as key factors mediating the relationship 
between physical activity and breast cancer risk.  Increased levels of estrogen from a high 
BMI are often found in postmenopausal females.  Additionally, a high BMI often is 
associated with lower levels of physical activity.  Postmenopausal females with a high 
BMI often have higher levels of circulating testosterone, which is associated with 
increased levels of estradiol, and therefore increased breast cancer risk [59]. Contrarily, 
increased levels of physical activity are associated with lower BMI among 
postmenopausal females.  However, increased amounts of physical activity also have 
been reportedly associated with lower serum estradiol and androgen hormone 
concentrations in postmenopausal females, independent of the level of body fatness [60, 
61].  Prior studies examining the association between physical activity and breast cancer 
have considered many issues of methodology specific to this relationship.  Specifically, 
prior research reported little confounding, which is present when a variable is associated 
with both the exposure and the disease, in the relationship between physical activity and 
breast cancer, but reported total caloric intake and BMI may be an effect modifier of the 
activity-breast cancer association, especially in postmenopausal females [55, 59, 62].  
The potential effects of confounding among studies of physical activity and cancer risk 
are further addressed in Chapter II.  The effect of physical activity on breast cancer risk 
reduction through alterations in energy balance and profile of endogenous hormone 
hormones must continue to be considered in order to better understand the role of activity 
in reducing breast cancer risk throughout the lifespan [55]. Also, appropriately measuring 





between various modes, frequencies, intensities, and durations of activity.  Prior research 
reported that highly validated instruments providing complete information on the 
aforementioned four primary components of physical activity are essential for 
epidemiological studies of the relationship between physical activity and breast cancer 
[63].  
 Currently, many breast cancers are diagnosed before the female is symptomatic 
through mammography, and early detection can prevent spreading to axillary lymph 
nodes and metastasis [39]. The American Cancer Society recommends that females aged 
20 years and older begin breast self-examination, while females aged 20-39 years should 
complete a clinical breast examination approximately every three years.  Females aged 40 
years and older should receive both a clinical breast exam and a mammography annually 
[37]. Nearly 60% of females over the age of 40 years receive mammograms, but many 
females remain unscreened due to lack of health insurance [37].  When breast cancer is 
detected via the aforementioned methods pathological reports confirm the need for 
appropriate treatment.  Presently, surgery that preserves as much of the breast as possible 
combined with post-operative radiation therapy and possible chemotherapy or tamoxifen 
is the typical treatment protocol [39].        
 Breast cancer is one of leading cancer-related causes of death among females [8].  
The physiological mechanisms associated with the positive effect of physical activity on 
breast cancer risk remain somewhat unclear compared to that of physical activity and 
colon cancer.  However, consistent activity during the lifespan appears to provide a 





positively impacting some of the hormonal and energy balance mechanisms associated 
with breast cancer risk. 
 
Physical Activity and Cancer Risk 
 In recent years, the association between physical activity and cancer risk has been 
widely published.  Studies have examined the relationship between physical activity and 
a potential reduction in all-cancer risk as well as site-specific cancer risk.  Currently, a 
consistent protective effect from physical activity has only been associated with cancer of 
the colon, and to a lesser extent, cancer of the breast.  While many studies have focused 
on the role of specific quantifications of physical activity in the prevention of these 
cancers, relatively fewer publications have provided specific assessments of physical 
activity and its impact on overall cancer risk.  Comprehensive reviews of the association 
between physical activity and risk of colon and breast cancer are provided later in this 
chapter. 
 
Study Rationale and Broader Impacts 
Currently, there are no recommended optimal amounts of physical activity for 
colon and breast cancer prevention.  Established physical activity guidelines may 
eventually play an important role in disease prevention among high-risk populations.  
While multiple studies have assessed the effect of physical activity on colon and breast 
cancer risk, it can be difficult to synthesize the results from all of these diverse studies, as 
individual studies report different effect measures, energy expenditure amounts, and use 





relationship between physical activity and the risk of colon and breast cancer, it is 
important to develop an overall, approximate estimate of the effect because individual 
studies use different methodologies to assess the relationship between activity and cancer 
risk.  Currently, there is no summary estimate for the effect of physical activity on the 
risk of colon and breast cancer.  
Completion of a meta-analysis of both prospective and retrospective studies 
allows for the development of a quantitative summary estimate from various effect 
measures.  Additionally, including only studies that quantify physical activity using the 
Compendium of Physical Activities allows the summary estimate to be derived from a 
common metric [64].  Results from this project may be important for researchers studying 
the role of physical activity in cancer prevention as well as exercise specialists seeking 
approximate guidelines for prescribing exercise to high-risk patients or clients as part of a 
comprehensive colon or breast cancer prevention program.  Additionally, this project 
may provide a foundation for more uniform and appropriate energy expenditure 
categorizations among future studies utilizing the Compendium to assess the relationship 
between physical activity and cancer, eventually leading to established physical 












       Many studies have examined the association between physical activity and the 
risk of colon and breast cancer.  Each study presents different methodology (e.g. type of 
study, effect measure, participant demographics, measurement and categorization of 
activity, and potential confounding variables studied) and results.  It is useful to develop 
an overall, approximate estimate of published studies examining the potential protective 
effect of physical activity associated with both colon and breast cancer risk using 
combined effect measures derived from individual study effect measures.  The purpose of 
this dissertation is to provide a comprehensive review of the existing study methodology 
to assess potential differences among studies, and to complete a series of meta-analyses 
to provide a quantitative summary of the overall measure of the effects of leisure-time 
physical activity on colon and breast cancer risk.  Overall effect measures will be 
developed for the relationship between leisure-time physical activity and colon cancer 
risk among males and females, and breast cancer risk among pre- and postmenopausal 
females.  The calculated effect measures will help determine whether specific amounts of 
physical activity are associated with the prevention of colon and breast cancer.  Complete 
study criteria for meta-analysis inclusion, as well as methods used to calculate all 






Biological Plausibility for the Relationship between Physical Activity and Colon 
Cancer 
 The relationship between physical activity and a reduced risk of colon cancer is 
‘highly consistent among epidemiologic studies for leisure-time physical activity, 
occupational activity, and total activity’ [15].  While the relationship between physical 
activity and rectal cancer has not been demonstrated, prior research reported that physical 
inactivity is a primary risk factor associated with an increased risk of colon cancer, as 
both case-control and cohort studies reported that higher amounts of physical activity 
were consistently associated with lower colon cancer risk [15].  
It is possible that physical activity provides protection against colon cancer by 
decreasing the amount of time the colonic contents remain in contact with the epithelium, 
however, further research needs to be completed [65]. Bingham and Cummings examined 
the effects of physical activity on large bowel function among 14 previously sedentary 
subjects beginning a physical activity program [21].  The researchers assessed colonic 
function by measuring stool rate and colonic transit time.  It was reported that overall 
colonic transit time increased for nine of the 14 subjects, while it decreased in the 
remaining five, suggesting that this relationship remains unclear.  The researchers 
suggested that physical activity may affect the colon relative to complete inactivity, but 
also reported that variations in normal physical activity encountered in daily life do not 
impact colonic function.  Further studies are necessary to compare the transit time of 
individuals completing activities of daily living to those completing higher amounts of 
leisure-time physical activity in addition to daily living activities.  Holdstock et al. (1978) 





colonic transit time [66].  It should be noted that the purpose of this study was not solely 
to examine the effects of activity on transit time, but rather to compare transit time 
function among individuals suspected of having irritable bowel syndrome.  However, 
when comparing sedentary versus physically active subjects, the active subjects had a 
substantial increase in colonic motility after a meal.   
Higher physical activity is typically associated with lower insulin, glucose, 
triacylglycerol levels, and BMI, all of which may play an important role in countering the 
development of colon cancer [28, 67].  Specifically, elevated serum levels of estrogen, 
testosterone, and insulin levels may be important factors in determining the effect of 
physical activity on colon cancer risk, as prior research reported that elevated serum 
levels of these hormones are associated with a greater risk of neoplastic development in 
the colon and breast [68, 69]. Obese postmenopausal females may be at a higher risk of 
developing both cancers, as increased testosterone leads to greater estrogen conversion in 
the fat cells of such females.  It was also reported that prolonged hyperinsulinemia may 
be associated with colon cancer development, and the effects of physical activity on 
reducing insulin resistance may be important in the prevention of colon cancer [22, 70].      
An established relationship exists between obesity and colon cancer, especially 
among individuals with greater amounts of abdominal adiposity [20, 23].  The reduction 
in body fat that often accompanies higher amounts of physical activity may play a role in 
physical activity’s positive effects on colon cancer prevention.  However, while it has 
been reported that confounding may remain an epidemiologic issue in the relationship 
between physical activity and colon cancer, studies controlling for BMI, diet, and other 





Physical activity appears to have an independent and important role in the 
prevention of colon cancer.  Slattery et al. (2002) evaluated confounding and effect 
modification for physical activity for 1993 cases against 2410 controls [18].  Associations 
between physical activity and colon cancer incidence were examined using responses 
from case-control studies.  No confounding was observed for the physical activity and 
colon cancer association.  However, differences in dietary factors were identified 
depending on the amount of physical activity completed.  The researchers reported that 
their findings were consistent with prior studies not reporting noticeable confounding in 
the relationship between physical activity and colon cancer [19, 23, 25, 65].  Specifically, 
Martinez et al. (1997) reported the association between physical activity and colon cancer 
risk was slightly modified and remained statistically significant after control for other risk 
factors such as age, smoking, family history of colorectal cancer, BMI, red meat intake 
and alcohol consumption (specific findings reported later in this chapter) [23]. 
Additionally, Ballard-Barbash et al. (1990) reported an increased risk of colon cancer 
among sedentary males compared to active males, and reported that all findings remained 
unchanged after adjustment for BMI, height, alcohol, and cholesterol (RR for moderately 
active = 1.4 (95% CI = 0.8-2.6); RR for least active = 1.8 (95% CI = 1.0-3.2)) [25]. 
  
The Effect of Physical Activity on Colon Cancer Risk 
Studies have reported a consistent protective effect of physical activity on colon 
cancer risk for both males and females.  Some of the earliest research examining the 
relationship between physical activity and colon cancer risk reported a protective effect 





physical activity may be most effective against colon cancer has not been established, 
prior studies examining the effects of lifetime occupational activity showed a greater 
protective effect compared to studies examining activity levels over a shorter period of 
time (e.g. 2-3 years prior to diagnosis) [71].  Potter et al. (1993) noted that the protective 
effect of lifetime activity could be because higher amounts of lifetime activity are 
reported, compared to the amounts reported over a shorter time period, or because 
individuals reporting consistent activity may truly be more physically active over the 
course of the lifetime [16].  While the effect of physical activity on site-specific colon 
cancer risk remains unclear, it is well established that physical activity is not associated 
with a reduction in rectal cancer risk [71, 72].  
Additional early studies reported a reduced risk with increased amounts of 
occupational activity for both sexes (OR = 1.6 (95% CI = 0.8-2.9) and RR = 1.3 (95% CI 
= 1.2-1.5) for sedentary occupations versus active occupations among males and females, 
respectively) [72, 73].  A few years later, the effects of both occupational and recreational 
activity on colon cancer risk among both males and females were examined [74].  The 
study included a cohort of 16,477 Swedes born between 1886 and 1925 and subjects were 
followed throughout a 14-year follow-up period from 1969-1982.  Occupational activities 
were classified as ‘sedentary’, ‘moderately active’, and ‘physically demanding’, while 
recreational activity was classified as ‘hardly any exercise’, ‘light exercise’, ‘regular 
exercise’, and ‘hard exercise’.  The RR for individuals with moderately active 
occupations was 1.6 (95% CI = 1.0-2.7) compared with the referent physically 
demanding occupations group.   Furthermore, males with sedentary occupations had an 





activity and increased colon cancer risk was reported for recreational activity as well, as 
individuals with ‘hardly any exercise’ had a RR of 1.3 (95% CI = 0.6-2.6) compared to 
the referent combined group of ‘regular’ and ‘hard’ activity.  Additionally, males 
completing ‘light exercise’ had a reported RR of 1.7 (95% CI = 1.0-2.8).  This study was 
also one of the first to report a lack of an association between physical activity and rectal 
cancer risk, as the RR for individuals completing low amounts of occupational and 
recreational activity were 0.4 (95% CI = 0.1-1.1) and 1.2 (95% CI = 0.7-2.2), 
respectively.  Despite the 95% confidence intervals including a value of 1.0, which 
indicates no association between the exposure and the outcome, it was concluded that 
lower amounts of occupational and recreational activity were associated with an 
increased risk of colon cancer among both males and females. Additionally, the 
researchers hypothesized that the reported relationship was due to the prolonged 
gastrointestinal transit time of the stool in the colon, which would increase the amount of 
contact time between fecal carcinogens and the mucosa [74].   
A few years later, Wu et al. (1987) reported that leisure-time physical activity was 
associated with a reduction in colon cancer risk for both males and females, but was only 
statistically significant among males (p for trend = 0.008) [75].  Specifically, individuals 
active less than one hour per day (4,112 subjects and 14,216 person-years of exposure 
time) were part of the reference group for both sexes.  Males exercising one to two hours 
per day had a RR of 0.89 (95% CI = 0.5-1.6), while females had a RR of 0.72 (95% CI = 
0.4-1.3) among 3,979 subjects and 14,377 person-years for combined sexes.    





0.2-0.8), while similar females had a RR of 0.89 (95% CI = 0.5-1.6) among 3,487 
subjects and 12,747 person-years for combined sexes. 
Both cohort and case-control studies have examined the relationship between 
physical activity and colon cancer risk.  Using the physical activity index from the 
Framingham study, Severson et al. (1989) completed a prospective analysis of physical 
activity and colon cancer risk and reported a statistically significant, inverse relationship 
between activity and colon cancer risk (p for trend = 0.027) [76].  The physical activity 
index is based on multiples of resting activity (which is given a weight of 1.0 in the 
index), and examples include sedentary (e.g. sitting or standing, index weight 1.1), slight 
(slower walking on a level surface, index weight 1.5), moderate (e.g. housework, index 
weight 2.4), and heavy (e.g. shoveling, index weight 5).  The total index scores were then 
divided into tertiles and males in the highest tertile had a RR for colon cancer of 0.71 
(95% CI = 0.51-0.99), while those in the second tertile had a RR of 0.56 (95% CI = 0.39-
0.80) compared to the lowest (first) referent tertile group.   
Whittemore et al. (1990) completed one of the earliest published studies of 
physical activity and colon cancer risk to study energy expenditure (e.g. a MET 
equivalent) and account for the intensities of measured activities[77].  The study 
examined the effects of being sedentary on Chinese individuals residing in the United 
States and China, and reported a statistically significant increase in colon cancer risk 
among individuals reporting 5 to 9 and 10+ hours of sitting compared to less than 5 hours 
of sitting on a daily basis (OR = 2.4 (P < .05) and 3.9 (p < .001), respectively.  When 
Chinese individuals were analyzed according to sex and geographic residence, the effects 





significant among Chinese-American males (p < .001) and females residing in both parts 
of the world (p < .10).  The researchers concluded that a greater duration of exposure to a 
sedentary lifestyle was generally associated with an increased risk of colon cancer 
development for individuals of both sexes residing in America and China [77]. 
Lee and Paffenbarger (1991) examined the effects of physical activity on the risk 
of colon cancer development among cohorts of college alumni [71].  The researchers 
examined 17,607 Harvard alumni aged 30-79 who were followed prospectively for the 
occurrence of colon cancer from 1965 to 1988.  280 of these individuals developed colon 
cancer.  The researchers converted MET values to kilocalories (1 MET is roughly 
equivalent to one kilocalorie per kilogram body weight per hour).  Energy expenditure 
was estimated for each activity by multiplying its MET score by body weight in 
kilograms and hours of participation. Physical activity was self-reported in questionnaires 
and consisted of stair climbing, walking, and sports play.  Alumni who expended more 
than 2,500 kilocalories/week exercising had half the risk of developing colon cancer 
compared to those who expended less than 1,000 kilocalories/week exercising (RR = 
0.19; 95% CI = 0.02-1.52 for >2,500 kcal/wk group versus RR= 0.56, 95% CI=0.29-1.09 
for 1,000 kcal/wk group).  Alumni who expended between 1,000 and 2,500 
kilocalories/week had a reduced risk as well (RR = 0.52; 90% CI = 0.28-0.94).  It was 
concluded that both moderate and high levels of physical activity were effective in 
preventing the development of colon cancer [71].  
A few years later, Longnecker et al. (1995) examined the effects of leisure-time 
physical activity on colon cancer risk among 163 males with colon cancer and 703 





completing activities with an intensity value > 4 METs was considered vigorous.  
Subjects were then categorized into four groups according to average time spent at 
vigorous leisure-time physical activity (0, <1/2, 1, or >2 hours per week).  Males 
exercising vigorously at least 2 hours per week had an odds ratio of 0.60 (95% CI, 0.35-
1.00) compared with the referent sedentary group, while individuals completing one hour 
of vigorous activity per week had an OR of 0.47 (95% CI = 0.16-1.36), and those with a 
half-hour of activity or less had an OR of 0.73 (95% CI = 0.23-2.29).  The researchers 
concluded physical activity is related to a reduced colon cancer risk (p for trend = 0.03). 
Thune et al. (1996) completed one of the earliest studies investigating the effects 
of both recreational and occupational activity on colon cancer risk for both sexes among a 
cohort over 53,000 males and 28,000 females followed over a six-year period [79].  
Females walking or cycling at least four hours per week had a statistically significant 
reduced colon cancer risk (RR = 0.62; 95% CI = 0.40-0.97; p for trend = 0.04), while a 
similar protective effect was reported for males (p for trend = 0.04).  Total activity 
(recreational plus occupational) was also associated with a statistically significant risk 
reduction (p for trend = 0.04), while a non-statistically significant colon cancer risk 
reduction was associated with solely occupational activity.  The researchers reported no 
association between physical activity and rectal cancer among males or females [79]. 
Beginning in the mid 1990’s, some studies examining the relationship between 
physical activity and colon cancer began utilizing the Compendium of Physical Activities 
to determine the quantity of total weekly energy expenditure [80].  Giovannucci et al. 
(1995) completed a prospective cohort study, administering questionnaires about physical 





persons, and colon cancer adenomas were diagnosed among 586 individuals.  This study 
was the first to utilize the Compendium to determine the quantity of energy expenditure.  
The reported time spent at each activity per week was multiplied by its typical energy 
expenditure requirements expressed in METs.  Energy expenditure was reported in 
median MET hours-per-week.  The researchers reported that physical activity was 
independently and inversely associated with risk for colon cancer, as males in the highest 
quintile of physical activity had approximately half the incidence of colon cancer seen in 
males in the lowest quintile of activity (age-adjusted RR = 0.44; 95% CI = 0.27-0.71).  
Also, individuals in the second and third highest energy expenditure quintile had a RR of 
0.67 (95% CI = 0.44-1.02) and 0.83 (95% CI = 0.56-1.23), respectively.  The second 
lowest activity quintile had a RR of 0.73 (95% CI = 0.48-1.10), so any amount of activity 
was effective compared to the referent sedentary group (p for trend = 0.03).  The 
researchers concluded that study results supported a strong inverse association between 
physical activity and the risk of colon cancer [81].   
White et al. (1996) reported a case-control study of 251 male and 193 female 
colon cancer cases diagnosed between 1985-1989 who were compared to 233 male and 
194 female control subjects, respectively [82].  Physical activity was assessed using a 
questionnaire to measure frequency and duration of types of recreational and 
occupational activities over a 10-year period ending 2 years prior to colon cancer 
diagnosis.  Using the Compendium, energy expenditure associated with recreational 
physical activity was categorized into sedentary (0 METs/week; referent group), low 
(<7.30 METS/week), moderate (7.30-17.88 METs/week), and high (!17.88 METs/week) 





0.64 (95% CI = 0.38-1.07), 0.59 (95% CI = 0.37-0.96), and 0.69 (95% CI = 0.42-1.13), p 
for trend = 0.05.  The researchers also classified activity by designating a MET value of 
<4.5 for low intensity activities and !4.5 for moderate to high intensity activities and 
comparing expenditure in total hours per week categorizations of 0 (referent group), <1, 1 
to <2.5, 2.5 to <4, and ! 4 hours per week.  Reported age-adjusted relative risks were 
1.00, 0.74 (95% CI = 0.41-1.33), 0.50 (95% CI = 0.28-0.88), 0.52 (95% CI = 0.29-0.92), 
and 0.79 (95% CI = 0.48-1.29), p for trend = 0.08.  The investigators concluded 
recreational physical activity, but not occupational activity (effect measures not reported 
here), was associated with a reduced risk of colon cancer [82].    
More recently, Martinez et al. (1997) assessed the relationship between leisure-
time physical activity and colon cancer risk among females in a prospective study using 
the cohort from the Nurses’ Health Study [23].  Subjects were administered leisure-time 
physical activity questionnaires and subjects were followed up every two years.  
Reported diagnoses of colon cancer were confirmed by review of hospital records and 
pathology reports.  Using the Compendium of Physical activities, an energy cost 
classification instrument that indexes activities by intensity measured in metabolic 
equivalents (METs), energy expenditure scores were reported in MET hours-per-week.  
Females who completed more than 21 MET-hours per week of leisure time physical 
activity had a lower risk of colon cancer (RR, 0.52, 95% CI = 0.33-0.90; p for trend = 
0.03) compared to the referent group of females who expended less than 2 MET-hours 
per week [80].  A MET unit is the ratio of the activity metabolic rate to the resting 
metabolic rate.  Both the Compendium and METs are further detailed in Chapter II. 





0.65 (95% CI = 0.42-1.07), and those expending 5-10 MET hours-per-week had a RR of 
0.74 (95% CI = 0.50-1.20).  Females with a lower amount of energy expenditure (2-4 
MET hours-per-week) had a RR of 0.69 (95% CI = 0.44-1.15). The researchers 
concluded there was a statistically significant inverse association between leisure-time 
physical activity and colon cancer incidence in females, and that the association was 
consistent with the inverse association typically reported in males.   
Tang et al. (1999) examined the relationship between colon cancer risk and 
physical activity in a relatively small case-control study (42 male cases, 43 male controls; 
27 female cases, 27 female controls) [83].  Using the Compendium to classify light, 
moderate, and heavy activities, leisure-time energy expenditure of both sexes was 
categorized into sedentary (0 MET hours-per-week), moderate (>0 to <20 MET hours-
per-week) and active (!20 MET hours-per-week) [80].  The OR for colon cancer risk 
among highly active males was 0.19 (95% CI = 0.05-0.77) compared to the referent 
sedentary males, while the OR for colon cancer risk among moderately active males was 
2.22 (95% CI = 0.68-7.21); p for trend = 0.03.  In this particular study, no statistically 
significant reduction was found among active females between the ages of 33 and 80, as 
the OR for the highly active females was 0.78 (95% CI = 0.19-3.14), while the OR for the 
moderately active females was 0.79 (95% CI = 0.30-2.08); p for trend = 0.73. 
It should be noted that energy expenditure categories were rather broad (e.g. three 
categorizations with a range of 20 MET hours-per-week in the moderately active group).  
Such a broad range of energy expenditure scores under one category may cause the effect 
measure to be slightly unclear, as higher values in the category may have a more positive 





 While the relationship between physical activity and colon cancer is consistent, it 
is not fully established.  Colbert et al. (2001) reported a greater protective effect of 
moderate to heavy occupational activity on colon cancer risk (RR = 0.45; 95% CI = 0.26-
0.78) compared to leisure-time physical activity (RR = 0.82; 95% CI = 0.59-1.13) [84].  
Also contrary to previous findings was the protective effect of physical activity on rectal 
cancer among individuals completing both light and moderate to heavy occupational 
activity (RR = 0.71; 95% CI = 0.36-1.37 and RR = 0.50; 95% CI = 0.26-0.97; p for trend 
= 0.04), while no statistically significant association was reported between leisure-time 
activity and rectal cancer risk.  It was concluded that occupational physical activity 
provides some degree of protection for both colon and rectal cancers, while leisure-time 
physical activity did not [84].  While these results are consistent with those of most other 
studies, they provide evidence that the relationship between physical activity and colon 
cancer requires further study.  The lack of a statistically significant association between 
leisure-time physical activity and colon cancer supports the similar non-statistically 
significant findings of leisure-time activity and colon cancer reported among a cohort of 
males in the Physicians’ Health Study [85].  Lee et al. (1997) also reported little 
association for various amounts of vigorous physical activity.  Even the most active 
individuals (> 5 hours per week) had a RR of 1.1 (95% CI = 0.8-1.6; p for trend = 0.60) 
compared to the reference group of individuals exercising vigorously less than one hour 
per week.  The researchers suggested the reason their findings did not support other 
studies may be due to an increased likelihood that physically active individuals may be 





 Recent research focused on the association between physical activity and colon 
cancer risk among females [86].  Calton et al. (2006) examined 31,783 females and 
reported 243 colon cancer cases over 270,325 person-years of follow-up.  Inconsistent 
with prior findings, the researchers reported no relationship between increasing amounts 
of physical activity and colon cancer risk.  The authors reported only total physical 
activity in MET hours-per-day, while the quantity of vigorous and moderate leisure-time 
physical activity was reported in hours-per-day without MET values.  Regardless, a 
reference group of 0 hours per day for vigorous activity was established.  Individuals 
exercising between 0.1 and 1.0 hours-per-day had an adjusted RR of 1.10 (95% CI = 
0.85-1.66), while females who were active between 1.1 and 2.0 hours per day had a RR 
of 0.87 (95% CI = 0.59-1.29).  The most active females (>2.1 hours per day) had a RR of 
1.10 (95% CI = 0.78-1.55, p for trend = 0.77).  It was concluded that the results of this 
cohort study did not support prior findings that physical activity is associated with a 
reduced colon cancer risk among females [86]. 
 A recent review of the association of physical activity and colon cancer risk was 
completed and effect measures were pooled in a meta-analysis [87].  Inclusion criteria for 
the 47 studies (worldwide) that were part of the analyses consisted of study design 
(cohort or case-control), exposure (leisure-time activity, occupational activity, or both), 
inclusion of a control (non-exercising) group, and outcomes of colon, rectal, or colorectal 
cancer.  The authors noted that no type of quantitative synthesis of the data could be 
completed due to the large amount of heterogeneity associated with the selection methods 
above.  While the methods of a meta-analysis are further described in Chapter II, it 





except in cases of greater amounts of heterogeneity among the studies, in which case a 
random effect meta-analysis was performed.  Potential examples of heterogeneity include 
the difference in the relationship between physical activity and colon cancer risk 
compared to physical activity and rectal cancer risk, or the difference in the relationship 
between leisure-time activity and cancer risk versus occupational activity and cancer risk.  
The review did not address the role of potential confounding variables in any of the 
analyses.  Despite the high amount of heterogeneity and non-specific inclusion criteria, a 
statistically significant protective effect of physical activity on colon caner risk was still 
reported.  A similar effect was reported for both males and females, and the study 
confirmed prior research that no statistically significant relationship exists between 
physical activity and cancer of the rectum.  The researchers also concluded that future 
studies should focus on biomarkers related to the insulin resistance and hyperinsulinemia 
that is hypothesized to be associated with colon cancer development [87].     
Prior research is consistent for the most part in reporting that physical activity is 
associated with a decreased risk of developing colon cancer.  The most recent study of 
quantifiable physical activity and colon cancer risk for both sexes concluded that 
activities with an intensity of 4.5 METs may be more protective than lighter activities (< 
4.5 METs), but acknowledged the importance of quantifying total activity in MET hours-
per-week when examining a possible protective effect of physical activity [88]. The 
researchers also noted that while the protective effect associated with an optimal 
mode, intensity, duration, and frequency of physical activity throughout an 
individual’s lifetime remains unclear, it is likely to be sex, age, and cancer-site 





combined with lack of knowledge regarding possible biological mechanisms 
operating between physical activity and cancer” [88].  Currently, a small proportion of 
physical activity and colon cancer studies have examined quantity-specific issues such as 






Biological Plausibility for the Relationship between Physical Activity and Breast 
Cancer 
 Many epidemiologic studies report some degree of association between physical 
activity and breast cancer risk [55].  However, this relationship is not as well elucidated 
as the association between physical activity and colon cancer because the biological 
associations between physical activity and breast cancer are likely more complex [44]. 
Much of the breast cancer risk is influenced by reproductive factors throughout the 
woman’s lifespan that are not easily altered, which makes it difficult to assess the 
relationship between breast cancer risk and a lifestyle risk factor such as physical activity 
because of the potential effects of activity on the hormonal profile of a woman 
throughout the lifespan [56]. A variety of biologic mechanisms have been hypothesized 
to link breast cancer with physical activity [57].  While such underlying mechanisms are 
not fully explained, it is widely accepted that moderate to vigorous physical activity is 
reportedly associated with a reduction in breast cancer risk for both premenopausal and 
postmenopausal females [58].  Research primarily has focused on the role of hormonal 
mechanisms, energy balance, and the relationship between the two as key factors 
mediating the relationship between physical activity and breast cancer. 
Typically, the time periods of a woman’s life in which the influence of physical 
activity on breast cancer risk is measured are separated into 1) infancy through menarche, 
2) menarche through first full term pregnancy, 3) first pregnancy through menopause, and 
4) post-menopause[57].  The effects of physical activity likely vary according to a 
woman’s age and reproductive phase.  Specifically, an early age at menarche (before age 





research reporting that the age at menarche is associated with ovarian function for 
females into their 30s [52, 89].  The protective effect associated with late menarche is 
likely related to the lower estradiol concentrations associated with a longer time of 
anovulatory cycles, as higher levels of endogenous steroid production is shown to be 
associated with elevated breast cancer risk [90].  Additionally, it was reported that 
increasing amounts of moderate physical activity were associated with a greater amount 
of anovular menstrual cycles throughout adolescence, even after adjusting for age at 
menarche [91]. Specifically, this potential mechanism for breast cancer prevention was 
more closely related to energy expenditure amounts of greater than 750 kilocalories per 
week, as menstrual cycle length was an average of 2.4 days longer among individuals 
with lower amounts of energy expenditure [91].  Because higher amounts of physical 
activity are associated with a delayed menarche among young girls, this may be an 
important factor in the association between physical activity and a reduction in breast 
cancer risk, as moderate amounts of physical activity may provide a protective effect 
against higher estrogen levels over a longer period of time.  Regarding the association of 
physical activity with hormonal mechanisms related to breast cancer risk, it should be 
noted that prior studies have not considered the relationship between physical activity and 
hormonal levels impacted by oral contraceptive use, especially over the long term.  Such 
oral contraceptive usage is associated with an increased risk of breast cancer and may act 
as a type of hormone replacement therapy and directly counter the beneficial endogenous 
hormone reductions associated with greater amounts of physical activity [57, 92]. 
Physical activity and energy balance play an important role in the optimal 





regulation.  Research reported that the protective effect of physical activity was 
substantial in younger lean females, whose increased levels of activity are associated with 
positive alterations in the hypothalamic-pituitary-ovarian function [62, 93].  However, the 
exact mechanisms leading to a reduction in breast cancer risk remain unknown.   
Increased levels of estrogen that are often a result from a high body mass index 
(BMI) are often found in postmenopausal females.  Additionally, a high BMI is often 
associated with lower levels of physical activity.  Postmenopausal females who meet 
such a description often have higher levels of circulating testosterone, which is a clear 
precursor to elevated levels of circulating estradiol, and therefore have an increased 
breast cancer risk.  Specifically, there is a greater amount of conversion from androgens 
to estrogens, which primarily takes place in the fat cells of postmenopausal females [59]. 
Contrarily, increased levels of physical activity are associated with lower BMI among 
postmenopausal females.  However, increased levels also have been reportedly associated 
with lower serum estradiol and androgen concentrations in postmenopausal females, 
independent of the level of body fatness [60, 61]. 
While energy expenditure in the from of physical activity clearly has some sort of 
mediating effect on breast cancer, an individual’s abnormal energy balance also is 
associated with breast cancer risk, as studies have reported that the presence of mammary 
carcinomas is highly correlated with increased energy intake [94, 95].  If energy intake is 
equal to energy expenditure, energy balance is achieved.  However, the association 
between increased energy intake, obesity, stage of life, hormonal levels, and breast cancer 
risk remains unclear.  For example, a higher BMI associated with increased energy intake 





females, and premenopausal weight gain is largely unrelated to breast cancer 
development [53, 96].  However, the same BMI profile is associated with increased 
breast cancer risk among postmenopausal females, especially among those receiving 
hormone replacement therapy [54, 97].  Such differences can likely be attributed to the 
effect of higher body mass on circulating steroid hormone levels at different times 
throughout the woman’s lifetime.  Specifically, a lower risk for breast cancer among 
females with a higher body mass at a younger age may be associated with higher rates of 
obesity-related anovulation and lower estrogen levels while additional amounts of 
estrogen over a long period of time may be responsible for an increased risk of breast 
cancer among postmenopausal females [97].  This may be a reason that the benefits of 
physical activity are likely greater among postmenopausal females, while the relationship 
between physical activity and premenopausal breast cancer risk remains less clear.  
 
Physical Activity Assessment Methods for Evaluating Breast Cancer Risk 
 Prior studies examining the association between physical activity and breast 
cancer have considered many issues of methodology. Specifically, the effect of physical 
activity on breast cancer risk reduction through alterations in energy balance and profile 
of endogenous hormones must be considered [55].  Also, appropriately measuring and 
reporting all components of the exposure (physical activity) is important, as variability 
can exist between various modes, frequencies, intensities, and durations of activity.  Prior 
research reported that highly validated instruments providing complete information on 
these four primary components of physical activity are essential for epidemiological 





Friedenreich (1998) notes “because the effect of physical activity on breast cancer risk is 
likely to be modest or vary throughout life, measurement of physical activity needs to be 
very accurate to minimize the possibility that an effect will not be observed because of 
measurement error [55]”.  Epidemiological studies assessing the effect of physical 
activity on breast cancer are also limited by missing information on activity quantities 
throughout the lifespan of an individual.   
 Many studies of physical activity and breast cancer have assessed key potential 
confounders, and no studies have reported a confounding of the relationship between 
physical activity and breast cancer to date.  Specifically, while most studies did not 
control for total dietary caloric intake, among those studies that did, there was minimal or 
no confounding of the activity-cancer relationship [43, 62, 98].  However, while no direct 
confounding is present, total caloric intake may act as an effect modifier, as higher 
caloric intake is associated with overweight individuals who are more likely to be 
inactive.  Additionally, obesity may also act as an effect modifier of the relationship 
between physical activity and breast cancer, as it is a risk factor for postmenopausal 
breast cancer that can be reduced by activity [54, 99].   
 Currently, epidemiologic research has not fully addressed the effects of physical 
activity on breast cancer risk in the context of other risk factors.  Specifically, many 
studies have not studied individuals of various body sizes and various hormonal profiles 
throughout the lifespan that would allow for a better understanding of the mechanisms 
mediating the relationship between physical activity and breast cancer risk.  However, 
research reports that the limitation to such a strategy is ensuring appropriate sample sizes 





appropriate interpretation of the relationship between physical activity and breast cancer 
[55]. 
 Ainsworth et al. (1998) evaluated various assessment methods of physical activity 
among studies examining the relationship between activity and breast cancer risk [100]. 
The researchers examined assessment methods of occupational and leisure-time physical 
activity with an activity recall period of one year to lifetime, and assigned a 
summarization quality score to each study.  The authors reported a great degree of 
methodological quality variability among the studies and recommended standardized 
physical activity measurement methods (e.g. uniform activity classification and recall 
time for studies).  The authors also suggested that physical activity be categorized by type 
and intensity measured in MET units.  Intensity classification cut-points could also be 
standardized if MET units are used to classify light (< 3 METs), moderate (3-6 METs) 
and vigorous (>6 METs) activity[100].  In addition to mode and intensity classification, it 
was concluded that future studies should be related to mechanisms mediating the 
relationship between physical activity and breast cancer, such as body mass, hormonal 












The Effect of Physical Activity on Breast Cancer Risk 
Physical activity generally appears to provide some degree of protection from 
breast cancer, although this relationship may be dependent on the physiological factors 
discussed above.  Methodological issues among studies in this area have also contributed 
to the uncertainty in assessing the effect of physical activity on breast cancer risk.     
 An early landmark study that examined the relationship between physical activity 
and breast cancer risk was completed by Thune et al. (1997) [62].  From 1974 to 1978 
and 1977 to 1983, over 25,000 females between the ages of 20 and 54 completed 
questionnaires related to their leisure-time and occupational activity.  After adjusting for 
age, BMI, and other possible confounders, the researchers reported a relative risk (RR) of 
0.63 (95% CI = 0.42-0.95; p for trend = 0.04) among regularly exercising females 
compared to their sedentary counterparts.  Additionally, risk reduction was greater in 
regularly active premenopausal females versus postmenopausal females.  While the effect 
of occupational activity was not as great, the effects of risk reduction were once again 
greater in premenopausal females. 
 While there appears to be a relationship between greater amounts of physical 
activity and reduced breast cancer risk, the relationship is not clearly defined, as some 
prior research did not find an association between leisure-time physical activity and 
breast cancer at any point in the female’s lifespan [32].  This remained true for even the 
most active females (> 4 hours per week or > 18 METs per week).  When activity was 
assessed over the two years prior to the reference date, females with >18 total METs of 
activity per week had an OR of 0.95 compared to females with 0 MET hours-per-week of 





assessed activity among females aged 21 to 45 for two years prior to the reference date 
and between the ages of 12 and 21.  Despite this finding, the overall body of evidence 
suggests that physical activity provides some level of protection against breast cancer.  
Rockhill et al. (1999) reported females completing at least seven hours of moderate or 
vigorous activity per week had a RR of breast cancer of 0.82 (95% CI = 0.70-0.97; p for 
trend = 0.004) compared to females exercising less then one hour per week [101].  Also, 
researchers examining the effects of occupational and leisure-time physical activity on 
breast cancer risk among European females reported odds ratios for the most active 
versus the least active females aged 50-59 years to be 0.68 (95% CI = 0.36-1.28; p = 
0.53) and 0.42 (95% CI = 0.22-0.80; p = .001), respectively[102].  Another European 
study examined the association between physical activity and risk of postmenopausal 
breast carcinoma among 60,000 females age 55-59 in the Netherlands [103].  Females 
reported baseline leisure-time physical activity levels as well as their history of sports 
participation.  It was reported that females who participated in leisure-time physical 
activity sessions of walking, cycling, and gardening had a RR of 0.76 (95% CI = 0.58-
0.99; p for trend = 0.001) for development of a breast carcinoma compared to females 
who participated for less than 30 minutes in the aforementioned activities.  These results 
were independent of BMI, energy intake and weight gain during adulthood.  Furthermore, 
there was little association between sports participation (at any point during the lifespan) 
and breast cancer risk, possibly because any sports participation among these females 
may have been for only a brief part of the lifespan.       
 One of the first studies to assess the effects of physical activity at various points 





was reported that more active females between the ages of 10 and 12 had an OR of 0.68 
(95% CI = 0.49-0.94).  Such effects were also reported for females who became active at 
any given point in the lifespan (OR = 0.70, 95% CI = 0.56-0.88).  Additionally, it was 
reported that females who became active after age 20, even if only becoming consistently 
active in the last five years, had a similar reduction in breast cancer risk compared to 
those who were initially active at a younger age and remained active throughout life.  It 
was concluded that while leisure-time physical activity was associated with a breast 
cancer risk reduction, such a protective effect was not dependent on the point of the 
lifespan in which one became physically active [104].  Furthermore, Dorn et al. (2003) 
examined the affects of physical activity in both pre- and postmenopausal females and 
reported a somewhat protective effect of physical activity (>182 hours per year 
consistently throughout the lifespan, reported as 2, 10, 20 years ago, at age 16, and adult 
lifetime total) within both groups of females.  The researchers concluded that such 
“effects appear strongest … among postmenopausal females who were consistently active 
throughout their lifetime” [105].   
European population-based cohort and case-control studies were published at 
approximately the same time.  The Finnish Adult Behavior Study included over 30,000 
Finnish females aged 15 to 64 years, and examined leisure-time and occupational 
physical activity, and breast cancer incidence annually from 1978 to 1993 [106].  
However, only a minor protective effect of consistent physical activity for breast cancer 
incidence was reported.  Further study of the role of physical activity in breast cancer 
prevention was recommended.  Moradi et al. (2000) examined the association between 





females aged 50-74 (3347 cases and 3455 controls) [107].  This was one of the earlier 
studies examining the specific effects of physical activity on females of postmenopausal 
status.  It was reported that females who were sedentary when they were 25-44 years old 
had a 50% greater risk for developing breast cancer during their postmenopausal years 
versus females with the highest levels of occupational activity. Only females completing 
leisure-time physical activity during their postmenopausal years had a reduction of breast 
cancer risk, and females who had sedentary jobs with no leisure-time physical activity 
had a 300% higher odds of developing breast cancer.  It was concluded “the effects of 
occupational and leisure-time physical activity on breast cancer risk appear to be effect-
modified by reproductive status” [107]. 
 In the United States, one of the first studies examining the effect of long-term 
leisure-time physical activity on breast cancer risk was an analysis of female participants 
of the Epidemiological Follow-up Study (NHEFS) of the first National Health and 
Nutrition Examination Survey (NHANES I) that occurred between 1971 and 1975 [108]. 
At follow-up, the study reported that among females over the age of 50 between 1982 and 
1984, those with higher amounts of leisure-time physical activity had a 67% breast cancer 
risk reduction (RR = 0.33, 95% CI = 0.14-0.82; p for trend = 0.026) compared to their 
sedentary counterparts.  After controlling for increases in adult BMI or weight, the 
association between physical activity and breast cancer was not altered.  Thus, it was 
concluded that higher amounts of leisure-time physical activity throughout the lifespan 
might reduce breast cancer risk in females over age 50 years, independent of the weight 





association was reported between physical activity and breast cancer risk, as active 
females had an RR of 1.19 (95% CI = 0.43 to 3.30; p for trend = 0.732). 
    Many cohort studies have focused on the effects of physical activity on 
postmenopausal breast cancer risk.  One of the first larger studies examined over 37,000 
participants in the Iowa Women’s Health Study [109].  It was reported that 
postmenopausal females with the highest level of physical activity had a slightly reduced 
risk compared to sedentary females (RR = 0.92, 95% CI = 0.80-1.05).  Females reporting 
lesser amounts of activity had a RR of 0.97 (95% CI = 0.87-1.08).  Participants reported 
whether the activity was ‘moderate’ (bowling, golf, light physical exercise, gardening, 
long walks) or ‘vigorous’ (jogging, racket sports, swimming, aerobics, strenuous sports) 
and the frequency as ‘rarely or never’, ‘a few times a year’, ‘a few times a month’, about 
once a week’, ‘two to four times per week’ and ‘more than four times per week’ [109]. 
Researchers concluded that the study did not provide evidence that physical activity 
during postmenopausal years is associated with breast cancer incidence. Sesso et al. 
(1998) also completed one of the earlier studies the effect of activity on postmenopausal 
breast cancer risk as part of the College Alumni Health Study [110].  Compared to the 
sedentary referent group of females expending less than 500 kilocalories per week 
(kcal/wk), the RR of breast cancer was 0.95 (95% CI = 0.58-1.57) for females with an 
energy expenditure of 500-999 kcal/wk after age 55.  The most active females (> 1000 
kcal/wk) had a RR of 0.49 (95% CI = 0.28-0.86; p for trend = 0.015).  No statistically 
significant association was reported between increased amounts of caloric expenditure 
and premenopausal breast cancer risk. Thus, it was concluded that a significant 





premenopausal) breast cancer risk.  Lee et al. (2001) reported a similar association 
between physical activity and breast cancer risk in over 39,000 participants from the 
Women’s Health Study [111].  The researchers assessed the relative risks of breast cancer 
associated with energy expenditures of <840, 840-2519, 2520-6299, and !6300 kilojoules 
per week from a variety of recreational activities including walking or hiking, jogging, 
running, bicycling, aerobic dance, strength exercise machines, flexibility exercises, racket 
sports, and swimming.  Results for postmenopausal females were RRs of 1.0, 0.97 (95% 
CI = 0.68-1.40), 0.78 (95% CI = 0.54-1.10), and 0.67 (95% CI = 0.44-1.0; p for trend = 
0.03), for each of the aforementioned energy expenditure groups, respectively [111].  The 
researchers did not find an association between energy expenditure and physical activity 
for pre- and postmenopausal females combined, but did report that higher levels of 
activity may decrease postmenopausal breast cancer risk.  
 Steindorf et al. (2003) completed a case-control study that examined the effects of 
physical activity on premenopausal breast cancer risk [112].  Females were placed into 
quartiles of physical activity in total (as opposed to only leisure-time) MET hours-per-
week.  The researchers compared each of the three higher quartiles with the referent 
lowest quartile group, and reported an inconsistent pattern of results, as odds ratios of the 
three quartiles (in increasing order) were 0.97 (95% CI = 0.68-1.38), 0.68 (95% CI = 
0.46-0.99), and 0.94 (95% CI = 0.65-1.35), respectively for females exercising between 
the ages of 12 and 30 (p for trend = 0.29).  The researchers concluded that while physical 
activity may be associated with somewhat of a breast cancer risk reduction among 






The Effect of Compendium-Quantified Leisure-Time Physical Activity on Breast 
Cancer Risk 
 In 1999, researchers began assessing the effects of physical activity on both pre- 
and postmenopausal breast cancer risk using the Compendium of Physical Activities, 
which was published a few years earlier [80].  A complete description of the methods and 
attributes associated with the Compendium can be found in Chapter II.  Using the 
Compendium, researchers were able to ask study participants about their types of activity 
and estimated the intensity (METs), duration (hours, or in the case of one study, minutes 
that could be converted to hours), and overall quantification of weekly energy 
expenditure (MET-hours per week).   
 Many Compendium-quantified studies of physical activity and breast cancer risk 
have focused on postmenopausal females.  Carpenter et al. (1999) investigated the effects 
of lifetime physical activity on breast cancer risk among females of Los Angeles County, 
California [113].  Subjects were Caucasian or Hispanic and between the age of 55 and 64.  
A total of 1123 cases and 904 controls were included as part of this case-control study.  
Females who engaged in activity levels of 0.1 to 17.59 MET-hours per week had an OR 
of 0.88 (95% CI = 0.72-1.07).  Females with a higher energy expenditure of at least 17.6 
MET hours-per-week had an OR of 0.55 (95% CI = 0.37-0.83; p for trend = 0.01).
 McTiernan et al. (2003) completed a prospective cohort study of 74,171 
postmenopausal females between the ages of 50 and 79 years with a mean follow-up time 
of 4.7 years [114].  A majority of the cohort consisted of Caucasian females, but 
approximately 15% of females were of minority races including African-American, 





five-year period.  The referent group consisted of females who did not complete any 
leisure-time activity.  Compared to the referent group, females completing between 0.1 
and 5 MET hours-per-week had a RR of 0.90 (95% CI = 0.77-1.07), and females 
completing 5.1-10 MET hours-per-week had a RR of 0.82 (95% CI = 0.68-0.97).  
Females with a moderate amount of physical activity had similar RRs (0.89 (95% CI = 
0.76-1.00); 10.1-20 MET hours-per-week and 0.83 (95% CI = 0.70-0.98); 20.1-40 MET 
hours-per-week).  The most active postmenopausal females (> 40 MET hours-per-week) 
had a RR of 0.78 (95% CI = 0.62-1.00; p for trend = 0.03).  The researchers concluded 
that increased amounts of physical activity are associated with postmenopausal breast 
cancer risk reduction.  It was also concluded that the total amount of weekly energy 
expenditure is more associated with risk reduction than merely completing higher-
intensity exercises of shorter duration [114]. 
 Another study of postmenopausal females during the same year reported a similar 
association between physical activity and breast cancer risk reduction.  Patel et al. (2003) 
collected information on the physical activity patterns over a five-year span (1992-1997) 
of over 72,000 postmenopausal females [115].  The referent group was females who 
completed only 0.1 to 7.0 MET hours-per-week of activity.  Compared to the referent 
group, females with both an energy expenditure of 7.0 to 17.5 and 17.5 to 31.5 MET 
hours-per-week had an age-adjusted RR of 0.92 (95% CI = 0.81-1.04) and 0.94 (95% CI 
= 0.81-1.09) respectively, while those completing a total of 31.5 to 42.0 MET hours-per-
week had a RR of 0.77 (95% CI = 0.56-1.06).  The most active postmenopausal females 





trend = 0.08).  Overall, results showed a similar association between physical activity and 
postmenopausal breast cancer risk as in other studies.    
 Friedenreich et al. (2001) were the authors of the first study assessing the effect of 
Compendium-quantified physical activity on the breast cancer risk of both premenopausal 
and postmenopausal females in separate analyses [116].  The researchers completed a 
population-based case-control study consisting of 1,233 cases and 1,237 controls.  More 
specifically, 462 breast cancer cases and 475 controls among premenopausal females 
were included in an analysis of the effects of lifetime recreational activity on breast 
cancer risk.  Females exercising between 0 and 6.7 MET hours-per-week were included 
in the referent group, and those expending energy of 6.7 to 11.79 MET hours-per-week 
had an OR of 0.81 (95% CI = 0.55-1.19).  Additionally, more active females expending 
between 11.8 and 20.69 MET hours-per-week had an age-adjusted OR of 1.03 (95% CI = 
0.70-1.52), while the most active premenopausal females also had an OR of 1.13 (95% CI 
= 0.77-1.66; P value for trend = 0.22).  Thus, the researchers reported that there was no 
relationship between recreational activity and breast cancer risk among premenopausal 
females.  A separate analysis was completed for postmenopausal females (771 breast 
cancer cases and 762 controls).  For this group of females, the referent group was those 
completing activity of 0 to 5.09 MET hours-per-week.  Females expending between 5.1 
and 9.39 MET hours-per-week had an OR of 0.96 (95% CI = 0.71-1.28) compared to the 
referent group, while those with an energy expenditure of 9.4 to 16.89 MET hours-per-
week had an OR of 0.88 (95% CI = 0.65-1.19), and the most active postmenopausal 
females had an OR of 1.10 (95% CI = 0.82-1.47; P value for trend = 0.33).  Friedenreich 





breast cancer risk reduction among postmenopausal females (a non-statistically 
significant trend existed) and that only total lifetime activity reduced the risk of breast 
cancer among postmenopausal females [116].  The researchers also concluded that total 
lifetime activity (recreational plus occupational and household) was associated with a 
breast cancer risk reduction in postmenopausal females only.  Details on the association 
between occupational physical activity and breast cancer risk are discussed later in this 
chapter. 
 Matthews et al. (2003) also examined the effect of physical activity on both pre- 
and postmenopausal females (combined in one analysis), as part of the Shanghai Breast 
Cancer Study that included Chinese residents of urban Shanghai [117].  Recreational 
physical activity amounts over the last ten years were measured for 1,459 breast cancer 
cases and 1,553 age-matched controls.  The study quantified physical activity using the 
Compendium in MET hours-per-day, and this was converted to MET hours-per-week for 
the purpose of the present meta-analysis.  Females completing no exercise were part of 
the referent group, and those with an expenditure of 0.01-0.35 MET hours-per-day 
(equivalent to 0.1 to 2.45 MET hours-per-week) had an OR of 0.56 (95% CI = 0.39-
0.80), while those expending between 0.36 and 0.88 MET hours-per-day per year 
(equivalent to 2.46 to 6.16 MET hours-per-week per year) had an OR of 0.80 (95% CI = 
0.60-1.07).  Females completing greater amounts of physical activity (0.89-1.91 MET 
hours-per-day, equivalent to 6.23 to 13.37 MET hours-per-week), had an OR of 0.66 
(95% CI = 0.48-0.91), while the most active females expending more than 1.92 MET 
hours-per-day (equivalent to >13.37 MET hours-per-week) had the lowest OR of 0.40 





“demonstrate that consistently high activity levels throughout life reduce breast cancer 
risk” [117]. The researchers also examined the effect of lifetime occupational activity on 
breast cancer risk, and those results are discussed near the end of this chapter.         
 A few other studies have examined the effects of physical activity on pre- and 
postmenopausal females in a combined analysis.  Yang et al. (2003) completed a 
population-based case-control study in Los Angeles County (the same area where 
Carpenter et al. conducted their study).  This was one of the few U.S. based studies on a 
sample of females that was not primarily Caucasian [118].  The study included 501 
Asian-American breast cancer cases and 594 Asian-American controls.  After adjusting 
for menopausal status and establishing a referent group that included females who did not 
complete any physical activity, the researchers reported a statistically significant risk 
reduction of breast cancer risk with increasing amounts of lifetime recreational physical 
activity (p for trend <0.001).  Females who logged activity amounts of 0.1 to 3 MET 
hours-per-week had an OR of 0.91 (95% CI = 0.55-1.49), while those expending between 
3 and 6 MET hours-per-week had a significantly reduced OR of 0.65 (95% CI = 0.39-
1.10).  This inverse relationship between activity and risk was further identified among 
females expending between 6 and 12 MET hours-per-week, as their OR was 0.53 (95% 
CI = 0.31-0.90).  The most active females with an energy expenditure of > 12 MET 
hours-per-week had the lowest odds of developing breast cancer, as their OR was 0.47 
(95% CI = 0.28-0.80).  The relationship between physical activity and breast cancer risk 
appears to be independent of race, as similar results among samples of different races 
have been reported [118].  Patel et al. (2003) completed another study of breast cancer 





opposed to Asian females [119].  Pre- and postmenopausal females were combined in the 
analysis, and the referent group included females with no recreational energy 
expenditure. After adjusting for menopausal status, females expending between 0.01 and 
3.0 MET hours-per-week had an OR of 0.70 (95% CI = 0.48-1.03) compared to the 
referent group.  Females completing between 3.01 and 8.0, and 8.01 and 16.0 had a 
reported OR of 0.65 (95% CI = 0.44-0.96) and 0.61 (95% CI = 0.41-0.92), respectively.  
However, the two most active groups (16.01 to 32.0 and >32.0 MET hours-per-week) had 
slightly higher relative odds of breast cancer development (OR = 0.63, 95% CI = 0.40-
0.98; OR = 0.65, 95% CI = 0.39-1.08, respectively).  The P trend for the physically active 
was a non-statistically significant 0.81, and the researchers concluded that physical 
activity may provide a risk modification for breast cancer, but the relationship remains 
unclear. 
More recently, the impact of lifetime recreational activity on breast cancer risk 
was assessed by Bernstein et al. (2005) [120].  This study included both black and White 
females in a pre- and postmenopausal combined analysis.  Females who were completely 
sedentary (zero MET hours-per-week) were considered the referent group, and minimal 
risk reduction was reported among females exercising between 0.1 and 2.2 MET hours-
per-week and 2.3 to 6.6 MET hours-per-week (OR = 0.95, 95% CI = 0.84-1.08 and OR = 
0.92, 95% CI = 0.81-1.04, respectively).  Females engaging in activity equivalent to 6.7 
to 15.1 MET hours-per-week had a slightly lower risk of breast cancer development (OR 
= 0.87, 95% CI = 0.77-0.99), while females expending the most energy per week (at least 
15.2 MET hours-per-week) had the lowest OR (0.85, 95% CI = 0.75-0.97; p for trend = 





reduction were reported between Black and White females, and the researchers reported a 
consistently inverse relationship between physical activity and breast cancer risk for 
females of both races.  
 While Bernstein studied the effects of physical activity on pre- and 
postmenopausal females combined, John et al. (2003) was one of two studies (the other 
was Friedenreich et al., 2001) that examined the effect of Compendium-quantified 
activity on breast cancer risk for pre- and postmenopausal females in separate analyses 
[121].  John et al. completed a population-based case-control study of White, black, and 
Latina females in the San Francisco Bay Area Breast Cancer Study.  Breast cancer cases 
were confirmed between 1995 and 1998, and the study included 403 premenopausal 
breast cancer cases, 483 premenopausal controls, 847 postmenopausal cases, and 1065 
postmenopausal controls.  The established referent groups were different for pre- and 
postmenopausal females, and in general, differed from most other studies.  All females 
expending 0 to 6.8 MET hours-per-week were considered part of the referent group, and 
females in the 6.9 to 16.6 MET hours-per-week category had an OR of 0.94 (95% CI = 
0.69-1.29) compared to the referent group.  The most active females whose energy 
expenditure was at least 16.7 MET hours-per-week were nearly half as likely to develop 
breast cancer (OR = 0.56, 95% CI = 0.46-0.96).  A separate analysis not included in the 
present meta-analysis was completed for more vigorous physical activity, and the 
investigators reported similar risk reductions for moderate and vigorous activities.  This 
supports earlier findings that one’s total energy expenditure is more important than the 
intensity of completed activities [121]. Additionally, it is important to note that risk 





premenopausal females relative to their postmenopausal counterparts.  Such a finding is 
inconsistent with much of the other literature that supports a greater effect of activity on 
postmenopausal breast cancer risk.   
 Colditz et al. (2003) completed the only study specifically assessing the 
relationship between Compendium-quantified physical activity and premenopausal breast 
cancer risk, analyzing data from the Nurses’ Health Study II [122].  Over a 10-year 
follow-up period of 934,100 person-years (questionnaires sent out every two years), 849 
premenopausal breast cancer cases were identified.  This study is essentially an extension 
of the Rockhill et al. study discussed earlier in the chapter that also used the Nurses 
Health Study II dataset, but only analyzed recent physical activity amounts, as opposed to 
10-years of follow-up, which allowed for an additional 477 cases and thousands of 
additional person-years [101].  Females exercising between 0 and 3 MET hours-per-week 
were included in the referent group.  There was no statistically significant reduction in 
risk among females at any exercise level, as the adjusted RR for females was 1.05 (95% 
CI = 0.82-1.34), 0.96 (95% CI = 0.75-1.23), 1.05 (95% CI = 0.80-1.37), and 1.07 (95% 
CI = 0.84-1.36) for energy expenditures of 3-8.9, 9-17.9, 18-26.9 and >26.9 MET hours-
per-week, respectively.  The p-value for the trend was a non-statistically significant 0.69 
and it was concluded “no overall association between physical activity and risk of breast 
cancer among premenopausal women”, but suggested the effects of physical activity on 
adiposity in these females required further research [122]. 
 One study that did not use multiple MET hours-per-week categorizations also 
examined the relationship between physical activity and breast cancer risk [123].  A study 





and 74 in New Mexico examined the effects of physical activity on breast cancer risk.  
Analyses were conducted separately for each race and menopausal status.  It should be 
noted that energy expenditure categories were not very specific, as the only quantities 
were 0, 1-25 and >25 MET hours-per-week.  This may have been responsible for the 
large risk reduction differences seen between races in the pre- and postmenopausal risk 
analyses.    Regardless of race or menopausal status, 0 was considered the referent group.  
Premenopausal Hispanic females expending 1-25 MET hours-per-week had an OR of 
0.50 (95% CI = 0.26-0.97) compared to the referent group, while the most active females 
had an OR of 0.17 (95% CI = 0.08-0.36; p for trend < 0.001).  Premenopausal White 
females expending 1-25 MET hours-per-week had an OR of 0.68 (95% CI = 0.32-1.42), 
while those expending >25 MET hours-per week had an OR of 0.85 (95% CI = 0.40-
1.79; p for trend = 0.834).  Postmenopausal Hispanic females expending between 1 and 
25 MET hours-per-week had an OR of 0.65 (95% CI = 0.38-1.10), while those who were 
more active had an OR of 0.52 (95% CI = 0.29-0.93; p for trend = 0.028).  Finally, 
postmenopausal White females expending 1-25 MET hours-per-week had an OR of 0.58 
(95% CI = 0.35-0.97), while those expending > 25 MET hours-per-week had an OR of 
0.50 (95% CI = 0.30-0.84; p for trend = 0.010).  A statistically significant interaction 
with ethnicity was reported among premenopausal females [123].  However, there is no 
current explanation for such a disparity. 
 
The Effects of Occupational Physical Activity on Breast Cancer Risk  
 Several research studies have assessed the effect of occupational physical activity 





using the Compendium and simply report a few occupational activities such as walking, 
lifting, and heavy manual labor. Thune et al. (1997) administered an occupational activity 
questionnaire to 25,624 females and examined their risk for breast cancer[62]. 
Postmenopausal females who were consistently active at work had a RR of 0.78 (95% CI 
= 0.52-1.18; p for trend = 0.24) compared to their moderately active counterparts (RR = 
0.87, 95% CI = 0.61-1.24).  Occupational physical activity provided a similar protective 
effect among highly active and moderately active postmenopausal females and 
comparable premenopausal females (RR = 0.82, 95% CI = 0.50-1.34; RR = 0.48, 95% CI 
= 0.24 to 0.95, respectively; p for trend = 0 .03).  The researchers concluded occupational 
physical activity was associated with a reduction in breast cancer risk, especially among 
premenopausal females.   
Levi et al. (1999) did not specifically utilize the Compendium, but analyzed a 
Swiss dataset of females and assigned grades of physical activity using activities that 
could be accessed in the Compendium [102].  Occupational activity was categorized as 1 
to 3, with 3 being the highest amount of occupational activities including walking and 
manual labor.  The most active females aged 50-59 years had an OR of 0.69 (95% CI = 
0.38-1.24) compared to moderately active females (OR = 0.64, 95% CI = 0.36-1.14) and 
the referent sedentary group.  Additionally, highly active females between the ages of 30 
and 39 had an OR of 0.53 (95% CI = 0.29-0.96), while moderately active females had an 
OR of 0.50 (95% CI = 0.27-0.94) compared to sedentary females.  Consistent with prior 
research, no additional protective effect of occupational physical activity was identified 





this study were similar for leisure-time and occupational activity, however such a finding 
may be associated with an overestimation of physical activity while at work.    
 More recently, two studies examined the association between occupational 
activity and breast cancer using the Compendium [116, 117].  Friedenreich et al. (2003) 
reported an OR of 0.90 (95% CI = 0.61-1.34; p for trend = 0.94) for premenopausal 
females expending at least 61.2 MET hours-per-week per year, while less active groups 
(47.5-61.19 and 35.0-47.49 MET hours-per-week per year) had a respective OR of 0.67 
(95% CI = 0.45-1.00) and 0.76 (95% CI = 0.51-1.11) compared to the referent group of 
0-34.99 MET hours-per-week per year.  Consistent with some other Compendium-
quantified studies of leisure-time physical activity, no statistically significant relationship 
was noted between increasing amounts of physical activity and premenopausal breast 
cancer risk.  However, a statistically significant association was reported between higher 
amounts of activity and postmenopausal breast cancer risk, as females expending greater 
than 61.8 MET-hours-per-week per year had an OR of 0.59 (95% CI = 0.44-0.81; p for 
trend = 0.003).  While the OR was slightly higher (0.67; 95% CI = 0.49-0.92) for females 
expending 43.6-61.79 MET hours-per-week per year, the OR for those expending 26.2-
43.59 was 0.77 (95% CI = 0.57-1.03).  Each OR was compared to the referent group 
which consisted of an expenditure of 0-26.19 MET hours-per-week per year.  The 
researchers concluded that higher amounts of occupational activity were associated with 
a notable breast cancer risk reduction among postmenopausal females.  Matthews et al. 
(2001) also concluded that lifetime occupational activity was associated with a reduction 
in breast cancer risk [117].  Using job-code classifications that were divided into quintiles 





activity), physical activity was quantified in MET hours-per-day per year using the 
Compendium.  Females with the highest amount of activity (and least amount of sitting 
time) on the job had an age-adjusted OR of 0.81 (95% CI = 0.63 to 1.04; p for trend 
<0.01) compared to the referent group with the lowest amount of job-related activity (and 
greatest amount of sitting time). Notably, Q2 and Q3 had an OR of 0.82 (95% CI = 0.66-
1.03) and 0.84 (95% CI = 0.67-1.06), respectively.  While this study did not adjust for 
menopausal status, Q4 had an OR of 1.10 (95% CI = 0.88-1.38), indicating that a 
somewhat linear inverse relationship existed between lifetime occupational activity level 
and breast cancer risk.   
Most recently, Kruk et al. (2003) completed an analysis of occupational activity 
and breast cancer risk by categorizing 257 breast cancer cases and 565 controls into 
sedentary (<2 METS), light (2-3 METS), and moderate (>3 METS) job activity classes 
[124].  The moderate group actually consisted of females with an activity amount of 3-6 
METS, as no woman reported having a job with high physical demands (!6 METS).  
There was no difference between the sedentary, light, and moderate activity groups in 
females younger than age 55.  However, for females over the age of 55, compared to the 
sedentary reference group, the light activity group had an OR of 0.51 (95% CI = 0.28-
0.95), while the moderate activity group had an OR of 0.49 (95% CI = 0.25-0.94).  The 
authors concluded that increased amounts of occupational activity were only statistically 
significantly associated a lower breast cancer risk (p for trend = 0.03) among females 
over the age of 55.  While the researchers did not adjust for menopausal status, the odds 
ratio trend associated with age suggests that occupational activity, much like leisure-time 





Summary of the Relationship between Physical Activity and Breast Cancer Risk 
 Studies examining the effect of physical activity on breast cancer risk are 
numerous and diverse.  In addition to evaluating the key methodological differences that 
exist among the studies of physical activity and breast cancer risk, an approximate overall 
estimate from these studies would allow for the synthesis and summary of data from 
studies in this research area.  This is important because there is not a consensus on the 
effect of activity on breast cancer risk, even among females of the same menopausal 
status.  Additionally, many of the studies described above employ different methodology, 
and only studies quantifying and measuring physical activity according to the 
methodological criteria outlined in Chapter II were included in the present meta-analyses.  
While these meta-analyses will not contain all the studies in this research area, the 
summarized effect measures of studies employing the most specific quantifications of 
physical activity using the Compendium will provide an approximate quantitative 
summary that allows for further understanding of the association between physical 





Summary of Project Rationale 
 
There is a large and rich body of research into the effects of physical activity on 
the risk of colon and breast cancer.  However, there is much heterogeneity across studies, 
with differences in terms of the type of study, the ethnicity and geographic location of the 
populations included, the instrumentation used to assess physical activity, and the time 
periods and total amount of time for which physical activity was measured.  Additionally, 
differences in the categorization of ‘low’, ‘moderate’, and ‘high’ activity and the types of 
confounding variables that were included in the analyses were present.  Currently, there 
are no summary estimates that assess the effect of leisure-time physical activity on colon 
and breast cancer risk.  A comprehensive analysis that provides a critique of study 
methodologies and a synthesis of results will help to assess the current state of the 

























Chapter II  
Methods 
 
Overview of Methods 
 The first part of this dissertation critiques the methodology of the published 
studies of the relationship between leisure-time physical activity and the risk of colon and 
breast cancer, to put the current evidence in context.  Summaries were provided of the 
types of studies (cohort vs. case-control), effect measures used, ethnicity and geographic 
location of study participants, and the potential confounding factors included in each 
study.  Additionally, aspects of physical activity assessment were compared, including 
the time period for which physical activity was measured, the instrumentation used to 
assess the type and amount of activity, and the categorization of activity intensity.  
 The second part of this dissertation included a series of meta-analyses that provide 
a quantitative estimate across studies of the relationship between leisure-time physical 
activity and the risk of colon and breast cancer.  The use of a meta-analysis allowed for 
the combination of results from studies to address the specific study hypotheses described 
on the next page. 
 Sutton et al. describe a meta-analysis as a quantitative summary of relevant 
studies, with a final selection based on clearly stated criteria [125].  The inclusion criteria 
for studies in each of the meta-analyses are discussed later in this chapter, when each of 








Study Questions and Hypotheses 
The present meta-analyses utilized Compendium-quantified or Compendium--
estimated studies of physical activity and cancer of the colon or breast to develop a 
quantitative summary estimate of the effect of physical activity on risk for these cancers.  
Unadjusted effect measures and confidence intervals from these studies were calculated 
and were used in the analyses.  Results from these analyses addressed the following 
research questions: 
 
Question One:  Is there an association between higher amounts of physical activity 
and a reduction in colon cancer risk in males?  
H0: There is no association between higher levels of physical activity and colon cancer 
risk in males  
HA: There is an association between higher levels of physical activity and colon cancer 
risk in males
 
Question Two:  Is there an association between higher amounts of physical activity 
and a reduction in colon cancer risk in females?  
H0: There is no association between higher levels of physical activity and colon cancer 
risk in females
HA: There is an association between higher levels of physical activity and colon cancer 









Question Three:  Is there an association between higher amounts of physical 
activity and a reduction in breast cancer risk among combined pre- and 
postmenopausal females?   
H0: There is no association between higher levels of physical activity and breast cancer 
risk among combined pre- and postmenopausal females 
HA: There is an association between higher levels of physical activity and breast cancer 
risk among combined pre- and postmenopausal females 
 
Question Four: Is there an association between higher amounts of physical activity 
and a reduction in breast cancer risk among premenopausal females? 
H0: There is no association between higher levels of physical activity and breast cancer 
risk among premenopausal females 
HA: There is an association between higher levels of physical activity and breast cancer 
risk among premenopausal females 
 
Question Five:  Is there an association between higher amounts of physical activity 
and a reduction in breast cancer risk among postmenopausal females?   
H0: There is no association between higher levels of physical activity and breast cancer 
risk among postmenopausal females 
HA: There is an association between higher levels of physical activity and breast cancer 








Q1 was addressed through meta-analyses of colon cancer risk for males, while 
Q2 was addressed through meta-analyses of colon cancer risk for females.  Q3 was 
addressed through meta-analyses of breast cancer risk for pre- and postmenopausal 
females combined.  Q4 was addressed through meta-analyses of breast cancer risk for 
premenopausal females, while Q5 was addressed through meta-analyses of breast cancer 
risk for postmenopausal females.   
 
Methodological Differences between Studies 
The overall methodological differences among studies included in the meta-
analyses were assessed.  Specifically, characteristics of study participants, selection 
criteria of study participants, and time frame for case diagnoses and selection of controls 
were included in Tables 3-5 for colon cancer studies and Tables 6-8 for breast cancer 
studies.  Also, the measurement of physical activity (length of time physical activity was 
measured, categorizations of quantified physical activity) and instrumentation used to 
record modes of physical activity were compared for each study. 
 
Confounding 
The issues of confounding and the use of unadjusted effect measures in the meta-
analyses were addressed by comparing the unadjusted measures to the age-adjusted and 
multivariate-adjusted effect measures to determine if any major differences existed.  
Unadjusted and adjusted effect measures for each level of physical activity 
quantification (i.e. each level of MET hours-per-week) were compared for the moderate 







by calculating the percent difference between the unadjusted and adjusted effect 
measures for each activity level.  A list of factors adjusted for in each study is included 
in a series of tables at the end of Chapter III.  
The meta-analyses combine a number of different studies, each of which adjusts 
for a number of different possible confounding variables.  In order to combine these 
studies without the availability of raw data, unadjusted measures were calculated.  The 
possible effects of confounding variables that may cause a potential bias among the study 
results, either by over- or underestimating the effects of physical activity on colon cancer 
risk, were addressed by calculating the percent differences between the adjusted and 
unadjusted effect measures using the formula shown below:  
  
% Difference in Unadjusted Effect measure vs. Adjusted Effect measure = 
100*[(Unadjusted Effect measure – Adjusted Effect measure) / Adjusted Effect measure]  
 
 
Because it is important to determine if a potential decrease in colon cancer risk is 
associated with higher amounts of physical activity, a higher odds ratio estimate actually 
means less of an effect.  For example, an odds ratio of 0.90 shows less of an activity 
effect than an odds ratio of 0.80 because 0.90 is closer to the no-effect level of 1.0.  An 
unadjusted measure that is consistently lower or higher than the adjusted measure is one 
potential indication of bias in the results.  When comparisons are calculated for all 
studies, it can be determined whether the unadjusted effect measures were likely to over- 








Definition of Meta-Analysis 
A meta-analysis is a quantitative summary of a number of study results [125].  It 
is a compilation of relevant studies, following a comprehensive search for all potentially 
relevant studies, with a final selection of studies based on clearly stated criteria.  The 
utilization of a meta-analysis allows for the combination of several studies in order to 
answer relevant hypotheses through the combination of smaller studies and sample sizes.  
The dependent variable in a meta-analysis is the effect size [125] (in this case, the effect 
measure reporting the relationship between physical activity and cancer risk).  Because 
physical activity has previously been reported to be an independent predictor of female 
breast cancer risk and combined male and female colon cancer risk, a primary goal of this 
meta-analysis was to quantify the effect of leisure-time physical activity on risk of these 
two cancers [18, 57]. 
      Cohort studies and case-control studies were included in the meta-analyses.  
Cohort studies typically include large subsets of a defined population followed over a 
long period of time for which individuals were identified as either exposed or not 
exposed to a risk factor (e.g. physical activity) hypothesized to influence occurrence of a 
given disease (e.g. breast or colon cancer) [126]. Case-control studies observe individuals 
having a given disease (e.g. breast or colon cancer) and a comparable group of persons 
without the disease (controls).  The past history of exposure to a risk factor such as 
physical activity is then compared between the two study groups [126].   
The meta-analyses were carried out separately for colon and breast cancer risk, 
with both groups of analyses using the following study criteria.  Studies examining the 







meta-analysis in order to prevent any results due to a potential confounding relationship 
between physical activity and diet from being included in the analysis.  Additionally, 
only studies that used the Compendium of Physical Activities to assign MET-scores to 
physical activities were included in the primary meta-analyses to ensure comparability in 
the quantification of physical activity assessment across all included studies [64].  Studies 
merely quantifying physical activity in terms of ‘low’, ‘moderate’, and ‘high’ without 
sufficient numerical quantification were excluded.  Although most studies included in the 
meta-analyses reported physical activity in MET-hours-per-week, additional studies that 
reported either a MET value or number of activity hours per week along with examples 
of specific completed activities allowed for a translation into MET hours-per-week, and 
were also included in some meta-analyses.  The method of estimating MET hours per 
week based on partial reports of physical activity is described in further detail later in this 
chapter.    
 
Compendium of Physical Activities 
 The Compendium of Physical Activities, originally published by Ainsworth et al. 
in 1993, was most recently revised in 2000 [64, 80].  The purpose of the Compendium is 
to “facilitate the coding of physical activity intensities obtained from physical activity 
records, logs, and surveys and to promote comparison of coded physical activity levels 
across observational studies” [64].  It is a widely used method for quantifying physical 
activity for epidemiological studies, and groups activities by intensities expressed as 
metabolic equivalents (METs), which are the ratio of working metabolic rate to the 







comprehensive classification of energy costs for a multitude of leisure-time, 
occupational, household, and self-care human physical activities.  Additionally, the 
coding of specific MET values allows for physical activity to be determined over a given 
time period (e.g. MET hours-per-week).      
 Activities are included in the Compendium as multiples of RMR and coded using 
a five digit coding sequence for the classification of physical activity.  The first two digits 
display the purpose of the activity, while the last three numbers are representative of the 
specific activity. Additionally, a specific MET intensity value for each activity is 
reported.  While the Compendium remains the most widely-used source of quantifying 
physical activity when completing occupational studies, research reports that the 
Compendium may underestimate the cost of energy cost of weight-bearing activities and 
overestimate the actual energy cost of non-weight-bearing activities among heavier 
individuals [127].  
 The inclusion of Compendium-quantified studies in an analysis allows for the 
consistent utilization of a physical activity instrument that is considered to be appropriate 
for quantifying physical activity in observational studies.  Examples of common activities 
among colon and breast cancer studies that are listed in the Compendium include 
recreational walking (4.0 METs), brisk walking (8.0 METs), jogging (7.0 METs), fast 
jogging (8.0-18.0 METs, depending on speed), stationary bicycling (7.0 METs) and 










Inclusion Criteria for Meta-Analyses 
 A comprehensive review of international literature in the English language was 
completed using the Cochrane, Embase, and Medline (PubMed) library databases, as well 
as the Proquest periodical database.  Studies in which MET hours-per-week could be 
directly calculated using the Compendium were included in the primary meta-analyses.  
No other physical activity quantification instrumentation was included.   
However, some studies provided partial information allowing for approximate 
quantification using the Compendium.  Specifically, some studies reported either the total 
METs or the total amount of weekly activity (typically in hours-per-week), along with a 
detailed description of the activity type.  These studies allowed for the MET value or 
hours-per-week to be estimated, to quantify indirectly the amount of completed activity 
in MET hours-per-week using the Compendium.  The estimated studies were combined 
with Compendium-quantified studies in larger, secondary analyses to provide additional 
assessment of the relationship between physical activity and cancer risk among a greater 
number of individuals.  It should be noted that while these additional analyses provided a 
greater number of studies for which the relationship between leisure-time physical 
activity and cancer risk could be assessed, inclusion of these studies was associated with 
limitations.  Specifically, the analyses that also included studies for which Compendium- 
quantified physical activity was estimated rather than directly quantified were subject to 
the conditions qualifying the studies for inclusion in the meta-analyses.  For example, 
noting the specific activities mentioned in the original studies and assigning a MET value 
from the Compendium is likely to produce a different result compared to a study that 







amount of activity completed during the week to accompany an activity of a given MET 
value reported in a study is likely to produce a different result than a study that directly 
quantified activity in MET hours-per-week from the beginning using the Compendium. 
  
Overview of Meta-Analyses  
Colon Cancer 
Two meta-analyses were performed to examine the relationship between physical 
activity and colon cancer risk.  Analyses I and II included only studies that used the 
Compendium to quantify leisure-time physical activity for males and females, 
respectively, while Analyses III and IV included studies from the first analysis as well as 
studies that provided either a MET value or number of hours of physical activity along 
with sample physical activities.  Including studies providing partial activity information 
allowed for an estimation of leisure-time physical activity in MET hours-per-week using 
the Compendium.  Information detailing the number of studies and study criteria for 




The specific relationship between leisure-time physical activity (as quantified by 
the Compendium of Physical Activities), and breast cancer risk was assessed using a total 
of seven meta-analyses.  Analysis I included only studies that used the Compendium to 
quantify leisure-time physical activity, while Analysis II included those studies from 







lifetime).  Eight of the ten Compendium-quantified studies met this requirement.  This 
analysis was completed to control for a possible measurement time effect.  Analysis III 
included studies from Analysis I as well as studies that provided either a MET value or 
number of hours of physical activity along with sample physical activities, so that MET 
hours-per-week could be estimated.  
Separate Compendium-quantified analyses were carried out for breast cancer risk 
for pre- and post-menopausal females.  Analysis IV included only Compendium-
quantified studies that examined the relationship between physical activity and breast 
cancer risk for premenopausal females.  Analysis V had the same study criteria for 
inclusion for postmenopausal females.  While there were insufficient studies to have a 
meta-analysis including both Compendium quantifications and MET hour-per-week 
estimations for premenopausal females, Analysis VI included studies from Analysis V as 
well as studies including either a MET value or number of hours of physical activity 
along with sample physical activities, allowing studies with estimated MET hours-per-
week to be included in this analysis.  Information detailing the number of studies and 
study criteria for inclusion for each physical activity and breast cancer meta-analysis can 
be found in Table 6.   
 
Statistical Methods used for Meta-Analyses 
Studies included in the meta-analyses differed in terms of the type of effect 
measures that they reported and the covariates that were controlled in the analysis.  
Prospective studies reported either relative risks (RR) or incidence density ratios (IDR) 







studies, relative risks and incidence density ratios were converted to approximate odds 
ratios.  The odds ratios were then converted to the log scale, and the variance, standard 
error (SE) of the log of OR, confidence intervals (CI) and p-values were calculated for 
each combined physical activity level for each study, based on the published, unadjusted 
data.  All hand-calculations of effect measures, log of the effect measures, standard error 
of the log of the effect measures, and confidence intervals are presented in Appendices I 
and II for studies of colon and breast cancer risk, respectively. Pooled effect measures 
and variances were calculated using the Mantel-Haenszel method and statistical analyses 
were completed using the Metan meta-analysis procedure with Stata 9.2 software [129].  
A significance level of alpha = 0.05 was used for all analyses. 
 
Effect Measures 
Because studies included in the present analyses controlled for different variables, 
unadjusted effect measures were calculated for each study to allow the studies to be 
combined.  Adjustments for covariates, such as age, were not included in the meta-
analyses, because studies controlled for a variety of different covariates and individual 
subject-level covariate values were not available for each study.  Five studies examined 
postmenopausal breast cancer risk, and three studies examined premenopausal breast 
cancer risk, including two studies that completed separate analyses by menopausal status 
within the same study.  This allowed for the analysis of the effect of physical activity on 









All effect measures were based on four possible exposure-disease categories, 
labeled a, b, c, and d, displayed below:  






Protective Factor Present a b a+b 
Protective Factor Absent c d c+d 
Protective Factor Total a+c b+d a+b+c+d 
 
Where a = the number of cases in the higher amount of activity group; b = the 
number of controls in the higher amount of activity group; c = the number of cases in the 
lower amount of activity referent group; d = the number of controls in the lower amount 
of activity referent group) [126, 128]. 
All effect measures were calculated to show the possible protective effect of the 
exposure (e.g. physical activity) on disease risk (e.g. colon or breast cancer).  For 
retrospective studies, the odds ratio is defined as the odds of the event (colon or breast 
cancer) among participants having a higher amount of physical activity divided by the 
odds of developing cancer among participants having a lower amount physical activity. 








Most cohort studies included in the meta-analysis reported the number of cases, 
based on the exposure time measured in person-years of risk. This allowed for the 


















where r2 = the number of cases in the higher amount of activity group; t1 = total number 
of person-years in low activity referent group; r1 = number of cases in low activity 
referent group; t2 = total number of person-years in higher activity group) [128].  The 
IDR is calculated as the number of incident cases occurring over a given time period and 
its units are defined as the number of cases per unit of person-time [130].  It is important 
to note that Mietennen (1976) reported the OR to be an unbiased estimator of the IDR, 
regardless of whether or not the condition is rare [131, 132].  
For two cohort studies of breast cancer risk, relative risks were calculated because 
the only available information was the number of cases and non-cases for each activity 
level, which is insufficient for IDR calculations because person-years were not reported.  
The relative risk is the probability of an event (e.g. breast or colon cancer) in the higher 




a / (a + b)
c / (c + d)
 
In this equation, the numerator represents the proportion of persons in the higher physical 
activity group who had an event (colon or breast cancer), and the denominator represents 
the proportion of persons in the lower physical activity group who had an event.   
 Prior research reports that while some measurement error may exist when the 
odds ratio is obtained as an estimate from another effect measure, such an estimate 
provides an acceptable approximation to the risk ratio and no assumption of rarity of 









Log and Standard Error of the Effect Measure             
When combining effect measures as part of a meta-analysis, it is recommended to 
log transform the data prior to combining, so each effect measure is transformed to the 
log scale. This allows for an easier method of calculating the variance of the log odds 
ratio can be calculated and confidence intervals for each study’s log odds ratio can be 
developed.  The variance for the log of the effect measure is calculated using the 
equation: 1/a + 1/b + 1/c + 1/d, for the OR and RR, while the variance of the log of the 
IDR is calculated as (r1+r2) / (r1 ! r2) [128]. 
The standard error (SE) is defined as the sampling variability of a particular 
estimate, and is determined by calculating the square root of the variance of the log effect 
measure ( 1/a + 1/b + 1/c + 1/d  for the OR and RR, and (r1+ r2) / (r1 ! r2) for the 
IDR). Utilizing the log of the effect measure and the SE of the log effect measure allow 
for the calculation of the 95% CI for the unadjusted effect measures:  
(Log Effect measure ± 1.96 · SE of Log Effect measure).  After confidence intervals have 
been determined, they can be transformed from the log scale back to the odds ratio scale 
by exponentiating the two endpoints of a 95% CI for the log effect measure to derive the 
endpoints of a 95% CI for the effect measure.  
 
Meta-Analytical Methodology 
Types of Meta-Analytical Methods 
 A variety of analytical methods are available for the pooling of existing data, 
including the general fixed effects model (the inverse variance-weighted method), the 







fixed effects methods for pooling odds ratios and combining effect measures, and do not 
account for heterogeneity between studies [133].  Another method used for combining 
study measures is the random effects model, which is widely considered a more 
conservative statistical method for combining effect measures, as it accounts for 
heterogeneity between studies [136].  In the mid 1980’s, DerSimonian and Laird 
developed the typical random effects model used in meta-analyses [137].  The primary 
difference between a fixed and random effects model is that the random effects model is 
based on an assumption that effect sizes are randomly distributed with a fixed mean and 
variance [137].  The fixed effects model is appropriate to use for analyses of smaller 
studies with more homogeneity in the effect measures from each study, while the random 
effects model is appropriate to use for analyses of a larger number of studies with greater 
heterogeneity, as often found in observational studies.  
The general fixed effects model was developed over 70 years ago [138, 139] and 
is based on giving each study effect measure a weight that is directly proportional to its 
precision, which would also be inversely proportional to its variance [133].  The fixed 
effects model is based on the assumption that all population effect sizes are equal and 
does not account for the study heterogeneity typically associated with analyses of 
observational studies [133, 140]. 
The Mantel-Haenszel (M-H) method is a commonly used fixed effect method for 
combining odds ratios from case-control studies [134].  In 1963, Mantel indicated that the 
M-H method was appropriate for combining effect measures from both retrospective and 







the present project [141].  The pooled M-H effect measure was calculated using the 
equation: 
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where ai, bi, ci, and di represent each of the four cells of the 2x2 tables for i =…k studies, 
and ni is the total number of people in the ith study.  The pooled variance for the Mantel-
Haenszel method is calculated using the equation: 
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where Pi = (ai+di)/ni, Qi = (bi+ci)/ni, Ri = aidi/ni, S = bici/ni[142].   
 The Mantel-Haenszel estimate of the combined effect was hand-calculated and 
also calculated using Stata 9.2 for all of the case-control studies for Analysis II of the 
colon cancer analyses and Analyses I, III, IV, V, and VI of the breast cancer analyses to 
compare results [129].  Additionally, the 95% confidence interval for the Mantel-
Haenszel estimate was hand-calculated for Analysis III of the breast cancer analyses (the 
analysis with the largest number of studies and subjects) and calculated using Stata for 
Analysis II of the colon cancer analyses and Analysis I, III, IV, V, and VI of the breast 







matched those from Stata within rounding error.  All Mantel-Haenszel and 95% 
confidence interval hand-calculations are included in Appendix III.  
 Another specific fixed effects method for the pooling of odds ratios is the Peto 
method, which is a modified version of the Mantel-Haenszel method that allows for 
calculation when there are occurrences of cell frequencies within the 2x2 tables of 
individual studies that are zero [135].  However, prior research reports that utilization of 
the Peto method for observational studies (e.g. epidemiological studies as opposed to 
clinical trials) is not ideal, as this method is associated with underestimations of risk 
when there is a large amount of variation in the odds ratio due to large treatment or 
exposure effects [143, 144].  Therefore, the Peto method was not used for the present 
analyses.   
 The random effects method is a more conservative statistical tool than the fixed 
effects method, as it assumes that individual studies have different treatment effects and 
that “study specific effect sizes come from a random distribution of effect sizes with a 
fixed mean and variance” [136].  Accounting for this additional variation among study 
effect sizes is appropriate for analyses of epidemiologic studies.  Typically, if results of 
fixed and random analyses are similar, it is unlikely that statistically significant 
heterogeneity exists.  However, because a fixed effects model does not account for 
random variation between studies, the more conservative random effects model is often 
considered a more appropriate statistical method to use if heterogeneity exists between 
studies. 
 When a fixed or random effects analysis is completed within Stata, a 







heterogeneity exists among the studies [145].  While the test for heterogeneity does not 
indicate the reasons for such an occurrence, likely factors contributing to methodological 
heterogeneity include differences in the ways subjects were selected and outcomes were 
measured, while statistical heterogeneity is often associated with varying sample sizes 
among studies within the analysis [146].  Such variation is sometimes responsible for the 
differing treatment effects that often exist among observational studies. 
 For the analyses of physical activity and colon cancer risk, fixed and random 
effects models were compared using the ‘Meta’ and ‘Metan’ meta-analytical procedures 
in Stata 9.2.  While the colon cancer analyses included a smaller number of studies that 
would typically warrant a fixed effects model, they also included one study (Tang et al., 
1999) that had fewer subjects, which had an effect measure that differed greatly from the 
other studies.  This heterogeneity in the study effect would indicate the use of a random 
effects model.  Fixed and random effects models were also compared for the analyses of 
physical activity and breast cancer risk among premenopausal females, as the analysis 
included a smaller number of studies, yet was also subject to the heterogeneity often 
found among observational studies.  Random effects models were completed for the 
larger analyses of physical activity and breast cancer risk among postmenopausal females 
and pre- and postmenopausal females combined because these analyses included a larger 
number of studies. 
 
Study Weighting for Meta-Analyses 
 Meta-analytical weights were initially developed by Hedges to account for study 







weight to studies providing greater information about the effect from the study through a 
larger sample size.  Each combined effect measure from a meta-analysis is based on a 
weighted average of the effect from each individual study.  The weight for a study 
represents a degree of precision derived from the random variation in effect size due to 
sample size [146].  A few years following Hedges’ development, Colditz et al. (1995) 
suggested that future research of random effects weighting is necessary, as it likely places 
too much emphasis on larger observational studies, but still weights them more favorably 
than the fixed effect model [81].   
 
Forest Plots 
The relative study weights are graphically displayed in forest plots for each meta-
analysis throughout the results section.  A greater study weight, which indicates a larger 
sample size, is associated with a larger box size as part of the forest plot.  The vertical 
line that intersects the x-axis at 1.0 indicates no effect. The relative horizontal placement 
along the x-axis represents the effect measure for each study.  Boxes farther to the left 
indicate more of a protective effect, while the horizontal line that intersects the box 
represents the 95% confidence interval for that particular effect measure.  The dashed 
vertical line that intersects the diamond at the bottom of the plot represents the pooled 
effect measure, with the left and right endpoints of the diamond representing the pooled 










Regression Model for Meta-Analyses 
 Random effects regression models for the meta-analyses, which are also known as 
mixed effects models, were completed.  These models attempted to assess whether the 
relationship between physical activity and colon and breast cancer risk differed by sex 
and menopausal status, respectively.  This model can be used to investigate the 
heterogeneity of effects across studies and examines the relationship between one or 
more study-level characteristics and the sizes of effect observed in the studies [140, 146]. 
This regression model can be used when variation between studies included in the meta-
analysis is due to sampling error and the covariates measured [147].  In the present 
analyses, it is important to determine whether statistically significant differences exist 




The study name and year, sex (colon cancer analyses), and menopausal status 
(breast cancer analyses) were entered into the Stata meta-analytical procedures.  The 
effect measure (odds ratio, approximate incidence density ratio, or relative risk), log 
effect measure, standard error of the log effect measure, number of cases, and number of 
controls (or person-years) for each study were calculated across all physical activity 
groups from all studies included in any of the meta-analyses.  Using this information, 
meta-analyses were calculated and the pooled estimate, upper and lower ends of the 95% 
summary confidence interval, p-value, and individual study weights were reported.  A 







summary effect measure listed on the X-axis.  The summary effect measure, summary 
95% confidence interval, effect measure for each study, and 95% confidence interval for 
each study were graphically displayed.  All analyses separately compared the ‘moderate’ 
and ‘high’ activity groups to the reference ‘low’ activity group.  
    
Organization of Data for All Meta-Analyses 
Because studies included in the analyses reported different physical activity 
categories, it was decided to combine the amount of physical activity from all studies into 
three groups for each of the meta-analyses.  Based on the amount of physical activity in 
total MET hours-per-week, information from all studies was combined, and the amount 
of physical activity was categorized as a ‘low’, ‘moderate’, or ‘high’.  The risks of the 
‘moderate’ and ‘high’ activity groups were separately compared to the referent ‘low’ 
activity group for all analyses.  Individual unadjusted effect measures, log of the effect 
measures, standard error of the log of the effect measures, and 95% confidence intervals 
were calculated for the moderate and high activity level groups and compared to the low 
physical activity group for all colon cancer (separately for males and females) and breast 
cancer (females only) analyses.  
 
Physical Activity Categorizations for Colon and Breast Cancer Meta-Analyses 
Because each study used different categories of MET hours-per-week to define 
amounts of physical activity, it was necessary to combine these categories for the meta-
analyses.  Table 1 illustrates the amounts of physical activity that were combined from 







meta-analyses.  Cut-points for each category were designed to be as inclusive as possible.  
Thus, for the Compendium-quantified colon cancer Analysis I, ‘low’ activity ranged from 
0 to 7.30 MET hours-per-week, ‘moderate’ activity ranged from 0.1 to 20.0 MET hours-
per-week, and ‘high’ activity ranged from > 11.3 MET hours-per-week (median) to > 20 
MET hours-per-week.  For females in Analysis II, ‘low’ activity ranged from 0 to 7.30 
MET hours-per-week, ‘moderate’ activity ranged from 0.1 to 21.0 MET hours-per-week, 
and ‘high’ activity ranged from > 16.0 to > 20.0 MET hours-per-week.  Categorizations 
for the Compendium combined and estimated colon cancer Analysis III ranged from 0 to 
7.30 MET hours-per-week for the ‘low’ activity group, 0.1 to 20.0 MET hours-per-week 
for the ‘moderate’ activity group, and ranged from > 11.3 MET hours-per-week (median) 
to >20.0 MET hours-per-week for the ‘high’ activity group for males, while the 
categorizations for females in Analysis IV ranged from 0 to 8.0 MET hours-per-week for 
the ‘low’ activity group, 0.1 to 21.0 MET hours-per-week for the ‘moderate’ activity 
group, and ranged from >16.0 to >20.0 MET hours-per-week for the ‘high’ activity 
group.  Specific physical activity categorizations in MET hours-per-week for the 
individual studies included in the colon cancer analyses are reported in Table 1 below.  
 
 
Table 1.  Physical activity categorizations (MET hours-per-week or estimated MET 










Giovannucci (’95) I, III M 0-4.8* 4.8-11.3* >11.3* 
Longnecker (’95) III M !4.0 4.1-16.0 >16.0 
White (’96) I, II, III, IV M, F <7.30 7.30-17.88 >17.88 
Martinez (’97) II, IV F <5.0 5.0-21.0 >21.0 
Tang (’99) I, II, III, IV M, F 0 0.1-20.0 >20.0 
Calton (’05) IV F <8.0 8.0-16.0 >16.0 







Categorizations for breast cancer Analyses I and II ranged from 0 to 8.9 MET 
hours-per-week for the ‘low’ activity group, 5.1 to 20.7 MET hours-per-week for the 
‘moderate’ activity group, and ranged from >12.0 to >20.7 MET hours-per-week for the 
high activity group.  Analysis III categorizations ranged from 0 to 10.0 MET hours-per-
week for ‘low’ activity group, 0.1 to 20.7 MET hours-per week for the ‘moderate’ 
activity group, and ranged from >12.0 to >20.7 MET hours-per-week for the ‘high’ 
activity group.  For Analysis III, one study (Thune et al., 1997) had a moderate activity 
categorization of 0.1 to 16.0 MET hours-per-week, while all of the others ranged from 
5.1 to 20.7 MET-hours-per-week.  The Analysis IV categorizations ranged from 0 to 8.9 
MET hours-per-week for the ‘low’ activity group, 6.7 to 20.7 MET hours-per-week for 
the ‘moderate’ activity group, and ranged from >16.6 to >20.7 MET hours-per-week for 
the ‘high’ activity group.  Physical activity categorizations for Analysis V ranged from 0 
to 7.6 MET hours-per-week for the ‘low’ activity group, 5.1 to 20.0 for the ‘moderate’ 
activity group, and ranged from >16.6 to >20.0 MET hours-per-week for the ‘high’ 
activity group.  Finally, physical activity categorizations for Analysis VI ranged from 0 to 
8.74 MET hours-per-week for the ‘low’ activity group, 5.1 to 20.7 MET hours-per-week 
for the ‘moderate’ activity group, and ranged from >16.6 to >20.0 MET hours-per-week 
for the ‘high’ activity group.  Specific physical activity categorizations in MET hours-















Table 2.  Physical activity categorizations (MET hours-per-week or estimated MET 










Thune (’97) III 0 0.1-16.0 >16.0 
Carpenter (’99) I, II, III, V, VI 0-8.74 8.75-17.59 >17.59 
Levi (’99) III <8.0 8.0-16.0 >16.0 
Rockhill (’99) III <9.75 9.75-17.5 >17.5 
Moradi (’00) III, VI 0-7.5 7.5-15.0 >15.0 
Friedenreich (’01) – Pre I, II, III, IV 0-6.7 6.7-20.7 >20.7 
Friedenreich (’01) – Post I, II, III, V, VI 0-5.1 5.1-16.9 >16.9 
Matthews (’01) I, II, III 0-6.16 6.16-13.37 >13.37 
Dirx (’01) III, VI <10.0 10.0-15.0 >15.0 
Colditz (’03) I, II, III, IV 0-8.9 9.0-17.9 >17.9 
John (’03) – Pre I, II, III, IV <6.8 6.9-16.6 >16.6 
John (’03) – Post I, II, III, V, VI <7.6 7.6-17.7 >17.7 
Patel (’03) – Cohort I, III, V, VI 0-7.0 7.0-17.5 >17.5 
Patel (’03) – Case-Control I, II, III 0-8.0 8.0-16.0 >16.0 
McTiernan (’03) I, III, V, VI <5.1 5.1-20.0 >20.0 
Yang (’03) I, II, III <6.0 6.0-12.0 >12.0 
Bernstein (’05) I, II, III <6.7 6.7-15.1 >15.1 
 
Physical Activity and Colon Cancer Risk Meta-Analyses  
Four studies (total = 874 cases, 221 controls, 564,722 person-years) measuring 
the effect of leisure-time physical activity on colon cancer risk using the Compendium to 
quantify the amount of physical activity (MET hours-per-week) were included in 
Analysis I for males and Analysis II for females.  Additionally, six studies (total = 1279 
cases, 758 controls, 835,047 person-years) were included in Analysis III for males and 
Analysis IV for females that allowed for both Compendium quantifications and MET 
hour-per-week estimations from studies providing either a weekly MET accumulation or 
weekly hours of physical activity.  A mixed effects model was also completed to assess 








Physical Activity and Breast Cancer Risk Meta-Analyses 
 Ten studies analyzing the effect of leisure-time physical activity on breast cancer 
risk among pre- and postmenopausal females using the Compendium to quantify the 
amount of physical activity (MET hours-per-week) were included in the largest meta-
analysis (Analysis I).  A total of 14,339 cases, 11,097 controls, 43,635 non-cases from 
cohort studies, and 1,250,896 person-years were included in Analysis I.  Additionally, 
after only including Compendium-quantified studies that measured the amount of 
physical activity for at least ten years, eight studies measuring breast cancer risk were 
included in Analysis II (total = 11,503 cases, 11,097 controls, and 934,100 person-years).  
Furthermore, Analysis III included fifteen studies examining the effect of leisure-time 
physical activity on breast cancer risk using both Compendium quantifications and MET 
hour-per-week estimations from studies providing either a weekly MET accumulation or 
weekly hours of physical activity (total = 27,208 cases, 14,098 controls, 68,894 non-cases 
from cohort studies, and 2,448,056 person years).  Analysis IV measured the effect of 
leisure-time physical activity on breast cancer risk among premenopausal females using 
the Compendium, and included three studies (total = 1714 cases, 958 controls, and 
934,100 person-years).  A similar analysis using Compendium-quantified activity solely 
among postmenopausal females utilized five studies (total = 5577 cases, 2731 controls, 
43,635 non-cases from cohort studies, and 316,796 person-years) as part of Analysis V. 
Analysis VI included seven studies of postmenopausal females that either quantified 
activity using the Compendium or contained a weekly MET accumulation or weekly 







Finally, a mixed effects model was completed to assess whether the relationship between 
physical activity and breast cancer risk differed by menopausal status.   
For each of the colon and breast cancer risk meta-analyses, specific information 
for each study is included (first author’s last name, year of study, type of study, age and 
sex distribution (colon cancer), menopausal status (breast cancer), number of cases, 
number of controls, number of non-cases or person-years for cohort studies, and 
estimation status of the quantified physical activity (Table 9 for colon cancer studies and 
Table 12 for breast cancer studies).  An additional table for each meta-analysis includes 
the length of time physical activity was measured for categorizing physical activity 
(reported in MET hours-per-week), effect measures, and confidence intervals for each 
category of physical activity for each study (Tables 10 and 11 for colon cancer analyses 
and Tables 13 through 18 for breast cancer analyses).  
 
Special Conditions for Meta-Analyses 
 As reported earlier, a few studies in the meta-analyses included some, but not all, 
of the relevant information necessary to be properly quantified according to the 
Compendium.  Some studies provided the total weekly physical activity in hours but did 
not provide a total weekly MET accumulation.  These studies reported the types of 
activities performed (e.g. walking, cycling) that assisted in the estimation of MET hours-
per-week, but did not assign a MET value and therefore did not directly quantify activity 
in MET hours-per-week.  Similarly, other studies provided only a weekly MET 
accumulation, allowing for an estimation of physical activity in MET hours-per-week 







the MET accumulation.  This hourly amount allowed for the amount of MET hours-per-
week to be comparable to that of other studies in a similar activity group, as these 
additional studies did not directly report a total weekly amount of physical activity in 
MET hours-per-week.  
For some of these Compendium ‘estimated’ studies, the MET level was 
determined according to the types of activity described in the study.  Weekly activity 
accumulation (in hours) was determined by the amount of total weekly METs in order to 
produce appropriate MET hour-per-week categorizations that were comparable to 
Compendium-quantified studies examining a similar relationship between physical 
activity and cancer risk.  Four meta-analyses (Analyses III and IV for colon cancer and 
Analyses III and VI for breast cancer) included studies that had these ‘estimated’ MET 
hours-per-week quantifications.  The studies in each of these respective analyses are 
listed below and accompanied by their assumptions and relevant analyses for which they 
are included.  For colon cancer analyses, a MET value of 8.0 for vigorous activity was 
assumed for Longnecker et al. (1995) and Calton et al. (2006).  For breast cancer 
analyses, an assumption of two hours per week of activity at the mean MET value 
originally reported in the Dirx et al. (2001) study was included in the ‘estimated’ 
analyses.  Additionally, MET values of 4.0, 4.0, and 6.0 were assumed to estimate MET 
hours-per-week for Levi et al. (1999), Rockhill et al. (1999) and Moradi et al. (2000), 
respectively.  Finally, for Thune et al. (1997), physical activity grades of 1, 2, 3, and 4, 
were placed into 0, <16, and >16 MET-hours-per week categorizations.  Such 
assumptions were based on a detailed description of the activity types and amount of 







Comparability of Studies within Meta-Analyses 
 Methodological differences among studies included in the meta-analyses were 
inevitable.  In the present study, study participant characteristics (Tables 3 and 6), time-
span of physical activity exposure (Tables 4 and 7), type of activity (Tables 5 and 8) 
instrumentation used to record modes of physical activity (Tables 5 and 8), and variables 
included in multivariate analyses (Tables 42.1-42.8 and Tables 43.1-43.17) were 
described in detail for all studies included in each of the colon and breast cancer meta-
analyses.   
 Tables 4 and 5 (colon cancer studies) and Tables 7 and 8 (breast cancer studies) 
were created to report the assessment methods of physical activity, type of physical 
activity quantification (e.g. Compendium or estimated using Compendium), time-span of 
exposure (e.g. years physical activity was followed), physical activity assessment 
instrumentation (e.g. self-developed by researchers or use of an established physical 
activity questionnaire), and activity type of the study (e.g. leisure-time/recreational).  For 
the breast cancer studies, three studies used a similar physical activity assessment tool 
developed by Bernstein et al. (1994), which was reportedly the most appropriate 
assessment instrumentation in a review of physical activity assessment methods for breast 
cancer studies [100, 148].  Additionally, two breast cancer studies and one colon cancer 
study used a physical activity assessment tool developed by Wolf et al. and used in the 
Nurses Health Study [149].  All analyses focused on the effect of leisure-time or 
recreational physical activity on colon and breast cancer risk, and specific activities 







were also included in the tables assessing physical activity (Table 5 for colon cancer 
studies and Table 8 for breast cancer studies). 
 Additionally, a thorough description of study participants was included in a series 
of tables for all studies included in the analyses of colon and breast cancer (Table 3 for 
colon cancer studies and Table 6 for breast cancer studies).  The study type (e.g. case-
control or cohort), participant characteristics (e.g. demographic information), selection 
criteria, and time period for participant selection and exposure measurement were 
included for all studies.  Furthermore, for cohort studies, the number of participants, 
study location(s), and total follow-up time was included, while information for the case-
control studies included the total number of cases, controls, a comprehensive description 
of selection criteria (e.g. community-based or hospital controls, geographic location, etc.) 
and the specific time period of case diagnoses and selection of controls. 
 Although the present colon and breast cancer effect measures were unadjusted 
and could not be controlled for confounding variables, the unadjusted effect measures 
were compared to the age-adjusted and multivariate-adjusted analyses in a table for each 
study (where applicable) to determine if any major differences existed.  Tables 42.1-42.8 
(colon cancer studies) and 43.1-43.17 (breast cancer studies) report the unadjusted effect 
measures for each level of physical activity quantification (e.g. each level of MET-hours-
per-week) compared to the age-adjusted and multivariate-adjusted effect measures for the 
moderate vs. low activity and high vs. low activity groups as a way of assessing the 










Several methodological limitations are present in this project.  Currently, more 
studies have utilized the Compendium to analyze the effect of physical activity on breast 
cancer risk compared to colon cancer risk.  As a result more data are available for the 
meta-analyses of breast cancer risk.  Additionally, there were not enough total studies or 
subjects to complete a meta-analysis examining the effect of occupational physical 
activity on colon and breast cancer risk, or an additional secondary meta-analysis on 
breast cancer risk among premenopausal females.  Each study utilized different 
classifications (e.g. MET hours-per-week) for ‘low’, ‘moderate’, and ‘high’ physical 
activity groups, which caused the activity category cut-points in the meta-analyses to 
overlap, as opposed to having an absolute cut-point between activity categories.  This 
results in a less precise estimate of the overall quantification of the relationship between 
physical activity and cancer risk than would be possible if all studies used similar activity 
categorizations.   
Finally, as described earlier in the section discussing confounding, original data 
could not be obtained from study authors, so all pooled effect measures from the meta-
analyses were unadjusted for individual participant characteristics.  The unadjusted 
analyses would not allow for the direct assessment of the effect of confounding variables 
or the assessment of effect modifying variables.  Because it is not possible to compare the 
adjusted and unadjusted effect measures statistically, calculations of the percent 
difference between the adjusted versus unadjusted effect measures were completed to 
determine if using unadjusted effect measures resulted in generally under- or 







and unadjusted rates were calculated using the formula described earlier in this chapter.  
Completion of percent difference calculations assisted in determining whether the 
unadjusted measures of risk would bias the study results, either by under- or 






Tables of Methodological Differences among Studies 
 
 
Summary of Colon Cancer Studies 
 
Table 3 describes each study and year, the type of study, number and detailed description of study participants, and time-period of 








Type Participants Time Period 
Giovannucci et al. (1995) Prospective 
Cohort 
47,723 male health professional questionnaire respondents 
in the United States between age 40 and 75; 200 cases were 
identified over 263,554 person-years of follow-up; No 
reporting of race distribution in this study 
Followed from 1986 
to 1992 




Longnecker et al. (1995) Case-Control Cases:  163 male cases with colon cancer were interviewed 
in Massachusetts, Rhode Island, Vermont, New Hampshire, 
and Connecticut identified through hospital records or the 
Massachusetts Cancer Registry; 19 cases aged 31-60; 34 
cases aged 60-69; 77 cases aged 70-79; 33 Cases over age 
80; 97.6% of cases were White individuals 
Controls: 275 community controls matched approximately 
1.5:1 to cases by age (±5 years) and matching zip code or 
next closest possible location by town; no history of colon 
cancer; over age 31, selected by random digit dialing; 275 
controls: 46 aged 31-60; 68 aged 60-69; 116 aged 70-79; 45 
over age 80; 96.7% of controls were White individuals 
Cases occurred from 
1986 to 1988; 
Controls selected 
from a list holding 
driver’s licenses from 
the same states as the 
cases in 1986 
White et al. (1996) Case-Control Cases:  251 White males (23 aged 30-44; 29 aged 45-49; 37 
aged 50-54; 94 aged 55-59; 68 aged 60-62) and 193 White 
females (14 aged 30-44; 24 aged 45-49; 34 aged 50-54; 63 
aged 55-59; 58 aged 60-62) in three counties in Seattle, 
Washington area identified by Seattle-Puget Sound 
Surveillance, Epidemiology and End Results Registry 
Controls: 233 White males (31 aged 30-44; 23 aged 45-49; 
31 aged 50-54; 89 aged 55-59; 59 aged 60-62) and 194 
White females (24 aged 30-44; 19 aged 45-49; 26 aged 50-
54; 70 aged 55-59; 55 aged 60-62); Frequency matched 
approximately 1:1 by age, sex, and county distribution of 
cases; Selected by random digit dialing of individuals with 
Cases occurred from 
July 1985 to 
September 1989; 
Controls selected 
during same time 
period 
  




no history of colon cancer or irritable bowel syndrome; No 
Discussion of race distribution in the study 
Martinez et al. (1997) Cohort 121,701 female registered nurses in the U.S. aged 30 to 55 
who were respondents to a questionnaire and cancer free in 
1976; Cohort taken from this group for the present study 
included 67,802 females and included 212 colon cancer 
cases over 67,802 person-years of follow-up; No reporting 
of race distribution in the study 
Followed from 1986 
to 1992 
Tang et al. (1999) Case-Control Cases: 163 Taiwanese individuals (92 males and 71 
females) between age 33 and 80; All cases were diagnosed 
in 1992 by one of two attending surgeons in the Chang 
Gung Medical Center in Taiwan; Mean age for cases was 
61.0 ± 17.5 years for males and 59.6 ± 11.8 for females; 
Specific age distribution not reported  
Controls: 163 individuals (92 males and 71 females) 
between the ages of 34 and 81 selected in 1992; History of 
cancer admitted to same hospital for unrelated treatment; 
Frequency-matched to cases for sex at a 1:1 ratio on age ±5 
years compared to case distribution; Mean age for controls 
was 60.1 ± 11.9 for males and 59.4 ± 11.7 for females  
Cases were identified 
and controls were 
selected in 1992 
Calton et al. (2006) Cohort 31,783 U.S. females participating in the Breast Cancer 
Detection Demonstration Project Follow-up Study without 
any type of cancer or missing/outlying values of energy 
intake and/or BMI; originally part of a cohort of 64,182 
Followed from 1987 
to 1998  




from 1979-1998; 243 cases identified among 270,325 
person-years of follow-up; 89% of females were White, 5% 
were African-American, 3% were Asian-American, 2% 








Table 4 provides the time frame for physical activity measurement and type of physical activity quantification utilized for each 
individual study.  The study name, year, and type, as well as the length of time physical activity was measured and method of physical 
activity quantification was included in this table.  Table 5 reports the same information for the breast cancer studies. 
 
 
Table 4.  Time frame of physical activity measured for studies in colon cancer analyses 
 
Study Type Time Frame Measured and Quantification of Activity 
 
Giovannucci et al. (1995) Prospective 
Cohort 
Previous 6 Years (MET-hr/week) 
Longnecker et al. (1995) Case-Control Previous 5 Years (MET values only – Estimated using Compendium) 
White et al. (1996) Case-Control Previous 10 Years (MET-hr/week) 
Martinez et al. (1997) Cohort Previous 1 Year (MET-hr/week) 
Tang et al. (1999) Case-Control Previous 1 Year (MET-hr/week) 








Table 5 provides an overview of the assessment of physical activity for each study included in the colon cancer meta-analyses.  
Specifically, the study name and year, type of physical activity quantification, length of time physical activity (the exposure) was 
measured, description of physical activity assessment instrumentation, and type of activity were included in this table.  It should be 
noted that analyses of occupational activity were not included in the colon cancer meta-analyses due to a lack of studies or lack of 
appropriate energy expenditure quantification.  Table 8 reports the same information for the breast cancer studies. 
 
 
Table 5.  Assessment of physical activity – studies in colon cancer analyses 
 
Study Quantification Exposure Time PA Assessment Instrumentation Activity Type 
 
Giovannucci et al. (1995) Compendium Previous 6 Years  Self-Developed Questionnaire; 5 
categories (median 0.9, 4.8, 11.3, 22.6, 
and 46.8 MET hrs-per-wk); Mentioned 
activities included walking, tennis, 
running 
Leisure-Time 
Longnecker et al. (1995) Estimated using 
Compendium; 
MET values given 
Previous 5 Years Self-Developed Interview; 4 
categories (0, !1/2, 1, or "2 hours per 
week of vigorous activity (>4 METs 
per week); activities included jogging, 









White et al. (1996) Compendium Previous 10 Years Interview and Questionnaire 
developed by Taylor et al. (1978) for 
assessing activity; 4 categories (0, 
<7.30, 7.30-17.88, >17.88 MET hrs-
per-wk); Mentioned activities included 
walking, dancing, running 
Leisure-Time 
Occupational 
Total (Leisure Time 
plus Occupational) 
Martinez et al. (1997) Compendium Previous 1 Year PA Questionnaire from the Nurses’ 
Health Study; 5 categories (<2, 2-4, 5-
10, 11-21, and >21 MET hrs-per-wk; 
Mentioned activities included walking, 
hiking, golf, jogging, running, 
bicycling, swimming, tennis, 
calisthenics, aerobics, rowing) 
Leisure-Time 
Tang et al. (1999) Compendium Previous 1 Year Self-Developed Interview and 
Questionnaire; 3 categories (Light, 
Moderate, and Heavy), Activities 
mentioned included walking, tennis, 
swimming, hiking, stair climbing, 




Calton et al. (2006) Estimated using 
Compendium; 
MET values given 
Previous 1 Year Self-Developed Questionnaire; 4 
categories (None; Light – Office work; 
Moderate – Hiking Golf, Light 
Housework; Heavy – Strenuous Sports 






Summary of Breast Cancer Studies 
 
 
Table 6.  Description of study participants – studies in breast cancer analyses 
 
Study Type Participants Time Period 





25,624 females aged 20 to 54 and free of cancer were 
invited by the National Health Screening Service in three 
counties in Norway; The cohort was initially followed 
between 1974 and 1978, but the second follow-up period 
of 1977 to 1983 was used as the baseline, as parity and 
nutritional factors were not initially assessed; Within this 
cohort, 351 cases were identified over a median follow-
up time of 13.7 years; Distribution of race not reported 
Followed between 
1977 and 1983; 
Median follow-up 
time was 13.7 years 
Carpenter et al. 
(1999) 
Case-Control Cases: 1,123 White and Hispanic female residents of Los 
Angeles County aged 55 to 64, born in the US, Canada, 
or Western Europe; Out of 2,373 cases Identified by the 
University of Southern California Cancer Surveillance 
Program (LA county cancer registry), 1,165 cases were 
initially eligible for the study and 1,123 cases were 
eventually included.  Controls: Out of an original 1,169 
controls, 904 healthy controls were able to be 
individually matched to cases on neighborhood, date of 
birth (within 36 months) and race (White or Hispanic); 
In-person interviews for each case-control pair were 
usually conducted by same female interviewer 
Cases were diagnosed 
between March 1, 
1987 and December 
31, 1989; Controls 
were selected during 
same time period 




Levi et al. (1999) Case-Control Cases: 246 females aged 29 to 74 (median age = 56) 
admitted to the University Hospital of Lausanne in 
Switzerland; Race distribution not reported 
Controls: 374 females aged 27-74 (median age = 58) 
admitted to the same hospital for non-cancer and non-
gynecological related conditions (usually orthopedic 
problems); Controls were matched on age, education, age 
at menarche, parity, age at birth of first child, 
menopausal status, BMI, family history, and total caloric 
intake; Interviews and questionnaire were the same for 
both cases and controls 
Cases were diagnosed 
between January 
1993 and August 
1998; Controls 
selected based on 
hospital admissions 
during same time 
period 
Rockhill et al. 
(1999) 
Cohort Among 121,701 females aged 30-55 in 1976 in the 
Nurses’ Health Study, 3,137 breast cancer cases (1,036 
premenopausal and 2,101 postmenopausal) were 
identified; Participants were female registered nurses in 
the U.S.; Distribution of race not reported 
Followed-up every 
other year from 1980 
to 1996; most activity 
assessed from 1986 to 
1996 
Moradi et al. 
(2000) 
Case-Control Cases: From the entire native population of females aged 
50-74 living in Sweden from October 1993 through 
March 1995, 2,838 postmenopausal cases without any 
previous cases were selected among 3,347 total cases that 
were identified from six Swedish regional cancer 
registers; Majority of cases were White (specific 
proportion not reported) 
Controls: Out of a potential 3,455 controls, 3,108 were 
Cases were diagnosed 
between October 
1993 and March 
1995; Controls were 
identified from same 
population during 
same time period 





randomly selected from the same 5-year age groups as 
the cases in the consistently updated Swedish register in 
an attempt to frequency match the expected age 
distribution of cases on a 1:1 basis; All controls and 
cases were free of previous cancer and premenopausal 
controls were excluded; Majority of controls were also 
White 
Friedenreich et al. 
(2001) 
Case-Control Cases:  1,233 were identified by the Alberta Cancer 
Registry; Cases were residents of Alberta, Canada, under 
the age of 80; 92.4% of cases were White 
Controls: 1,237 female controls were identified through 
random digit dialing and frequency matched to cases on a 
1:1 basis; Controls were frequency matched on age (±5 
years) and place of residence, and were cancer-free; 
94.8% of controls were White 
Cases were diagnosed 
between August 1995 
and August 1997; 
Controls were 
selected from same 
population during 
same time period 
Matthews et al. 
(2001) 
Case-Control Cases: 1,459 females aged 25 to 64 who were residents 
of urban Shanghai, China between August 1996 and 
March 1998; No prior history of cancer and all 
completed interviews (out of the 1,602 originally 
identified by the population-based Shanghai Cancer 
Registry); All cases were Asian individuals 
Controls: 1,556 females were randomly selected among 
permanent female residents of urban Shanghai and 
frequency matched to cases on an approximate 1:1 ratio 
Cases were diagnosed 
between August 1996 
and March 1998; 
Controls were 
identified from same 
population during 
time period; however 
age-matching of 
controls was based on 





by age (±5 years) and place of residence; All controls 
were Asian individuals 
age distribution of 
cases in Shanghai 
Registry from 1990-
1993 
Dirx et al. (2001)  Prospective 
Cohort 
62,537 postmenopausal females aged 55-69 in 1986 as 
part of the Netherlands Cohort Study were included in 
the study; Among the cohort, 1,208 cases were identified 
over 7.3 years of follow-up from over 200 municipalities 
with population cancer registries throughout the country; 




September 1986 to 
December 1993 




74,171 females (including 10,863 non-White females) 
aged 50-79 recruited by 40 clinical centers throughout 
the United States; Out of original cohort of 93,676, 
females were eligible if postmenopausal, planned to live 
in clinical center area for at least 3 years, and free of 
serious health conditions; 1780 breast cancer cases were 
identified during follow-up; 85% of all study participants 
were White, while the remaining 15% of females were 
African-American, Hispanic, Asian/Pacific Islander, and 
Native American  
Followed from 
October 1993 to 
December 1998 with 
a mean follow-up 
time of 4.7 years 
Yang et al. (2003) Case-Control Cases: 501 Asian-American females aged 25 to 74 living 
in Los Angeles County; Identified through the Los 
Angeles County Cancer Surveillance Program that is part 
Cases were diagnosed 
between January 1, 
1995 through the end 





of the Surveillance, Epidemiology, and End Results 
(SEER) program and the statewide California Cancer 
Registry; All cases were Asian-American 
Controls: 594 Asian-American females living in Los 
Angeles Country; Controls were frequency matched on 
an approximate 1:1 ratio for place of residence, Asian 
ethnicity and age (±5 years); All controls were Asian-
American 
of 1997; Controls 
were selected from 
same time period 




72,608 American postmenopausal females aged 50-74 
who were cancer free at the age of enrollment in 1992; 
Females were drawn from the American Cancer Society 
Cancer Prevention Study II Nutrition Cohort; 1520 cases 
were identified over a five-year period; Approximately 
97.4% of participants were White, 1.5% were Black, and 
1.1% were of another or missing race 
Individuals were 
followed from 1992 
until August, 1998 
 
Patel et al. (2003; 
C-C) 
Case-Control Cases: 567 White and Black females aged 35 to 64 
living in Los Angeles County with no previous history of 
breast cancer identified by the University of Southern 
California Cancer Surveillance Program, the population-
based cancer registry for Los Angeles County; 
Approximately 84% of cases were White and 16% were 
Black 
Controls: 616 White and Black females selected from 
the Females’ Contraceptive and Reproductive 
Cases were diagnosed 
between March 1, 
1995 and May 31, 
1998; Controls were 
selected during the 
identical time period 





Experiences (CARE) Study in Los Angeles County using 
random-digit dialing from the same counties as the case 
patients; Controls reported a mammogram within the 
previous two years and were frequency matched based 
on race (White or Black) and age (± 5 years); 
Approximately 59% of controls were White and 41% 
were Black 
Colditz et al. 
(2003) 
Cohort 110,468 premenopausal participants of the Nurses Health 
Study II aged 25 to 42 living within 14 U.S. states 
without any previous history of cancer other than a 
nonmelanoma skin cancer; Within this cohort, 849 breast 
cancer cases over a 10-year follow-up period were 
included in the present study; Distribution of race not 
reported 
Individuals were 
followed from 1989 
through June 1, 1999 
John et al. (2003) Case-Control Cases:  403 premenopausal cases and 847 
postmenopausal cases; Females were Latina, African-
American, and White aged 35 to 79, and resided in a five 
county area in the San Francisco Bay area; Cases were 
identified by a population-based cancer registry that is 
part of the Surveillance, Epidemiology, and End Results 
(SEER) program and the statewide California Cancer 
Registry; Approximately 41% of cases were Latina, 31% 
were African-American, and 28% were White 
Controls: 483 premenopausal females and 1065 
Cases were diagnosed 
between April 1, 
1995 and April 30, 
1998; Controls were 
selected during the 
same time period 





postmenopausal females; Resided in the same San 
Francisco Bay area as cases and were frequency matched 
1:1 for African Americans and Whites and 1:1.5 for 
Latinas; All controls were matched to the age distribution 
of cases (± 5 years) and were identified through random 
digit dialing; Approximately 47% were Latina, 26% were 
African-American, and 26% were White 
Bernstein et al. 
(2005) 
Case-Control Cases: 4538 females (1605 Black and 2933 White) 
diagnosed with breast cancer between July 1, 1994 and 
April 30, 1998 in Atlanta, Detroit, Los Angeles, Seattle, 
and Philadelphia and identified by the Surveillance, 
Epidemiology and End Results (SEER) cancer registries; 
Approximately 65% of cases were White and 35% were 
Black 
Controls: 4649 females (1646 Black and 3033 White) 
selected via random digit dialing from the same 
geographic regions as the corresponding case patients; 
Frequency matched approximately 1:1 to case patients 
based on geographic site, race, and age (±5 years); 
Approximately 65% of controls were White and 35% 
were Black 
Cases were identified 
between July 1, 1994 
and April 30, 1998; 
Controls were 
selected during the 








Table 7.  Time frame of physical activity measured for studies in breast cancer analyses 
 
Study Type Time Frame Measured and Quantification of Activity 
 
Thune et al. (1997) Prospective Cohort 3 to 5 years prior to study (Graded 1 to 4: 1 = sedentary; 2 = !4 hours recreational activity; 3 = !4 
hours Moderate Activity; 4 = !4 hours vigorous leisure-time physical activity 
Carpenter et al. (1999) Case-Control Lifetime (MET-hr/week) 
Levi et al. (1999) Case-Control Age 15-19; Age 30-39; Age 50-59  (Graded 1 to 3: 1 = < 2 hrs/wk; 2 = 2-4 hrs/wk; 3 = ! 5 hrs/wk of 
leisure-time physical activity) 
Rockhill et al. (1999) Cohort Assessed 6 Times over a 14-Year Period (<1, 1-1.9, 2-2.9, 3-3.0, 4-6.9, ! 7 hrs/week of moderate or 
vigorous activity 
Moradi et al. (2000) Case-Control Age 30 up to Study; Age 18-30; Before Age 18  (<1, 1-2, >2 hours/week) 
Friedenreich et al. (2001) Case-Control Lifetime (MET-hr/week) 
Matthews et al. (2001) Case-Control 10 Years Prior to Study; Age 13-19 (MET-hr/day ! MET-hr/week) 
Dirx et al. (2001)  Prospective Cohort Current year - recreational activity (MET scores and minutes/day); Lifetime - sports participation 
(MET scores and duration of sports in years) 
McTiernan et al. (2003) Prospective 
Cohort 
Current (MET-hr/week); Age 18, 35, 50 (Activity reported dichotomously) 
Yang et al. (2003) Case-Control Age 10 to reference age = 1 year before diagnosis/interview (MET-hr/week) 
Patel et al. (2003; Cohort) Cohort Current; At age 40  (MET-hr/week); 10 Years Prior (Graded ‘Slight’, ‘Moderate’, and ‘Heavy’ – 
Dichotomous) 
Patel et al. (2003; C-C) Case-Control Lifetime (MET-hr/week); 10 Years after menarche; Age 20-34; 10 Years Prior (<1, 1-4, >4 
hours/wk) 
Colditz et al. (2003) Cohort Assessed 3 Times over a 10-Year Period (MET-hr/week) 
John et al. (2003) Case-Control Lifetime – from Menarche (MET-hr/week) 






Table 8.  Assessment of physical activity – studies in breast cancer analyses 
 
 




PA Assessment Instrumentation Activity Type 
 






Previous 3 to 
5 Years 
Self-developed questionnaire; 
Leisure-time activity graded 1 to 4 
where 1= sedentary; 2= !4 hrs/wk 
walking, bicycling; 3= !4 hours 
recreational sports; 4= regular, 
vigorous activity or sports several 
times a week; Occupational 
activity coded as 1) sedentary; 2) 
job with walking; 3) job with 
lifting and walking; 4) heavy 
manual labor; For occupational 
analysis, METs can be estimated 
based on activity type 
Leisure-Time 
Occupational 
Carpenter et al. (1999) Post Compendium Lifetime Self-developed questionnaire;  
Type and duration (at least 2 
hrs/wk of activity) was assessed 
over the lifetime (from menarche 
to reference date) and MET-hr/wk 
categorizations were 0, 0.1-17.59 
and !17.6; Activity in the 
previous 10 years before reference 
Leisure-Time 
 





date were also categorized in 
MET-hrs/wk (0, 0.1-6.9, 7.0-13.9, 
14.0-24.4, and !24.5); Activities 
included walking, jogging, field 
hockey, and aerobics 











Activities throughout lifespan 
(age 15-19, 30-39, and 50-59) 
were elicited; Number of hours 
were reported for leisure-time; 
specific examples included 
walking, gardening, and cycling; 
Cut-offs were <2, 2-4, and ! 5 
hours per week); Occupational 
was graded as 1, 2, or 3 (‘very 
tiring’ or ‘tiring’, ‘standing’ and 
‘mainly sitting’, respectively 
Leisure-Time 
Occupational 








PA Questionnaire from the Nurses 
Health Study was used; Number 
of hours of activity each week 
during for moderate and vigorous 
activity were reported; Specific 
mentioned activities included 
walking, hiking, jogging, running, 
bicycling, swimming, tennis, 
Leisure-Time 
 





calisthenics, aerobics, and rowing; 
Vigorous activity included those 
with a MET value over 6.0 





Age 30 to 
time of study 
(total of 20 
to 44 years) 
Self-Developed questionnaire on 
exercise during three periods: 1) 
before age 18, 2) age 18-30, and 
3) age 30 to time of data 
collection; 4 Categories: Never, 
<1 hour per week, 1-2 hours per 
week, >2 hours per week; Aerobic 
exercise and sport were 
specifically mentioned; 
Occupations were classified as 
‘very high’, ‘high’, ‘moderate’, 
‘light’, or ‘sedentary’, but were 
not part of any analyses 
Leisure-Time 
Occupational* 
Friedenreich et al. (2001) Pre, Post 
Stratified 
Compendium Lifetime Self-developed questionnaire 
separately assessed recreational, 
occupational, and household 
activity throughout the lifetime; 
Frequency, duration were 
obtained and MET values were 
assigned to specific activities for 
leisure-time activities including 














categorizations were 0-<6.7, 6.7-
<11.8, 11.8-<20.7, and !20.7 for 
leisure-time activity for 
premenopausal females and 0-
<5.1, 5.1-<9.4, 0.4-<16.9, and 
!16.9 MET-hr/wk for 
postmenopausal females; for 
occupational activities, intensity 
was self-reported as ‘light’, 
moderate’, or ‘heavy’ and 
estimated and also estimated as 
MET-hr/wk 
Matthews et al. (2001) Pre and Post 
Combined 
Compendium Previous 10 
Years 
Self-developed questionnaire for 
leisure-time (walking, cycling, 
aerobic exercises, sports), 
occupational (‘sitting’, ‘standing’ 
or ‘walking’), and household 
activities; Leisure-time activity 
was assessed 10-years prior to 
entering the study and between 
age 13 and 19, and was reported 
in MET-hrs/day (0.01-0.35, 0.36-
0.88, 0.89-1.91, >1.91, which can 









hrs/wk; Occupational activity was 
reported in average time ‘standing 
or walking’ and classified into 
heavy, medium, light, or non-
physical work (not part of 
analyses) 





Current Self-developed questionnaire 
assessed baseline recreational 
activity (e.g. walking, bicycling, 
various sports); Mean MET scores 
for recreational activities were 
provided (<4.00, 4.01-6.00, >6.00 
Mean MET score per year); A 
history of sports participation was 
also assessed and a MET score 
was provided; Lifetime 
occupational activity was 
categorized as low, moderate, or 
high activity according to amount 
of time sitting and estimated 
energy expenditure in kJ/minute 




McTiernan et al. (2003) Post Compendium Current Self-developed questionnaire 
assessed current moderate and 
Leisure-Time 





strenuous physical activity; 
Specific activities included 
walking, bicycling, calisthenics, 
aerobics, dancing, jogging, tennis, 
and swimming, and MET-hr/wk 
categorizations were 0, "5, 5.1-10, 
10.1-20, 20.1-40, >40 




Lifetime PA Questionnaire developed by 
Bernstein et al. (1994) that 
assessed frequency, duration, and 
type of activity; Recreational 
activity was reported in MET-
hrs/wk over the lifetime (age 10 to 
reference age); MET-hr/wk 
categorizations were "3, >3-6, >6-
12, >12) Recreational activities 
included walking and bicycling; 
Occupational activities were 
coded into four categories: 
sedentary, mixed sedentary and 
moderately active, moderately 
active, and highly active (not part 
of the occupational analysis)  
Leisure-Time 
Occupational* 
Patel et al. (2003; Cohort) Post Compendium Current; At Self-developed questionnaire 
assessed baseline physical activity 
Leisure-Time 





age 40 over the past year for the 
following activities: walking, 
jogging, running, swimming, 
racquet sports, bicycling, aerobics, 
calisthenics, and dancing; MET-
hrs/wk categorizations were >0-
7.0, >7.0-17.5, >17.5-31.5, >31.5-
42.0, >42.0 
Patel et al. (2003; C-C) Pre and Post 
Combined 
Compendium Lifetime Self-developed questionnaire 
included the type and average 
duration per week of activity; 
Specific activities included 
walking, jogging, bicycling, 
aerobics, swimming, sports, and 
dance; MET-hrs/wk were 
calculated over the lifetime (>0-
3.0, >3.0-8.0, >8.0-16.0, >16.0-
32.0, >32.0), as well as for the 
first 10 years after menarche, ages 
20-34, and previous 10 years 
before reference date 
Leisure-Time 




PA questionnaire from the Nurses 
Health Study was used and 
average amount of time spent per 
week during the previous year for 
Leisure-Time 





each of the following activities 
was recorded; Activities included 
walking, hiking, jogging, running, 
bicycling, racquet sports, 
swimming, calisthenics, and 
aerobics; Each activity was 
assigned a MET value and MET-
hrs/wk categorizations were <3, 3-
8.9, 9-17.9, 18-26.9, and !27 




Compendium Lifetime PA Questionnaire developed by 
Bernstein et al. (1994) that 
assessed frequency, duration, and 
type of activity; Amount of 
recreational activity over the 
lifespan were recorded in MET-
hrs/wk ("6.8, 6.9-16.6, !16.7); 
Leisure-time activities included 
walking and bicycling; 
occupational activities were 
recorded as ‘mostly sitting’, 
‘mostly standing or walking’, 
‘mostly moderate physical 
activities’, or ‘mostly strenuous 
activities’, or ‘hard labor’; 










‘scrubbing floors, weeping’, 
washing windows’ ‘mowing 
lawn’, other outdoor chores 
Bernstein et al. (2005) Pre and Post 
Combined 
Compendium Lifetime Self-developed questionnaire 
included type and duration of 
activity in hours; Specific 
activities included walking, 
jogging, running, hiking, 
bicycling, aerobics, swimming, 
and dancing; Average number of 
MET-hrs/wk over the lifespan 





















Summary of Meta-Analyses for Colon Cancer Studies 
 
Table 9 summarizes the four meta-analyses examining the relationship between physical activity and colon cancer risk.  Analysis I 
only includes studies using the Compendium to quantify physical activity for males, while Analysis II only includes studies using the 
Compendium for females.  Analysis III uses all studies from Analysis I, as well as additional studies with estimated Compendium 
quantification for males, based on total MET value or number of weekly physical activity hours, while Analysis IV includes all studies 
from Analysis II as well as additional studies with estimated Compendium quantification for females. 
 
 
Table 9.  Studies in colon cancer meta-analyses 
 
  Analysis       Sex  # Studies  Exposure Time 
 
Quantification 
I Males 3 Previous 1-10 Years Compendium 
 
II Females 3 Previous 1-10 Years Compendium 
III Males 4 Previous 1-10 Years Compendium or estimated from 
Compendium using provided MET value 
or number of activity hours 
IV Females 4 Previous 1-10 Years Compendium or estimated from 
Compendium using provided MET value 













Table 10.  Analyses I and II – Description of studies included in Compendium-quantified colon cancer risk meta-analyses 
 
Study Year Study Type Sex Age # M / F Cases # M / F Controls Person-Yrs 
 
Giovannucci et al. 1995 Prospective Cohort M 40-75 200 / - - 263,554 
White et al. 1996 Case-Control M, F 30-62 251 / 193 233 / 194 - 
Martinez et al. 1997 Cohort F 30-55 - / 161 - 301,168 







Table 11 reports the specific information about the six studies included in Analysis II of colon cancer risk. 
 
 
Table 11.  Analyses III and IV – Description of studies included in Compendium-quantified and estimated colon cancer risk  
meta-analyses 
 
Study Year Study Type Sex Age # M / F Cases # M / F Controls Person-Yrs Estimated 
MET hrs/wk 
Giovannucci et al. 1995 Cohort M 40-75 200 / - - 263,554 No 
Longnecker et al. 1995 Case-Control M 31-81 162 / -  261 / - - Yes 
White et al. 1996 Case-Control M, F 30-62 251 / 193 233 / 194 - No 
Martinez et al. 1997 Cohort F 30-55 - / 161 - 301,168 No 
Tang et al. 1999 Case-Control M, F 33-81 42 / 27 43 / 27 - No 









IV.  Summary of Meta-Analyses for Breast Cancer Studies 
 
Table 12 reports specific information for the six meta-analyses that will examine the effects of physical activity on breast cancer risk 
for pre- and postmenopausal females.  The analysis title, number of studies included in each meta-analysis, minimum exposure time to 
physical activity for each meta-analysis, and physical activity quantification type are included in the table.   Analyses I, II, IV and V 
included only studies utilizing the Compendium for physical activity quantification, while Analyses III and VI included additional 
studies that only provided total MET values or weekly physical activity hours allowing for estimation using the Compendium.  
 
 
Table 12.  Studies in breast cancer meta-analyses 
 
Analysis # Studies Menopausal Status Exposure Time Quantification 
 
I 10 Pre and Post At least one year of leisure-time physical 
activity 
Compendium 
II 8 Pre and Post At least seven years of leisure-time physical 
activity 
Compendium 
III 15 Pre and Post At least one year of leisure-time physical 
activity 
Compendium or estimated from 
Compendium using provided MET value 
or number of activity hours  
IV 3 Premenopausal At least 10 years of leisure-time physical 
activity (up to lifetime) 
Compendium 
V 5 Postmenopausal Current (1 study) to lifetime (4 studies) 
leisure-time physical activity 
Compendium 
VI 7 Postmenopausal Current (2 studies) to lifetime (5 studies) 
leisure-time physical activity 
Compendium or estimated from 
Compendium using provided MET value 






Tables 13 through 18 report specific information for each of the breast cancer meta-analyses.  The study name, year, and type, 
menopausal status of the subjects, number of cases, controls (for case-control studies), non-cases, and person-years (cohort studies) 
were included in the tables for each specific meta-analysis. 
 
 
Table 13.  Analysis I – Description of studies included in Compendium-quantified pre- and postmenopausal breast cancer risk Meta-
analysis 
 
Study Year Study Type Menopausal 
Status 




Carpenter et al. 1999 Case-Control Post 1123 904 - 
Friedenreich et al. 2001 Case-Control Pre, Post Stratified 1233 1237 - 
Matthews et al. 2001 Case-Control Pre and Post 
Combined 
1459 1553 - 
McTiernan et al. 2003 Cohort Post 1316 43635 (NC) - 
Yang et al. 2003 Case-Control Pre and Post 
Combined 
484 590 - 
Patel et al. 2003 Case-Control Pre and Post 
Combined 
567 616 - 
Patel et al. 2003 Cohort Post 1520 - 316,796 
Colditz et al. 2003 Cohort Pre 849 - 934,100 
John et al. 2003 Case-Control Pre, Post Stratified 1250 1548  - 
Bernstein et al. 2005 Case-Control Pre and Post       
Combined 








Table 14.  Analysis II – Description of studies included in Compendium-quantified pre- and postmenopausal breast cancer risk meta-
analysis (quantity of physical activity measured for ! 10 years) 
 
Study Year Study Type Menopausal 
Status 
# Cases # Controls Person-Yrs 
 
Carpenter et al. 1999 Case-Control Post 1123 904 - 
Friedenreich et al. 2001 Case-Control Pre, Post 
Stratified 
1233 1237 - 
Matthews et al. 2001 Case-Control Pre and Post 
Combined 
1459 1553 - 
Yang et al. 2003 Case-Control Pre and Post 
Combined 
484 590 - 
Patel et al. 2003 Case-Control Pre and Post 
Combined 
567 616 - 
Colditz et al. 2003 Cohort Pre 849 - 934,100 
John et al. 2003 Case-Control Pre, Post 
Stratified 
1250 1548 - 
Bernstein et al. 2005 Case-Control Pre and Post 
Combined 









Table 15.  Analysis III – Description of studies included in Compendium-quantified and estimated pre- and postmenopausal  
breast cancer risk meta-analysis 
 
Study Year Study Type Menopausal 
Status 




Thune et al. 1997 Cohort Pre and Post 
Combined 
351 25259 (NC) - Yes 
Carpenter et al. 1999 Case-Control Post 1123 904 - No 
Levi et al. 1999 Case-Control Pre and Post 
Combined 
246 371  Yes 
Rockhill et al. 1999 Cohort Pre and Post 
Combined 
3137 - 1,193,235 Yes 
Moradi et al. 2000 Case-Control Post 2534 2630 - Yes 
Friedenreich et al. 2001 Case-Control Pre, Post Stratified 1233 1237 - No 
Matthews et al. 2001 Case-Control Pre and Post 
Combined 
1459 1553 - No 
Dirx et al. 2001 Cohort Post 428 - 3925 Yes 
McTiernan et al. 2003 Cohort Post 1316 43635 (NC) -  
Yang et al. 2003 Case-Control Pre and Post 
Combined 
484 590 - No 
Patel et al. 2003 Case-Control Pre and Post 
Combined 
567 616 - No 
Patel et al. 2003 Cohort Post 1520 - 316,796 No 
Colditz et al. 2003 Cohort Pre 849 - 934,100 No 
John et al. 2003 Case-Control Pre, Post Stratified 1250 1548 - No 
Bernstein et al. 2005 Case-Control Pre and Post 
Combined 













Year Study Type # Cases # Controls Person-Yrs 
Friedenreich et al. 2001 Case-Control 462 475 - 
Colditz et al. 2003 Cohort 849 - 934,100 




Table 17.  Analysis V – Description of studies included in Compendium-quantified postmenopausal breast cancer risk 
meta-analysis 
 




Carpenter et al. 1999 Case-Control 1123 904 - 
Friedenreich et al. 2001 Case-Control 771 762 - 
McTiernan et al. 2003 Cohort 1316 43635 (NC) - 
Patel et al. 2003 Cohort 1520 - 316,796 











Table 18.  Analysis VI – Description of studies included in Compendium-quantified and estimated postmenopausal breast  
cancer risk meta-analysis 
 






Carpenter et al. 1999 Case-Control 1123 904 - No 
Moradi et al. 2000 Case-Control 2534 2630 - Yes 
Friedenreich et al. 2001 Case-Control 771 762 - No 
Dirx et al. 2001 Cohort 428 - 3925 Yes 
McTiernan et al. 2003 Case-Control 1316 43635 (NC) - No 
Patel et al. 2003 Cohort 1520 - 316,796 No 







Table 19 details the relationship between occupational activity and breast cancer risk, which were not able to be included in any meta-
analyses due to a lack of utilization of the Compendium 
 
 
Table 19.  Description of studies of occupational physical activity and breast cancer risk* 
 
Study Year Study Type Menopausal 
Status 




Thune et al. 1997 Cohort Pre, Post 
Stratified 
350 25192 (NC) - Yes 
Levi et al. 1999 Case-Control Pre and Post 
Combined 
181 260 - Yes 
Friedenreich et al. 2001 Case-Control Pre, Post 
Stratified 
1233 1237 - No 
Matthews et al. 2001 Case-Control Pre and Post 
Combined 
1440 1534 - No 
Kruk et al.** 2003 Case-Control Pre and Post 
Combined 
257 565 - Yes 
 
* It was determined that too much heterogeneity in the quantification of physical activity existed among the five studies to complete 
an appropriate and meaningful meta-analysis using the studies included in Table 19 
** The Kruk et al. study only appears in Table 19 and was not part of any analysis because the study only assessed the relationship 











Overview of Results 
 
 The first portion of this chapter discusses the results of the meta-analyses of the 
relationship between leisure-time physical activity and the risk of colon and breast 
cancer.  There are four meta-analyses of the effect of leisure-time physical activity on 
colon cancer risk.  Analyses I and II report the effect of physical activity on the colon 
cancer risk of males and females, respectively, using only studies that quantified physical 
activity using the Compendium of Physical Activities.  Analyses III and IV report the 
effect of physical activity on the risk of colon cancer among males and females, 
respectively, using studies that quantified and estimated physical activity in MET hours-
per-week using the Compendium.     
There are six meta-analyses of the effect of leisure-time physical activity on 
breast cancer risk.  Analysis I reports the effect of physical activity on the risk of breast 
cancer among pre- and postmenopausal females combined using only studies with 
Compendium-quantified physical activity.  Analysis II reports the effect of physical 
activity on the risk of breast cancer for pre- and postmenopausal females combined, 
including only studies with Compendium-quantified activity that was assessed for a time 
 
126 
period of ten years or longer.  Analysis III reports the effect of physical activity on breast 
cancer risk among pre- and postmenopausal females combined, using studies with both
Compendium-quantified and estimated amounts of physical activity.  Analysis IV reports 
the effect of physical activity on breast cancer risk among premenopausal females, using 
only studies with Compendium-quantified activity.  Analysis V examines the effect of 
physical activity on breast cancer risk among postmenopausal females, using only studies 
with Compendium-quantified activity.  Finally, Analysis VI reports the effect of physical 
activity on breast cancer risk among postmenopausal females, including studies with both 
Compendium-quantified and estimated activity amounts. 
The potential impact of confounding factors on results was assessed by 
calculating the percentage difference between the multivariate-adjusted effect measures 
in the original studies and the unadjusted effect measures used in the present meta-
analyses, to determine if there was a bias in the reported results, introduced by not using 
age-adjusted or multivariate-adjusted effect measures for the individual studies in the 
meta-analyses.  
 
Results for Colon Cancer Analyses  
 The relationship between physical activity and colon cancer was assessed for 
males and females in four meta-analyses, titled Analysis I through Analysis IV.  For both 
sexes, moderately and highly active individuals were compared to the more sedentary 
individuals in the low activity reference group.  Each unadjusted effect measure, 
confidence interval, log of the effect measure, and standard error calculations for the 
individual studies included in the colon cancer meta-analyses are included in Appendix I.  
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Additionally, calculating the percent-difference between the adjusted effect measures in 
the original studies and the unadjusted effect measures in the present analyses assessed 
the effect of confounding on the relationship between physical activity and colon cancer. 
 
Analyses of Compendium-Quantified Studies (Males and Females) 
 Analysis I assessed colon cancer risk among moderately and highly active males 
versus low activity males in studies quantifying physical activity using the Compendium 
of Physical Activities.  Three studies (Giovannucci et al., 1995; White et al., 1996; Tang 
et al., 1999) were included in this meta-analysis.  This analysis included 202 cases, 108 
controls, and 51,660 person-years in the low activity group; 183 cases, 101 controls, and 
104,939 person-years in the moderate activity group; and the high activity group included 
111 cases, 67 controls, and 106,955 person-years.  For moderately active males, the
unadjusted effect measure for the Giovannucci et al. (1995) study was 0.788  (95% CI = 
0.562-1.103), and the weight of the study for the meta-analysis was 47.37%.  The White 
et al. (1996) study measure was 0.606 (95% CI = 0.405-0.906), with a weight of 43.70%, 
while the Tang et al. (1999) effect measure was 4.286 (95% CI = 0.854-21.506) with a 
study weight of 8.92%.  There was no statistically significant difference between the 
moderate and low activity groups.  Additionally, there was some evidence of 
heterogeneity among these studies (!
2
 test for heterogeneity = 5.63, df = 2, p = 0.060), 
although the p-value for the test of heterogeneity did not reach significance based on the 
prespecified alpha level of .05.  The fixed effects pooled estimate was 0.740 (95% CI = 





estimate for this meta-analysis was 0.817 (95% CI = 0.484-1.379, p = 0.449).  The 








Figure 1.  Meta-analysis of colon cancer risk among moderate versus low activity males 
in Compendium quantified studies in analysis I  
 
A non-statistically significant difference (p = 0.449) between the moderate and low 
activity groups was present. 
 
 
Table 20.  Colon cancer risk among moderate versus low activity males in Compendium 












Giovannucci (1995) 0.788 0.562-1.103 47.37 
White (1996) 0.606 0.405-0.906 43.70 
Tang (1999) 4.286 0.854-21.506 8.92 
  
D+L Pooled Effect Size 0.817 0.484-1.379 100.00 -0.757 0.449 
 
  Heterogeneity !
2
 = 5.63 (d.f. = 2) p = 0.060 
  Estimate of between-study variance "
2







 For the high activity group, the effect measure from Giovannucci et al. (1995) 
was 0.527 (95% CI = 0.365-0.760), with a study weight of 51.19%, while White et al. 
(1996) had a effect measure of 0.664 (95% CI = 0.408-1.079), with a weight of 38.89%.  
Tang et al. (1999) reported a effect measure of 0.202 (95% CI = 0.060-0.682), with a 
weight of 9.93%. The high activity group effect measure was statistically significantly 
lower than the estimate for the low activity group, and no statistically significant 
heterogeneity was reported for this analysis (p = 0.200).  The fixed effects pooled 
estimate was 0.541 (95% CI = 0.407-0.719), p < 0.001 while the D+L random effects 
pooled estimate was 0.524 (95% CI = 0.348-0.788), p = 0.002.  The results from the 








Figure 2.  Meta-analysis of colon cancer risk among high versus low activity males in 
Compendium quantified studies in Analysis I 
 






Table 21.  Colon cancer risk among high versus low activity males in Compendium 












Giovannucci (1995) 0.527 0.365-0.760 51.19 
White (1996) 0.664 0.408-1.079 38.89 
Tang (1999) 0.202 0.060-0.682 9.93 
  
D+L Pooled Effect Size 0.524 0.348-0.788 100.00 -3.107 0.002 
 
  Heterogeneity !
2
 = 3.22 (d.f. = 2) p = 0.200 





 Colon cancer risk among moderately and highly active females in Compendium 
quantified studies was assessed in Analysis II.  Three studies (White et al. (1996), 
Martinez et al. (1997), and Tang et al. (1999) were included in this analysis.  This 
analysis included 175 cases, 97 controls, and 115,147 person-years in the low activity 
group; 149 cases, 81 controls, and 127,204 person-years in the moderate activity group; 
and 57 cases, 43 controls, and 58,817 person-years in the high activity group.  For the 
moderately active group, the effect measure for the White et al. (1996) study was 0.990 
(95% CI = 0.640-1.532), with a study weight of 35.90%.  The effect measure for 
Martinez et al. (1997) was 0.806 (95% CI = 0.577-1.126), with a weight of 61.24%, 
while the estimate for Tang et al. (1999) was 0.941 (95% CI = 0.201-4.412), with a 
weight of 2.87%.  Both the fixed effects and D+L random effects pooled estimate for this 
meta-analysis were 0.872 (95% CI = 0.671-1.132), p = 0.760).  These results are 














Figure 3.  Meta-analysis of colon cancer risk among moderate versus low activity 
females in Compendium quantified studies in Analysis II 
 
A non-statistically significant difference (p = 0.760) between the moderate and low 
activity groups was present. 
 
 
Table 22.  Colon cancer risk among moderate versus low activity females in 












White (1996) 0.990 0.640-1.532 35.90 
Martinez (1997) 0.806 0.577-1.126 61.24 
Tang (1999) 0.941 0.201-4.412 2.87 
  
D+L Pooled Effect Size 0.872 0.671-1.132 100.00 -1.030 0.303 
 
  Heterogeneity !
2
 = 0.55 (d.f. = 2) p = 0.760 
  Estimate of between-study variance "
2







There was no statistically significant difference between the effect measures of 
the moderate and low activity females, and no statistically significant heterogeneity 
existed among the studies (p = 0.760).   
Among highly active females, the effect measure for White et al. (1996) was 
0.741 (95% CI = 0.415-1.324), with a study weight of 36.55%, while Martinez et al. 
(1997) had a effect measure of 0.617 (95% CI = 0.386-0.986), with a weight of 56.02%.  
The effect measure for Tang et al. (1999) was 0.807 (95% CI = 0.223-2.920) with a 
weight of 7.43%.  Both the fixed effects and D+L random effects pooled estimate for this 
meta-analysis were 0.673 (95% CI = 0.474-0.956; p = 0.027).  These results are displayed 









Figure 4.  Meta-analysis of colon cancer risk among high versus low activity females in 
Compendium quantified studies in Analysis II 
 








Table 23.  Colon cancer risk among high versus low activity females in Compendium 












White (1996) 0.741 0.415-1.324 36.55 
Martinez (1997) 0.617 0.386-0.986 56.02 
Tang (1999) 0.807 0.223-2.920 7.43 
  
D+L Pooled Effect Size 0.673 0.474-0.956 100.00 -2.213 0.027 
 
  Heterogeneity !
2
 = 0.32 (d.f. = 2) p = 0.854 
  Estimate of between-study variance "
2
 = 0.0000 
  
 
Analyses of Compendium-Quantified and Estimated Studies (Males and Females) 
 
Analysis III included studies of males in which physical activity could be 
quantified or estimated using the Compendium.  Four studies (Giovannucci et al. (1995), 
Longnecker et al. (1995), White et al. (1996), Tang et al. (1999) were included in this 
analysis.  A total of 306 cases, 249 controls, and 51,660 person-years were in the low 
activity group; 191 cases, 120 controls, and 104,939 person-years in the moderate activity 
group; and 161 cases, 168 controls, and 106,955 person-years in the high activity group.  
For moderately active males, the effect measures and confidence intervals for 
Giovannucci et al. (1995), White et al. (1996), and Tang et al. (1999) are reported above 
in the Analysis I section, while the study weights of the three studies for Analysis III 
were 41.01%, 36.75%, and 5.91%, respectively.  The effect measure for Longnecker et 
al. (1995) was 0.571 (95% CI = 0.241=1.355), with a study weight of 16.33%. No 
statistically significant difference existed between the moderate and low activity group 
for males in Analysis III.  Additionally, no statistically significant heterogeneity was 
reported within Analysis III (p = 0.114).  The fixed effects pooled estimate was 0.724 





was 0.750 (95% CI = 0.496-1.135), p = 0.174.  These results are displayed in Figure 5 on 










Figure 5.  Meta-analysis of colon cancer risk among moderate versus low activity males 
in Compendium quantified and estimated studies in Analysis III 
 
A non-statistically significant difference (p = 0.174) between the moderate and low 
activity groups was present. 
 
Table 24.  Colon cancer risk among moderate versus low activity males in Compendium 












Giovannucci (1995) 0.788 0.562-1.103 41.01 
Longnecker (1995) 0.571 0.241-1.355 16.33 
White (1996) 0.606 0.405-0.906 36.75 
Tang (1999) 4.286 0.854-21.506 5.91 
  
D+L Pooled Effect Size 0.750 0.496-1.135 100.00 -1.360 0.174 
 
  Heterogeneity !
2
 = 5.95 (d.f. = 3) p = 0.114 
  Estimate of between-study variance "
2





For the male high activity group, the effect measures and confidence intervals for 
Giovannucci et al. (1995), White et al. (1996), and Tang et al. (1999) are reported above 
in the Analysis I section, while the study weights for the three aforementioned studies are 
38.08%, 25.52%, and 5.10%, respectively.  Longnecker et al. (1995) reported a effect 
measure of 0.671 (95% CI = 0.440-1.025) and a study weight of 31.31% for the meta-
analysis.  A statistically significant difference between the high and low activity groups 
existed among males, and no statistically significant heterogeneity was reported (p = 
0.272).  The fixed effects pooled estimate was 0.579 (95% CI = 0.457-0.733), p < 0.001, 
while the D+L random effects pooled estimate was 0.574 (95% CI = 0.433-0.761), p       









Figure 6.  Meta-analysis of colon cancer risk among high versus low activity males in 
Compendium quantified and estimated studies in Analysis III 
 






Table 25.  Colon cancer risk among high versus low activity males in Compendium 












Giovannucci (1995) 0.527 0.365-0.760 38.08 
Longnecker (1995) 0.671 0.440-1.025 31.31 
White (1996) 0.664 0.408-1.079 25.52 
Tang (1999) 0.202 0.060-0.682 5.10 
  




 = 3.90 (d.f. = 3) p = 0.272 
  Estimate of between-study variance "
2
 = 0.0195 
   
 
Colon cancer risk among moderately and highly active females in Compendium 
quantified and estimated studies were assessed in Analysis IV.  A total of four studies 
(White et al. (1996), Martinez et al. (1997), Tang et al. (1999), and Calton (2006) were 
included in this meta-analysis.  A total of 334 cases, 97 controls, and 280,216 person-
years comprised the low activity group; 183 cases, 81 controls, and 177,935 person-years 
were included in the moderate activity group; and 107 cases, 43 controls, and 113,342 
person-years were included in the high activity group.  For moderately active females, the 
effect measures and confidence intervals for the White et al. (1996), Martinez et al. 
(1997), and Tang et al. (1999) studies are reported above in the Analysis II section.  The 
weights for each of those three studies in Analysis IV are   40.86%, 23.95%, and 1.91%, 
respectively.  The effect measure for Calton et al. (2006) was 0.696 (95% CI = 0.480- 
1.008), with a study weight of 33.28%.  A slight, but non-statistically significant 
difference existed between the moderate and low activity groups and there was no 
evidence of statistically significant heterogeneity in this analysis (p = 0.683). Both the 





(0.653-1.001), p = .051, as the estimate of between-study variance was zero ("
2
 = 0).  










Figure 7.  Meta-analysis of colon cancer risk among moderate versus low activity 
females in Compendium quantified and estimated studies in Analysis IV 
 
A non-statistically significant difference (p = 0.051) between the moderate and low 
activity groups was present. 
 
 
Table 26.  Colon cancer risk among moderate versus low activity females in 












White (1996) 0.806 0.577-1.126 40.86 
Martinez (1997) 0.990 0.640-1.532 23.95 
Tang (1999) 0.941 0.201-4.412    1.91 
Calton (2006) 0.696 0.480-1.008 33.28 
  
D+L Pooled Effect Size 0.809 0.653-1.001 100.00 -1.949 0.051 
 
  Heterogeneity !
2
 = 1.50 (d.f. = 3) p = 0.683 
    Estimate of between-study variance "
2







Among highly active females, the effect measures and confidence intervals for  
White et al. (1996), Martinez et al. (1997), and Tang et al. (1999) were included above in 
the section reporting Analysis II results.  The aforementioned three studies had study 
weights of 16.47%, 25.25%, and 3.35% for Analysis IV.  The effect measure for Calton 
et al. (2006) was 0.952 (0.693-1.308) and the study weight of 54.93%. A non-statistically 
significant difference existed between the effect measures of the high and low activity 
groups among females in Analysis IV, and there was no statistically significant 
heterogeneity in this analysis (p = 0.497).  Both the fixed effects and random effects D+L 
pooled estimate were the same for this meta-analysis (Pooled Effect Measure = 0.814 
(95% CI = 0.643-1.030), p = 0.087) because the estimate of between-study variance was 
zero ("
2









Figure 8.  Meta-analysis of colon cancer risk among high versus low activity females in 
Compendium quantified and estimated studies in Analysis IV 
 
A non-statistically significant difference (p = 0.497) between the high and low activity 





Table 27.  Colon cancer risk among high versus low activity females in Compendium 












White (1996) 0.741 0.415-1.324 25.25 
Martinez (1997) 0.617 0.386-0.986 16.47 
Tang (1999) 0.807 0.223-2.920 3.35 
Calton (2006) 0.952 0.693-1.308 54.93 
  
D+L Pooled Effect Size 0.814 0.643-1.030 100.00 -1.711 0.087 
 
  Heterogeneity !
2
 = 2.38 (d.f. = 3) p = 0.497 





Results for Breast Cancer Analyses 
The relationship between physical activity and breast cancer risk was assessed for 
pre- and postmenopausal females combined, premenopausal females, and 
postmenopausal females in six meta-analyses, titled Analysis I through Analysis VI.  
Unadjusted effect measures, confidence intervals, log of the effect measures, and 
standard errors for the original studies were calculated and included in Appendix II.  For 
all females, moderately and highly active individuals were compared to the more 
sedentary low activity reference group.  Additionally, calculating the percent-difference 
between the adjusted effect measures in the original studies and the unadjusted effect 
measures in the present analyses assessed the effect of confounding on the relationship 
between physical activity and breast cancer.  The effects of confounding are reported 
later in this chapter. 
 Analysis I assessed breast cancer risk among moderately and highly active pre- 
and postmenopausal females combined in studies quantifying physical activity using the 




al., 2001; Matthews et al., 2001; McTiernan et al., 2003; Yang et al., 2003; Patel et al., 
2003; Patel et al., 2003; Colditz et al., 2003; John et al., 2003; Bernstein et al., 2005) 
were included in this random effects meta-analysis.  This analysis included 7889 cases, 
5,972 controls, 23,826 non-cases, and 415,128 person-years in the low activity group; 
3706 cases, 2,555 controls, 29,200 non-cases, and 328,211 person-years in the moderate 
group; and 2,947 cases, 2,192 controls, 18,576 non-cases, and 462,641 person-years in 
the high activity group.  
For moderately active females in Analysis I, the unadjusted effect measure for the 
Carpenter et al. (1999) study was 1.043 (95% CI = 0.773-1.406), and the weight of the 
study for the meta-analysis was 4%.  The Friedenreich et al. (2001) study estimate was 
0.867 (95% CI = 0.634-1.185), with a weight of 3.70% for premenopausal females and 
0.852 (95% CI = 0.669-1.086), with a weight of 5.81% for postmenopausal females.  
Matthews et al. (2001) had a pooled effect measure of 0.738 (95% CI = 0.538-1.014) and 
study weight of 3.61%, while McTiernan et al. (2003) had an estimate of 0.996 (95% CI 
= 0.894-1.109) and weight of 19.03%.   
The pooled effect measure for Yang et al. (2003) was 0.640 (95% CI = 0.469-
0.873) with a 3.73% weight, while Colditz et al. (2003) had a effect measure of 0.927 
(95% CI = 0.775-1.109) and weight of 9.58%.  Patel et al. (2003) published a cohort and 
a case-control study examining the relationship between Compendium-quantified 
physical activity and breast cancer risk.  The cohort study had a effect measure of 0.924 
(95% CI = 0.818-1.044) and study weight of 16.49%, while the case-control study had a 
effect measure of 0.987 (95% CI = 0.726-1.341) and study weight of 3.82%.  Similar to 




females separately.  The effect measure and weight for the premenopausal females were 
0.938 (95% CI = 0.687-1.281) and 3.71%, while the postmenopausal effect measure was 
0.787 (95% CI = 0.634-0.977) and weight was 7.05%.  Most recently, the effect measure 
for Bernstein et al. (2005) was 0.982 (95% CI = 0.884-1.092), with a study weight of 
19.46%. 
 The overall D+L random effects pooled estimate for moderate versus low active 
females in Analysis I was 0.919 (95% CI = 0.863-0.978); p = 0.008, and a statistically 
significant difference existed between the effect measures of the two groups.  No 
statistically significant heterogeneity existed among the studies in this analysis (p = 

















Figure 9.  Meta-analysis of breast cancer risk among moderate versus low activity pre-
and postmenopausal females combined in Compendium quantified studies in Analysis I 
 
A statistically significant difference (p = 0.008) between the moderate and low activity 





Table 28.  Breast cancer risk among moderate versus low activity pre- and 












Carpenter (1999) 1.043 0.773-1.406 4.00 
Friedenreich-Pre (2001) 0.867 0.634-1.185 3.70 
Friedenreich-Post (2001) 0.852 0.669-1.086 5.81 
Matthews (2001) 0.738 0.538-1.014 3.61 
McTiernan (2003) 0.996 0.894-1.109 19.03 
Yang (2003) 0.640 0.469-0.873 3.73 
Patel-C (2003) 0.924 0.818-1.044 16.49 
Patel-CC (2003) 0.987 0.726-1.341 3.82 
Colditz (2003) 0.927 0.775-1.109 9.58 
John-Pre (2003) 0.938 0.687-1.281 3.71 
John-Post (2003) 0.787 0.634-0.977 7.05 
Bernstein (2005) 0.982 0.884-0.977 19.46 
  
D+L Pooled Effect Size 0.919 0.863-0.978 100.00 2.65 0.008 
 
  Heterogeneity !
2
 = 13.88 (d.f. = 11) p = 0.240 
  Estimate of between-study variance "
2
 = 0.0024 
 
 
 For highly active females, the effect measure for Carpenter et al. (2001) was 
0.702 (95% CI = 0.518-0.952), with a study weight of 7.09%.  Friedenreich et al. (2001) 
examined pre- and postmenopausal separately and had an estimate of 1.000 (95% CI = 
0.700-1.429) and weight of 6.11% for premenopausal females, and an estimate of 0.906 
(95% CI = 0.685-1.199) and weight of 7.58% for postmenopausal females.  The effect 
measure for Matthews et al. (2001) was 0.480 (95% CI = 0.336-0.687), with a study 
weight of 6.09%, while the estimate for McTiernan et al. (2003) was 1.017 (95% CI = 
0.901-1.145) and larger study weight of 11.02%.  The effect measure for Yang et al. 
(2003) was 0.544 (95% CI = 0.398-0.744) with a 6.92% study weight, while Colditz et al. 
(2003) had an estimate of 0.956 (95% CI = 0.820-1.115) and weight of 10.77%.  The 
pooled effect measure from the cohort study of Patel et al. (2003) was 0.882 (95% CI = 




control study was higher (Pooled Effect Measure = 1.110, 95% CI = 0.826-1.464), with a 
smaller weight of 7.46%.  John et al. (2003) reported separate estimates and weights for 
pre- and postmenopausal females (Pooled Effect Measure = 0.553, 95% CI = 0.394-0.775 
and study weight of 6.46%; Pooled Effect Measure = 0.678, 95% CI = 0.544-0.847 and 
study weight of 8.85%, respectively).  The pooled effect measure for Bernstein et al. 
(2005) was 0.982 (95% CI = 0.884-1.092) with a study weight of 11.29%.   
 The random effects pooled estimate for the highly active pre- and postmenopausal 
females combined compared to relatively sedentary group of females was 0.823 (95% CI 
= 0.725-0.933), p = 0.001.  There was a statistically significant lower effect measure for 
the high versus low active females, and statistically significant heterogeneity within this 
analysis (p < 0.001).  These results are reported below in Figure 10 and the Stata output 

















Figure 10.  Meta-analysis of breast cancer risk among high versus low activity pre-and 
postmenopausal females combined in Compendium quantified studies in Analysis I 
 





Table 29.  Breast cancer risk among high versus low activity pre- and postmenopausal 












Carpenter (1999) 0.702 0.518-0.952 7.09 
Friedenreich-Pre (2001) 1.000 0.700-1.429 6.11 
Friedenreich-Post (2001) 0.906 0.685-1.199 7.58 
Matthews (2001) 0.480 0.336-0.687 6.09 
McTiernan (2003) 1.017 0.901-1.148 11.02 
Yang (2003) 0.544 0.398-0.744 6.92 
Patel-C (2003) 0.882 0.771-1.008 10.77 
Patel-CC (2003) 1.100 0.826-1.464 7.46 
Colditz (2003) 0.956 0.820-1.115 10.35 
John-Pre (2003) 0.553 0.394-0.775 6.46 
John-Post (2003) 0.678 0.544-0.847 8.85 
Bernstein (2005) 0.982 0.884-1.092 11.29 
  
D+L Pooled Effect Size 0.777 0.659-0.915 100.00 3.20 0.001 
 
  Heterogeneity !
2
 = 47.96 (d.f. = 11) p < 0.001 
  Estimate of between-study variance "
2
 = 0.0329 
   
 
 Analysis II included Compendium-quantified studies from Analysis I that 
measured physical activity for at least ten years.  Eight studies and their respective 
weights (Carpenter et al., 1999 (6.77%); Friedenreich et al., 2001 (6.29% for 
premenopausal females and 9.54% for postmenopausal females); Matthews et al., 2001 
(6.14%); Yang et al., 2003 (6.34%); Patel et al., 2003 (6.49%); Colditz et al., 2003 
(14.79%); John et al., 2003 (6.31% for premenopausal females and 11.32% for 
postmenopausal females); and Bernstein et al., 2005 (26.02%) were included in this 
random effects meta-analysis for moderate activity.  The random effects D+L pooled 
estimate was 0.890 (95% CI = 0.818-0.969) with a significance level of p = 0.007.  Both 
a statistically significant difference between moderate and low activity females and non-
statistically significant amount of heterogeneity (p = 0.221) were present in this analysis, 


















Figure 11.  Meta-analysis of breast cancer risk among moderate versus low activity pre- 
and postmenopausal females combined in Compendium quantified (>10 years) studies in 
Analysis II 
 
A statistically significant difference (p = 0.007) between the moderate and low activity 
groups was present. 
 
 
Table 30.  Breast Cancer Risk among Moderate Versus Low Activity Pre-and 













Carpenter (1999) 1.043 0.773-1.406 6.77 
Friedenreich-Pre (2001) 0.867 0.634-1.185 6.29 
Friedenreich-Post (2001) 0.852 0.669-1.086 9.54 
Matthews (2001) 0.738 0.538-1.014 6.14 
Yang (2003) 0.640 0.469-0.873 6.34 
Patel-CC (2003) 0.987 0.726-1.341 6.49 
Colditz (2003) 0.927 0.775-1.109 14.79 
John-Pre (2003) 0.938 0.687-1.281 6.31 
John-Post (2003) 0.787 0.634-0.977 11.32 
Bernstein (2005) 0.982 0.884-1.092 26.02 
  
D+L Pooled Effect Size 0.890 0.818-0.969 100.00 2.69 0.007 
 
  Heterogeneity !
2
 = 11.86 (d.f. = 9), p = 0.221 
    Estimate of between-study variance "
2
 = 0.0043 





For the high activity analysis, the random effects D+L pooled estimate was 0.777 
(95% CI = 0.659-0.915), p = 0.002, as reported below in Figure 12 and the Stata output.  
A statistically significant difference between the effect measures of the high and low 
activity females was reported.  Additionally, statistically significant heterogeneity (p < 
0.001) was reported for this analysis.  Carpenter et al. (1999) had a weight of 9.37%, 
while Friedenreich et al. (2001) had a weight of 8.35% for premenopausal females and 
9.86% for postmenopausal females, and the weight for Matthews et al. (2001) was 
8.33%.  In 2003, Yang et al., Patel et al., and Colditz et al. had weights of 9.19%, 9.73%, 
and 12.33%, respectively.  Study weights for John et al. (2003) were 8.71% for 
premenopausal females and 11.04% for postmenopausal females.  Finally, the Bernstein 
et al. (2005) study weight was 13.09%. The moderate and high activity effect measures 
and confidence intervals for the following studies are described above in the discussion 








Figure 12.  Meta-analysis of breast cancer risk among high versus low activity pre- and 
postmenopausal females combined in Compendium quantified (>10 Years) studies in 
analysis II 
 




Table 31.  Breast cancer risk among high versus low activity pre- and postmenopausal 




 95% Confidence  







Carpenter (1999) 0.702 0.518-0.952 9.37 
Friedenreich-Pre (2001) 1.000 0.700-1.429 8.35 
Friedenreich-Post (2001) 0.906 0.685-1.199 9.86 
Matthews (2001) 0.480 0.336-0.687 8.33 
Yang (2003) 0.544 0.398-0.744 9.19 
Patel-CC (2003) 1.100 0.826-1.464 9.73 
Colditz (2003) 0.956 0.820-1.115 12.33 
John-Pre (2003) 0.553 0.394-0.775 8.71 
John-Post (2003) 0.678 0.544-0.847 11.04 
Bernstein (2005) 0.982 0.884-1.092 13.09 
  
D+L Pooled Effect Size 0.777 0.659-0.915 100.00 3.03 0.002 
 
  Heterogeneity !
2
 = 42.60 (d.f. = 9) p = <0.001 
    Estimate of between-study variance "
2




 Fifteen studies were included in Analysis III.  In addition to the ten studies 
included in Analysis I that directly quantified physical activity using the Compendium, 
five additional studies (Thune et al., 2007; Levi et al., 1999; Rockhill et al., 1999); 
Moradi et al., 2000; Dirx et al., 2001) for which the quantity of physical activity could be 
indirectly estimated using the Compendium were also included in this random effects 
meta-analysis.  For moderately active pre- and postmenopausal females combined, the 
effect measures and confidence intervals for the five aforementioned studies were 
reported as 0.087 (95% CI = 0.676-1.163); 0.447 (95% CI = 0.334-0.598); 0.908 (95% CI 
= 0.844-0.976); 1.100 (95% CI = 0.960-1.260); and 1.164 (95% CI = 0.8731.551), 
respectively.   
The effect measures and confidence intervals for moderately active females from the 
remaining ten studies included in Analysis III are described above with the Analysis I 
results.  
The same study may have a different weight in each analysis dependent on this 
study’s relative sample size compared to the other studies included in the analysis.  For 
Analysis III, the following weights from the fifteen studies are included in parentheses 
next to the study author: Thune et al., 1997 (4.66%); Carpenter et al., 1999 (4.15%); Levi 
et al., 1999 (4.30%); Rockhill et al., 1999 (9.96%); Moradi et al., 2000 (8.17%); 
Friedenreich et al., 2001 (3.93% for pre- and 5.27% for postmenopausal females); 
Matthews et al., 2001 (3.86%); Dirx et al., 2001 (4.36%); McTiernan et al., 2003 
(9.00%); Yang et al., 2003 (3.95%); Patel et al., 2003 (8.59% for the cohort study and 
4.02% for the case-control study); Colditz et al., 2003 (6.89%); John et al., 2003 (3.94% 




 The random effects D+L pooled estimate for the moderate versus low active 
females for Analysis III was 0.897 (95% CI = 0.831-0.970), p = 0.006.  A statistically 
significant difference existed between the moderate and low active females, and a 
statistically significant amount of heterogeneity between studies was reported (p < 























Figure 13.  Meta-analysis of breast cancer risk among moderate versus low activity pre- 
and postmenopausal females combined in Compendium quantified and estimated studies 
in Analysis III 
 
A statistically significant difference (p = 0.006) between the moderate and low activity 












Table 32.  Breast cancer risk among moderate versus low activity pre- and 













Thune (1997) 0.887 0.676-1.163 4.66 
Carpenter (1999) 1.043 0.773-1.406 4.15 
Levi (1999) 0.447 0.334-0.598 4.30 
Rockhill (1999) 0.908 0.844-0.976 9.96 
Moradi (2000) 1.100 0.960-1.260 8.17 
Friedenreich-Pre (2001) 0.867 0.634-1.185 3.93 
Friedenreich-Post (2001) 0.852 0.669-1.086 5.27 
Matthews (2001) 0.738 0.538-1.014 3.86 
Dirx (2001) 1.164 0.873-1.551 4.36 
McTiernan (2003) 0.996 0.894-1.109 9.00 
Yang (2003) 0.640 0.469-0.873 3.95 
Patel-C (2003) 0.924 0.818-1.044 8.59 
Patel-CC (2003) 0.987 0.726-1.341 4.02 
Colditz (2003) 0.927 0.775-1.109 6.89 
John-Pre (2003) 0.938 0.687-1.281 3.94 
John-Post (2003) 0.787 0.634-0.977 5.88 
Bernstein (2005) 0.982 0.884-1.092 9.07 
  
D+L Pooled Effect Size 0.897 0.831-0.970 100.00 2.74 0.006 
 
  Heterogeneity !
2 
= 46.98 (d.f. = 16) p = < 0.001 
  Estimate of between-study variance "
2
 = 0.0143 
   
 
Highly active females had effect measures of 0.647 (95% CI = 0.431-0.971) for 
the Thune et al. (1997) study; 0.387 (95% CI = 0.222-0.674) for the Levi et al. (1999) 
study; 0.790 (95% CI = 0.718-0.868) for the Rockhill et al. (1999) study; 0.817 (95% CI 
= 0.715-0.933) for the Moradi et al. (2000) study, and 1.145 (95% CI = 0.861-1.524) for 
the Dirx et al. (2001) study.  The effect measures and confidence intervals for the highly 
active females from the remaining ten studies included in Analysis III are discussed 
above with the Analysis I results. 
The weights for the fifteen studies are included in parentheses next to the study 




(2.66%); Rockhill et al., 1999 (7.43%); Moradi et al., 2000 (7.77%); Friedenreich et al., 
2001 (4.50% for pre- and 5.55% for postmenopausal females); Matthews et al., 2001 
(4.49%); Dirx et al., 2001 (5.46%); McTiernan et al., 2003 (7.93%); Yang et al., 2003 
(5.08%); Patel et al., 2003 (7.76% for the cohort study and 5.46% for the case-control 
study); Colditz et al., 2003 (7.48%); John et al., 2003 (4.75% for pre- and 6.43% for 
postmenopausal females); and Bernstein et al., 2005 (8.12%).  
 The random effects D+L pooled estimate for the moderate versus low activity 
females for Analysis III was 0.797 (95% CI = 0.715-0.889), and the difference was 
statistically significant (p < 0.001).  A statistically significant amount of heterogeneity 
between studies was also present (p < 0.001).  These analyses are presented below in 
Figure 14 and the corresponding Stata output. 
 
Figure 14.  Meta-analysis of breast cancer risk among high versus low activity pre- and 










Table 33.  Breast cancer risk among high versus low activity pre- and postmenopausal 






% Weight Asymptotic 
  Z- Value 
P-
Value 
Thune (1997) 0.647 0.421-0.971 3.94 
Carpenter (1999) 0.702 0.518-0.952 5.20 
Levi (1999) 0.387 0.222-0.674 2.66 
Rockhill (1999) 0.696 0.595-0.815 7.43 
Moradi (2000) 0.817 0.715-0.933 7.77 
Friedenreich-Pre (2001) 1.000 0.700-1.429 4.50 
Friedenreich-Post (2001) 0.906 0.685-1.199 5.55 
Matthews (2001) 0.480 0.336-0.687 4.49 
Dirx (2001) 1.145 0.861-1.524 5.46 
McTiernan (2003) 1.017 0.901-1.148 7.93 
Yang (2003) 0.544 0.398-0.744 5.08 
Patel-C (2003) 0.882 0.771-1.008 7.76 
Patel-CC (2003) 1.100 0.826-1.464 5.46 
Colditz (2003) 0.956 0.820-1.115 7.48 
John-Pre (2003) 0.553 0.394-0.775 4.75 
John-Post (2003) 0.678 0.544-0.847 6.43 
Bernstein (2005) 0.982 0.884-1.092 8.12 
  
D+L Pooled Effect Size 0.797 0.715-0.889 100.00 4.09 <0.001 
 
  Heterogeneity !
2 
= 71.36 (d.f. = 16) p < 0.001 
    Estimate of between-study variance "
2
 = 0.0348 
    Test of Effect Size=1: z = 4.09, p < 0.001 
 
Analyses of Premenopausal Females 
 Analysis IV consisted of three studies (Friedenreich et al., 2001; Colditz et al., 
2003; John et al., 2003) included in an analysis of the relationship between Compendium-
quantified physical activity and breast cancer risk among premenopausal females.  The 
effect measures and confidence intervals for moderately and highly active females within 
these three studies are included above in the Analysis I results section.  Both the fixed 




(Pooled Effect Measure = 0.917, 95% CI = 0.798-1.054, p = 0.222), as the estimate of 
between-study variance was zero ("
2
 = 0).  There was no statistically significant 
difference between the effect measures of the moderate versus low activity 
premenopausal females. The weights for the three studies included in the random effects 
analysis were 19.82% (Friedenreich et al., 2001), 60.28% (Colditz et al., 2003), and 
19.90% (John et al., 2003). No statistically significant heterogeneity was reported for the 
random effects analysis (p = 0.924) and the fixed and random effects results are 
compared in the Stata output below.  The random effects analysis results are displayed in 









Figure 15.  Meta-analysis of breast cancer risk among moderate versus low activity 
premenopausal females in Compendium quantified studies in Analysis IV 
 
A non-statistically significant difference (p = 0.222) between the moderate and low 






Table 34.  Breast cancer risk among moderate versus low activity premenopausal 











Friedenreich (2001) 0.867 0.634-1.185 19.82 
Colditz (2003) 0.927 0.775-1.109 60.28 
John (2003) 0.938 0.687-1.281 19.90 
  
D+L Pooled Effect Size 0.917 0.798-1.054 100.00 -1.222 0.222 
 
  Heterogeneity !
2
 = 0.16 (d.f. = 2) p = 0.924 
    Estimate of between-study variance "
2
 = 0.0000 
 
 
For the high activity group, the fixed effects pooled estimate was 0.887 (95% CI 
= 0.778-1.010), p = 0.070, while the D+L random effects pooled estimate was 0.820 
(95% CI = 0.584-1.151), p = 0.251.  The slight difference in pooled effect measures ("
2
 = 
0.0684) indicated a slight of variance between the studies.  A non-statistically significant 
difference existed between the effect measures of the high and low activity 
premenopausal females.  These results are displayed in Figure 16 below.  The weights for 
the Friedenreich et al. (2001), Colditz et al. (2003), and John et al. (2003) studies were 
29.43%, 40.09%, and 30.48%, respectively, and a statistically significant amount of 
heterogeneity was present (p = 0.012), as reported in the Stata output below with the 














Figure 16.  Meta-analysis of breast cancer risk among high versus low activity 
premenopausal females in Compendium quantified studies in Analysis IV 
 
A non-statistically significant difference (p = 0.012) was present between the high and 
low activity groups. 
 
 
Table 35.  Breast cancer risk among high versus low activity premenopausal females in 










Friedenreich (2001) 1.000 0.700-1.429 29.43 
Colditz (2003) 0.956 0.820-1.115 40.09 
John (2003) 0.553 0.394-0.775 30.48 
  
D+L Pooled Effect Size 0.820 0.584-1.151 100.00 -1.148 0.251 
 
  Heterogeneity !2 = 8.88 (d.f. = 2) p = 0.012 
  Estimate of between-study variance "
2








Analyses of Postmenopausal Females 
  Five studies and their respective weights for the moderate versus low activity and 
analysis (Carpenter et al., 1999 (7.03%); Friedenreich et al., 2001 (10.36%); McTiernan 
et al., 2003 (37.85%); Patel et al., 2003 (32.08%); and John et al., 2003 (12.67%) were 
included in Analysis V, a meta-analysis of the relationship between Compendium-
quantified physical activity and postmenopausal breast cancer risk.  The effect measures 
and confidence intervals for the aforementioned five studies are included above in the 
Analysis I results section.  The random effects D+L pooled estimate for this meta-
analysis was 0.932 (95% CI = 0.858-1.011), p = 0.302, and no statistically significant 
difference between the effect measures of moderate and low activity postmenopausal 
females was reported.  The between-study heterogeneity was not statistically significant 










Figure 17.  Meta-analysis of breast cancer risk among moderate versus low activity 





A non-statistically significant difference (p = 0.090) between the moderate and low 
activity groups was present. 
 
Table 36.  Breast cancer risk among moderate versus low activity postmenopausal 










Carpenter (1999) 1.043 0.773-1.406 7.03 
Friedenreich (2001) 0.852 0.669-1.086 10.36 
McTiernan (2003) 0.996 0.894-1.109 37.85 
Patel - C (2003) 0.924 0.818-1.044 32.08 
John (2003) 0.787 0.634-0.977 18.96 
  
D+L Pooled Effect Size 0.932 0.858-1.011 100.00 1.69 0.090 
 
  Heterogeneity !
2 
= 4.86 (d.f. = 4) p = 0.302 
    Estimate of between-study variance "
2
 = 0.0016 
 
    
 Among highly active postmenopausal females, the study weights in the meta-
analysis for the five studies were 14.03% (Carpenter et al., 1999); 15.34% (Friedenreich 
et al., 2001); 26.30% (McTiernan et al., 2003); 25.38% (Patel et al., 2003), and 18.96% 
(John et al., 2003), while the effect measures and confidence intervals for the five studies 
are included above in the Analysis I results section.  The random effects D+L pooled 
estimate for this analysis was 0.847 (95% CI = 0.727-0.987), with a statistical 
significance of p = 0.034.  A statistically significant difference between the effect 
measures of the high and low activity postmenopausal females was reported, as was a 
statistically significant amount of between-study heterogeneity (p = 0.012).  These results 


















Figure 18.  Meta-analysis of breast cancer risk among high versus low activity 
postmenopausal females in Compendium quantified studies in Analysis V 
 




Table 37.  Breast cancer risk among high versus low activity postmenopausal females in 










Carpenter (1999) 0.702 0.518-0.952 24.03 
Friedenreich (2001) 0.906 0.685-1.199 15.34 
McTiernan (2003) 1.017 0.901-1.148 26.30 
Patel - C (2003) 0.882 0.771-1.008 25.38 
John (2003) 0.678 0.544-0.847 18.96 
  
D+L Pooled Effect Size 0.847 0.727-0.987 100.00 2.12 0.034 
 
  Heterogeneity !
2
 = 12.77 (d.f. = 4), p = 0.012 
    Estimate of between-study variance "
2
 = 0.0194 





Analysis VI includes the five studies from Analysis V as well as two additional 
studies (Moradi et al., 2000; Dirx et al., 2001) for which MET hours-per-week could be 
estimated using the Compendium.  The effect measures and confidence intervals for these 
two studies are included in the Analysis III results, while the estimates and intervals from 
the other five studies are included in the results discussion of Analysis I.  The weights for 
the studies in this analysis of moderate versus low activity postmenopausal females were 
7.01% (Carpenter et al., 1999); 19.49% (Moradi et al., 2000); 9.69% (Friedenreich et al., 
2001); 7.48% (Dirx et al., 2001); 23.51% (McTiernan et al., 2003); 21.44% (Patel et al., 
2003); and 11.38% (John et al., 2003).  The random effects D+L pooled estimate was 
0.973 (95% CI = 0.890-1.062), p = 0.536.  Both a non-statistically significant difference 
between the two effect measures and non-statistically significant level of between-study 
heterogeneity were reported for this analysis (p = 0.105).  These results are reported in 



































Figure 19.  Meta-analysis of breast cancer risk among moderate versus low activity 
postmenopausal females in Compendium quantified and estimated studies in Analysis VI 
 
A non-statistically significant difference (p = 0.536) between the moderate and low 
activity groups was reported. 
 
 
Table 38.  The risk among moderate versus low Activity postmenopausal females in 










Carpenter (1999) 1.043 0.773-1.406 7.01 
Moradi (2000) 1.100 0.960-1.260 19.49 
Friedenreich (2001) 0.852 0.669-1.086 9.69 
Dirx (2001) 1.164 0.873-1.551 7.48 
McTiernan (2003) 0.996 0.894-1.109 23.51 
Patel - C (2003) 0.924 0.818-1.044 21.44 
John (2003) 0.787 0.634-0.977 11.38 
  
D+L Pooled Effect Size 0.973 0.890-1.062 100.00 0.62 0.536 
 
  Heterogeneity !
2
 = 10.51 (d.f. = 6), p = 0.105 
  Estimate of between-study variance "
2






 For highly active postmenopausal females, the effect measures and confidence 
intervals are reported in the Analysis I and III sections. The weights for the studies in this 
analysis of moderate versus low activity postmenopausal females were 9.51% (Carpenter 
et al., 1999); 18.60% (Moradi et al., 2000); 10.48% (Friedenreich et al., 2001); 10.25% 
(Dirx et al., 2001); 19.34% (McTiernan et al., 2003); 18.55% (Patel et al., 2003); and 
13.27% (John et al., 2003).  The random effects D+L pooled estimate was 0.870 (95% CI 
= 0.771-0.982), p = 0.024, and a statistically significant difference between the effect 
measures of the high and low activity postmenopausal females was reported.  
Additionally, a statistically significant amount of heterogeneity was reported for this 
analysis (p = 0.008).  These results are reported in Figure 20 and the Stata output below.   
 
 
Figure 20.  Meta-analysis of breast cancer risk among high versus low activity 


















Table 39.  Breast cancer risk among high versus low activity postmenopausal females in 












Carpenter (1999) 0.702 0.518-0.952 9.51 
Moradi (2000) 0.817 0.715-0.933 18.60 
Friedenreich (2001) 0.906 0.685-1.199 10.48 
Dirx (2001) 1.145 0.861-1.524 10.25 
McTiernan (2003) 1.017 0.901-1.148 19.34 
Patel - C (2003) 0.882 0.771-1.008 18.55 
John (2003) 0.678 0.544-0.847 13.27 
  
D+L Pooled Effect Size 0.870 0.771-0.982 100.00 2.26 0.024 
 
  Heterogeneity !
2
 = 17.37 (d.f. = 6) p = 0.008 
    Estimate of between-study variance "
2
 = 0.0158 
    
 
Summary of Results from Meta-Analyses 
 Tables 40 and 41 provide a summary of the effect measures, confidence intervals, 
and p-values for the four meta-analyses of physical activity and colon cancer risk and the 
six meta-analyses of physical activity and breast cancer risk, respectively. 
 
Colon Cancer Analyses 
Table 40.  Summary of results from colon cancer meta-analyses 



















I 0.817 0.484-1.379 0.449 0.524 0.348-0.788 0.002 
II 0.872 0.671-1.132 0.303 0.673 0.474-0.956 0.027 
III 0.750 0.496-1.135 0.174 0.574 0.433-0.761 <0.001 







Breast Cancer Analyses 
 
Table 41.  Summary of results from breast cancer meta-analyses 
 



















I 0.919 0.863-0.978 0.008 0.816  0.721-0.924 0.033 
II 0.890 0.818-0.969 0.007 0.777 0.659-0.915 0.002 
III 0.897 0.831-0.970 0.006 0.797 0.715-0.889 <0.001 
IV 0.917 0.798-1.054 0.222 0.820 0.584-1.151 0.251 
V 0.932 0.858-1.011 0.090 0.847 0.727-0.987 0.034 
VI 0.973 0.890-1.062 0.536 0.870 0.771-0.982 0.024 
 
Comparisons of Unadjusted and Adjusted Effect measures  
Colon Cancer Analyses 
 To assess the possible impact of confounding, all unadjusted, age-adjusted (where 
applicable), and multivariate-adjusted (where applicable) effect measures, confidence 
intervals, and percent differences between the effect measures across all physical activity 
categories are included in Tables 42.1-42.8.  Overall, the percent difference between the 
adjusted and unadjusted estimates ranged from 0-31% across all physical activity 
categories for 5 of 6 studies, with one study (Tang et al., 1999) reporting a difference 
ranging from 5% to 93% between the adjusted and unadjusted effect measures. 
Giovannucci et al. (1995) percent-differences between the multivariate-adjusted 
and unadjusted effect measures were calculated to be -1.37%, 10.64%, 16.67%, and 
24.53% across five physical activity categories, while differences for Longnecker et al. 
(1995) were -30.86%, -21.28%, and -17.54% across three activity categories.  While 
these two studies examined colon cancer risk in males, White et al. (1996) examined 




1.56%, -25.42%, and 4.35% across three activity categories were calculated in males and 
3.45%, 1.67%, and -23.33% were calculated in females.  Martinez et al. (1997) produced 
differences of 2.82%, 6.41%, 2.99%, and -14.81% in females, while differences of        
-93.24% and -5.26% across two activity categories in males and -80.77% and -28.57% in 
females were calculated for Tang et al. (1999).  More recently, estimate differences for 
Calton et al. (2006) were calculated as 31.09%, 19.54%, and 13.64%.           
 
Breast Cancer Analyses 
 To assess the possible impact of confounding on breast cancer analyses, all 
unadjusted, age-adjusted (where applicable), and multivariate-adjusted (where 
applicable) effect measures, confidence intervals, and percent differences between the 
effect measures across all physical activity categories are included in Tables 43.1 through 
43.17.  Overall, the percent difference between the adjusted and unadjusted estimates 
ranged from 0-21% across all physical activity categories for 14 of 15 studies, with one 
study (Patel et al., 2003) reporting a difference ranging from 20% to 64%.    
Specifically, differences between the multivariate-adjusted and unadjusted effect 
measures for Thune et al. (1997) were calculated as 4.30% and -3.17% across two 
physical activity categories for pre- and postmenopausal females combined, while 
differences for Carpenter et al. (1999) were 4.65%, -2.17%, 2.80%, and 13.58% across 
four activity categories for postmenopausal females.  Levi et al. (1999) produced 
differences of -2.27% and 7.14% across two activity categories for pre- and 
postmenopausal females combined, and differences for Rockhill et al. (1999) were 




and postmenopausal females combined.  In 2000, Moradi et al. reported consistently 
larger differences of 18.00%, 15.38%, and 12.73% across three physical activity 
categories for postmenopausal females.  A year later, Friedenreich et al. (2001) allowed 
for a separate analysis of pre- and postmenopausal females. Estimate differences for 
premenopausal females were 7.41%, 4.85%, and 11.50% across three activity categories 
while postmenopausal differences were 7.29%, 6.82%, and 17.27%.  The Matthews et al. 
study (2001) produced effect measure differences of -7.41%, -12.82%, -7.58%, and             
-20.00% across four activity categories for pre- and postmenopausal females combined, 
while differences for Dirx et al. were -5.41% and -7.48% across two categories for 
postmenopausal females.   
 More recently, differences between adjusted and unadjusted estimates for 
McTiernan et al. (2003) were -.6.67%, -10.98%, -14.61%, -18.07%, and -14.10% across 
five activity categories for postmenopausal females, while differences for Yang et al. 
(2003) were -2.20%, -2.99%, -20.75%, and -14.89% across four categories for pre- and 
postmenopausal females combined.  In 2003, Patel et al. completed both a cohort and 
case-control study of the relationship between physical activity and breast cancer risk.  
Estimate differences for the cohort study were 1.06%, 1.30%, and 1.41% across three 
activity categories for postmenopausal females, while much larger differences of               
-20.00%, -27.69%, -63.93%, -52.38%, and -53.85% were calculated for combined pre- 
and postmenopausal females in the case-control study.  Premenopausal effect measure 
differences from Colditz et al. (2003) were calculated as -2.86%, 2.11%, -0.97%, and 
4.81% across four physical activity categories.  Similar to the Friedenreich et al. (2001) 




differences in effect measures for premenopausal females were 10.48% and 17.91% 
across two activity categories, while differences of 7.06% and 8.11% were calculated for 
postmenopausal females.  Most recently, Bernstein et al. (2005) had estimate differences 
of -3.23%, -8.05%, -19.51%, and -12.50% across four activity categories for pre- and 
postmenopausal females combined.                    
 
Results from Meta-Regression Model for Breast Cancer Analyses 
 Two mixed effects meta-regression models were completed for moderate and high 
activity females to determine if the relationship between physical activity and breast 
cancer risk differed between females of differing menopausal status.  Only studies that 
stratified females by menopausal status when assessing the effect of physical activity on 
breast cancer risk were included in the mixed effects models.  For the moderate activity 
females, there was no statistically significant difference in breast cancer risk between 
females of differing menopausal status (p = 0.476).  A similar non-statistically significant 
difference was found between high activity pre- and postmenopausal females (p = 0.865).  
Results from the meta-regression analyses are in Appendix IV and possible reasons for 







Tables of Confounding Effects for All Meta-Analyses 
 
Table 42.  Overview of the Effects of Confounding Variables – Colon Cancer 
 
Table 42 shows the physical activity quantification level (e.g. # of MET Hours-Per-Week), the unadjusted effect measure for each of 
the combined physical activity categories, the unadjusted effect measure, age-adjusted effect measure (where included in the original 
study), and multivariate-adjusted effect measure (where included in the original study) are included for each individual physical 
activity categorization level.  Finally, the percent different between the unadjusted effect measure and multivariate-adjusted effect 
measure (except in cases where only age-adjusted was reported) for each individual physical activity categorization level were 
calculated and reported. For each of the studies included in the meta-analyses, weekly physical activity quantifications were analyzed 
across three categories – low, moderate, and high activity.  For some studies this required combining some of the original physical 
activity categories. 












































0.9  1.0 1.0 1.0 1.0 - 
4.8 0.74 (0.49-1.10) 0.69 (0.46-1.02) 0.73 (0.48-1.10) -1.37% 
11.3 
 
0.79 (0.56-1.10) 0.84 (0.57-1.24) 0.83 (0.56-1.23) 0.94 (0.63-1.39) 10.64% 
22.6 0.65 (0.43-0.99) 0.67 (0.44-1.02) 0.78 (0.51-1.20) 16.67% 
46.8 
 
0.53 (0.36-0.76) 0.40 (0.25-0.66) 0.44 (0.27-0.71) 0.53 (0.32-0.88) 24.53% 
 
* 4.8 and 11.3 median MET-hr/wk groups combined for moderate vs. low activity comparison 
* 22.6 and 46.8 median MET-hr/wk groups combined for high vs. low activity comparison 
** Multivariate model adjusted for body mass index, age, and history of endoscopic screening or polyp 
    diagnosis, family history of colorectal cancer, smoking, aspirin use, folate, alcohol, methione, dietary fiber and red meat 
    intake 
 
 












































0  1.0 1.0 1.0 - 
!1/2 
1.0 
1.06 (0.38-2.94) 0.73 (0.23-2.29) 0.81 (0.26-2.54) -30.86% 
1 0.57 (0.24-1.36) 0.57 (0.24-1.36) 0.47 (0.16-1.36) 0.36 (0.11-1.14) -21.28% 
2+ 0.67 (0.44-1.02) 0.67(0.44-1.02) 0.60 (0.35-1.00) 0.57 (0.33-0.97) -17.54% 
 
* 0 and !1/2 hr/wk groups combined for low activity and compared to 1 hr/wk for moderate vs. low activity  
* 0 and !1/2 hr/wk groups combined for low activity and compared to 2+ hrs/wk for high vs. low activity 
** Multivariate model adjusted for smoking, income , race, family history of colorectal cancer, body mass index, and 
    alcohol intake  
*** Multivariate model adjusted for same variables as above, as well as total energy, fat, fiber, and calcium intake 
 
 














Effect Measure  













0  1.0 1.0 1.0 - 
! 7.30 0.63 (0.37-1.05) 0.64 (0.38-1.07) 1.56% 
7.30-17.88 
0.61 (0.41-0.91) 
0.74 (0.45-1.22) 0.59 (0.37-0.96) -25.42% 
" 17.88 0.66 (0.41-1.08) 0.66 (0.41-1.08) 0.69 (0.42-1.13) 4.35% 
 
* ! 7.30 and 7.30-17.88 MET-hr/wk groups combined for moderate vs. low activity comparison 











Combined Unadjusted  














0  1.0 1.0 1.0 - 
! 7.30 0.84 (0.49-1.43) 0.87 (0.51-1.49) 3.45% 
7.30-17.88 
0.99 (0.64-1.53) 
1.18 (0.68-2.03) 1.20 (0.69-2.08) 1.67% 
" 17.88 0.74 (0.41-1.32) 0.74 (0.41-1.32) 0.60 (0.41-1.34) -23.33% 
 
* ! 7.30 and 7.30-17.88 MET-hr/wk groups combined for moderate vs. low activity comparison 













































<2 1.0 1.0 1.0 - 
2-4 
1.0 
0.69 (0.49-0.95) 0.69 0.71 (0.44-1.15) 2.82% 
5-10 0.73 (0.48-1.13) 0.74 0.78 (0.50-1.20) 6.41% 
11-21 
 
0.81 (0.58-1.13) 0.65 (0.41-1.03) 0.65 0.67 (0.42-1.07) 2.99% 
>21 0.62 (0.39-0.99) 0.62(0.39-0.99) 0.52 0.54 (0.33-0.90) -14.81% 
 
* <2 and 2-4 MET-hr/wk groups combined in low group and 5-10 and 11-21 MET-hr/wk groups combined in moderate 
   group for moderate vs. low activity analysis 
** No confidence intervals reported for the age-adjusted effect measures 
*** Multivariate model adjusted for age, cigarette smoking, family history of colorectal cancer, body mass index, postmenopausal 





























Combined Unadjusted  




















0 1.0 1.0 1.0 - 
<20 4.29 (0.85-21.41) 4.65 (0.54-40.12)       2.22 (0.68-7.21) -93.24% 
>20 0.20 (0.06-0.68) 0.11 (0.01-0.87) 0.19 (0.05-0.77) -5.26% 
 
  * Multivariate model adjusted for total energy intake, dietary fiber, total vegetable protein, smoking, alcohol use, and 





Table 42.7.  Tang et al. (Case-Control; Females) 
 




  MET-Hours Per  




Combined Unadjusted  




















0 1.0 1.0 1.0 - 
<20 0.94 (0.20-4.41) 0.88 (0.11-7.09) 0.52 (0.13-2.03) -80.77% 
>20 0.81 (0.23-2.92) 0.78 (0.19-3.14) 0.63 (0.18-2.18) -28.57% 
 












































0 1.0 1.0 1.0 - 
0.1-1.0 
1.0 
0.82 (0.59-1.14) 1.02 (0.73-1.43) 1.19 (0.85-1.66) 31.09% 
1.1-2.0 0.70 (0.48-1.01) 0.70 (0.48-1.01) 0.78 (0.53-1.14) 0.87 (0.59-1.29) 19.54% 
2.1-14.0 0.95 (0.69-1.31) 0.95 (0.69-1.31) 0.99 (0.71-1.39) 1.10 (0.78-1.55) 13.64% 
 
* Hours per Day converted to Hours per Week 
* MET value assumed from activities listed in study to estimate MET-hours/week 
** 0 and 0.1-1.0 Hr/day groups combined in low activity group for moderate and high vs. low activity analyses 
*** Multivariate model adjusted for age, body mass index, education, family history of colorectal cancer, smoking status, 






Table 43.  Overview of the Effects of Confounding Variables – Breast Cancer  
 
Table 43 shows the physical activity quantification level (e.g. # of MET Hours-Per-Week), the unadjusted effect measure for each of 
the combined physical activity categories, the unadjusted effect measure, age-adjusted effect measure (where included in the original 
study), and multivariate-adjusted effect measure (where included in the original study) are included for each individual physical 
activity categorization level.  Finally, the percent different between the unadjusted effect measure and multivariate-adjusted effect 
measure (except in cases where only age-adjusted was reported) for each individual physical activity categorization level were 
calculated and reported. For each of the studies included in the meta-analyses, weekly physical activity quantifications were analyzed 
across three categories – low, moderate, and high activity.  For some studies this required combining some of the original physical 
activity categories. 
 
      











Combined Unadjusted  




















<2 1.0 1.0 1.0 - 
2-4 0.89 (0.68-1.16) 0.98 (0.75-1.28) 0.93 (0.71-1.22) 4.30% 
"5  0.65 (0.43-0.97) 0.67 (0.44-1.00) 0.63 (0.42-0.95) -3.17% 
 
* MET values developed based on reported activities in study to estimate MET-hours per week 



















Combined Unadjusted  










% Difference between 
Multivariate-adjusted 
and Unadjusted Effect 
Measures 
0  1.0 1.0 - 




0.94 (0.67-1.31) 0.92 (64-1.31) -2.17% 
8.75-17.59 1.04 (0.77-1.41) 1.04 (0.77-1.41) 1.07 (0.77-1.49) 2.80% 
" 17.6 .70 (0.52-0.95) .70 (0.52-0.95) 0.81 (0.57-1.15) 13.58% 
 
* 0, 0.1-3.74, and 3.75-8.74 MET-hr/wk groups combined into low activity group for moderate vs. low activity analysis 
** Multivariate model adjusted for body mass index, age at first full-term pregnancy, family history of breast cancer, age at 
    menarche, and age at menopause 
 
 






 Table 43.3.  Levi et al. (Case-Control) – Pre and Postmenopausal Females Combined 
 




      Hours Per   




Combined Unadjusted  




















<2 1.0 1.0 1.0 - 
2-4 0.45 (0.33-0.60) 0.43 (0.28-0.67) 0.44 (0.28-0.70) -2.27% 
"5  0.39 (0.22-.0.67) 0.39 (0.21-0.72) 0.42 (0.22-0.80) 7.14% 
 
* Multivariate model adjusted for age, education, age at menarche, age at first birth, number of births, menopausal status,  
  age at menopause, caloric intake, previous benign breast disease, and breast cancer history in first-degree relatives 












































<1 1.0 1.0 1.0 1.0 - 
1.0-1.9 0.86 (0.77-0.96) 0.90 (0.81-1.00) 0.88 (0.79-0.98) 2.27% 
2.0-3.9 
 0.86 (0.79-0.94) 
0.87 (0.78-0.96) 0.91 (0.82-1.00) 0.89 (0.81-0.99) 2.25% 
4.0-6.9 0.83 (0.75-0.92) 0.88 (0.80-0.97) 0.85 (0.77-0.94) 2.35% 
"7 
 0.79 (0.72-0.87) 
0.65 (0.55-0.76) 0.81 (0.69-0.95) 0.82 (0.70-0.97) 20.73% 
 
*1.0-1.9 and 2.0-3.9 hr/wk groups combined in moderate activity group for moderate vs. low activity analysis 
*4.0-6.9 and "7 hr/wk groups combined in high activity group for high vs. low activity analysis 
** Multivariate model adjusted for age, age at menarche, history of benign breast disease, breast cancer history in first 
    degree relative, height, parity, age at first birth, body mass index, menopausal status, and postmenopausal hormone 












































>2 0.82 (0.71-0.93) 0.82 (0.71-0.93) 1.0 1.0 18.00% 
1-2 1.10 (0.96-1.26) 1.10 (0.96-1.26) 1.3 (1.2-1.5) 1.3 (1.1-1.5) 15.38% 
<1 0.96 (0.86-1.16) 1.2 (1.0-1.4) 1.1 (1.0-1.3) 12.73% 
0 
 
1.0 1.0 1.3 (1.1-1.5) 1.3 (1.1-1.5) - 
 
*Most active group instead of sedentary group used as the reference group 
** 0 and <1 hr/wk groups combined in low activity group for moderate and high vs. low activity analyses 
*** Multivariate model adjusted for age, age at menarche, parity, age at first birth, body mass index, height, use of 
     hormone replacement therapy, age at menopause, and use of oral contraceptives 
 
 












































0 - <6.7 1.0 1.0 1.0 1.0 - 
6.7 - <11.8 0.75 (0.52-1.09) 0.76 (0.53-1.11) 0.81 (0.55-1.19) 7.41% 
11.8 - <20.7 
                   
 0.86 (0.63-1.18) 0.98 (0.69-1.40) 1.00 (0.70-1.44) 1.03 (0.70-1.52) 4.85% 
" 20.7 1.00 (0.70-1.43) 1.00 (0.70-1.43) 1.00 (0.70-1.45) 1.13 (0.77-1.66) 11.50% 
 
* 6.7- <11.8 and 11.8- <20.7 MET-hr/wk groups combined in moderate activity group for moderate vs. low activity analysis 
** Multivariate model adjusted for age, waist-hip ratio, education, hormone replacement therapy use, benign breast 
    disease, breast cancer history in first-degree relatives, alcohol consumption, and cigarette smoking 
      
      












































0 - <5.1 1.0 1.0 1.0 1.0 - 
5.1 - <9.4 0.89 (0.67-1.17) 0.89 (0.67-1.19) 0.96 (0.71-1.28) 7.29% 
9.4 - <16.9 
   0.85 (0.67-1.09) 
0.82 (0.62-1.08) 0.82 (0.61-1.09) 0.88 (0.65-1.19) 6.82% 
" 16.9 0.91 (0.68-1.20) 0.91 (0.68-1.20) 0.93 (0.70-1.23) 1.10 (0.82-1.47) 17.27% 
 
*   5.1- <9.4 and 9.4- <16.9 MET-hr/wk groups combined in moderate activity group for moderate vs. low activity analysis 
** Multivariate model adjusted for age, waist-hip ratio, education, hormone replacement therapy use, benign breast 



























































0  1.0 1.0 1.0 - 
0.01-0.35 
1.0 
0.58 (0.40-0.83) 0.56 (0.39-0.80) 0.54 (0.37-0.79) -7.41% 
0.36-0.88 0.88 (0.67-1.17) 0.80 (0.60-1.07) 0.78 (0.58-1.05) -12.82% 
0.89-1.91 
   0.83 (0.67-1.03) 
0.71 (0.58-0.89) 0.66 (0.48-0.91) 0.66 (0.47-0.92) -7.58% 
1.92 + 0.48 (0.33-0.68) 0.48 (0.33-0.68) 0.40 (0.28-0.58) 0.40 (0.27-0.59) -20.00% 
 
* MET-Hr/day converted to MET-Hr/wk 
** 0 and 0.01-0.35 MET-hr/day groups were combined in low activity group for moderate and high vs. low activity analyses 
** 0.36-0.88 and 0.89-1.91 MET-hr/day groups were combined in moderate activity group for moderate vs. low activity 
    analysis 
*** Multivariate model adjusted for age, education, household income, breast cancer history in first-degree relatives, 




























<4 1.0 1.0 1.0 - 
4.01-6.00 1.17 (0.87-1.55) 1.09 1.11 (0.74-1.66) -5.41% 
>6.00 1.15 (0.86-1.52) 1.12 1.07 (0.71-1.60) -7.48% 
 
*METs combined with estimated hours-per-week of activity to estimate MET-hours per week of lifetime sports and 
 exercise participation 
** No confidence intervals reported with age-adjusted effect measures 
** Multivariate model adjusted for age, age at menarche, age at menopause, history of benign breast disease, parity, age  
    at first birth, breast cancer history in first-degree relatives, education, height, alcohol consumption, and energy intake 




























Combined Unadjusted  










% Difference between 
Multivariate-adjusted 
and Unadjusted Effect 
Measures 
0  1.0 1.0 - 
!5.0 
1.0 
0.96 (0.81-1.13) 0.90 (0.77-1.07) -6.67% 
5.1-10.0 0.91 (0.76-1.08) 0.82 (0.68-0.97) -10.98% 
10.1-20.0 
 
0.62  1.02 (0.88-1.20) 0.89 (0.76-1.00) -14.61% 
20.1-40.0 0.98 (0.83-1.15) 0.83 (0.70-0.98) -18.07% 
>40.0 
 
0.61  0.89 (0.71-1.13) 0.78 (0.62-1.00) -14.10% 
 
* 0 and !5.0 MET-hr/wk groups combined in low activity group for moderate and high vs. low activity analyses 
* 5.1-10.0 and 10.1-20.0 MET-hr/wk groups combined in moderate activity group for moderate vs. low activity analysis 
* 20.1-4.0 and >40.0 MET-hr/wk groups combined in high activity group for high vs. low activity analysis 
** Multivariate model adjusted for age, age at menarche, age at menopause, body mass index, hormone therapy status, 
    race, geographic location, income, education, breastfed status, hysterectomy status, breast cancer history in first 
    degree relative, smoking status, parity, age at first birth, number of mammograms in 5 years prior to study enrollment, 























































0 1.0 1.0 1.0 - 




0.69 (0.43-1.12) 0.64 0.67 (0.39-1.10) -2.99% 
>6-12 0.64 (0.47-0.87) 0.64 (0.47-0.87) 0.52 0.53 (0.31-0.90) -20.75% 
>12 0.54 (0.40-0.74) 0.54 (0.40-0.74) 0.45 0.47 (0.28-0.80) -14.89% 
 
* 0, !3, and >3-6 MET-hr/wk groups combined into low activity group for moderate and high vs. low activity analyses 
** No confidence intervals reported with first multivariate-adjusted model 
** Multivariate-adjusted model 1 adjusted for age, ethnicity, education, and migration history 
** Multivariate-adjusted model 2 adjusted for age, ethnicity, education, migration history, parity, family history of breast 
























































>0 – 7.0 1.0 1.0 1.0 1.0 - 
> 7.0 – 17.5 0.95 (0.85-1.07) 0.95 (0.85-1.07) 0.92 (0.82-1.04) 0.92 (0.81-1.04) 0 
> 17.5 – 31.5 0.93 (0.80-1.07) 0.92 (0.80-1.07) 0.94 (0.81-1.09) 1.06% 




0.70 (0.49-1.01) 0.70 (0.49-1.01) 0.71 (0.49-1.02) 1.41% 
 
*  >17-31.5, >31.5-42.0, and >42.0 MET-hr/wk groups combined in high activity group for high vs. low activity analysis 
** Multivariate model adjusted for age, race, body mass index, lifetime weight change, family history of breast cancer, 
    history of benign breast disease, duration of oral contraceptive use, hormone replacement therapy use, parity, age at 































0 1.0 1.0 1.0 - 
>0-3.0 0.84 (0.59-1.20) 0.84 (0.59-1.20) 0.70 (0.48-1.03) -20.00% 
>3.0-8.0 
1.0 
0.83 (0.58-1.20) 0.84 (0.58-1.20) 0.65 (0.44-0.96) -27.69% 
>8.0-16.0 1.00 (0.73-1.34) 1.00 (0.73-1.34) 0.89 (0.61-1.29) 0.61 (0.41-0.92) -63.93% 
>16.0-32.0 0.96 (0.64-1.44) 0.96 (0.64-1.44) 0.63 (0.40-0.98) -52.38% 
>32.0 
 
1.10 (0.83-1.46) 1.00 (0.63-1.60) 1.00 (0.63-1.60) 0.65 (0.39-1.08) -53.85% 
 
* 0, >0-3.0, >3.0-8.0 MET-hr/wk groups combined into low activity group for moderate and high vs. low activity analyses 
* >16.0-32.0 and >32.0 MET-hr/wk groups combined into high activity group for high vs. low activity analyses 
** Multivariate model adjusted for age, race, age at menarche, income, body mass index, family history of breast cancer, 
    menopausal status, age at menopause, postmenopausal hormone use, smoking, and number of pregnancies 
 
 












































<3.0 1.0 1.0 1.0 - 
>3.0-8.9 
1.0 
1.08 (0.84-1.36) 1.07 (0.84-1.37) 1.05 (0.82-1.33) -2.86% 
9.0-17.9 0.93 (0.77-1.11) 0.93 (0.77-1.11) 0.99 (0.77-1.26) 0.95 (0.74-1.21) 2.11% 
18.0-26.9 1.04 (0.80-1.36) 1.08 (0.83-1.41) 1.03 (0.79-1.35) -0.97% 
>27.0 
 
0.96 (0.82-1.12) 0.99 (0.77-1.25) 1.07 (0.84-1.36) 1.04 (0.82-1.33) 4.81% 
 
* <3.0 and >3.0-8.9 MET-hr/wk groups combined into low activity group for moderate and high vs. low activity analyses 
* 18.0-26.9 and >27.0 MET-hr/wk groups combined into high activity group for high vs. low activity analysis 
** Multivariate model adjusted for age, height, alcohol consumption, age at menarche, age at first birth, oral contraceptive 
    use, history of benign breast disease, breast cancer history in first degree relative, and body mass index 
 
 




























<6.8 1.0 1.00 1.00 - 
6.8-16.6 0.94 (0.69-1.28) 0.94 (0.69-1.29) 1.05 (0.75-1.47) 10.48% 
"16.7 0.55 (0.39-0.77) 0.56 (0.40-0.78) 0.67 (0.46-0.96) 17.91% 
 
* Multivariate model adjusted for age, race/ethnicity, country of birth, education, breast cancer family history, prior biopsy 
  for benign breast disease, age at menarche, parity, age at first full-term pregnancy, breast-feeding status, and body     


























<7.6 1.0 1.00 1.00 - 
7.6-17.7 0.79  (0.64-0.98) 0.79 (0.64-0.98) 0.85 (0.68-1.06) 7.06% 
"17.8 0.68 (0.54-0.85) 0.70 (0.56-0.88) 0.74 (0.59-0.94) 8.11% 
 
* Multivariate model adjusted for age, race/ethnicity, country of birth, education, breast cancer family history, age at 
  menarche, parity, breast-feeding status, and age at menopause 
 













































0 1.0 1.0 1.0 - 




0.94 (0.83-1.06) 0.92 (0.81-1.04) 0.87 (0.77-0.99) -8.05% 
6.7-15.1 0.98 (0.88-1.09) 0.98 (0.88-1.09) 0.87 (0.77-0.99) 0.82 (0.71-0.93) -19.51% 
"15.2 0.90 (0.81-1.00) 0.90 (0.81-1.00) 0.85 (0.75-0.97) 0.80 (0.70-0.92) -12.50% 
 
* 0, <2.2, and 2.3-6.6 MET-hr/wk groups combined into low activity group for moderate and high vs. low activity analyses 
** Multivariate model adjusted for age, race, study site, exercise activity questionnaire type, breast cancer history in a 
    first degree relative, age at menarche, menopausal status, age at menopause, age at first term pregnancy, total 











 The relationship between physical activity and cancer of the colon and breast is 
complex.  The quantity of activity is likely an important factor in the reduction of risk of 
developing these two cancers, as combined effect measures of studies using the 
Compendium indicate that higher amounts of leisure-time physical activity appear to 
reduce the risk for colon cancer among males and females, and reduce the risk of breast 
cancer for postmenopausal females.  However, the association between activity and 
premenopausal breast cancer risk remains unclear.  While the physical activity 
quantification instrumentation was consistent among studies included in the meta-
analyses (i.e. all studies used the Compendium), physical activity quantification 
categories differed widely across studies.  Additionally, methodological differences such 
as the number and demographic characteristics of individuals studied, length of time that 
physical activity was measured, and potential confounding variables inevitably differed 
among studies.  Future studies examining the relationship between physical activity and 
cancer risk should stratify pre- and postmenopausal females in their analyses, and should 
also adhere to both a standardized questionnaire for assessing modes of physical activity 






Colon Cancer Meta-Analyses 
Methodological Differences between Studies of Colon Cancer Risk among Males
Three case-control studies (Longnecker et al., 1995; White et al., 1996; Tang et 
al., 1999) and one cohort study (Giovannucci et al., 1995) examined the effects of activity 
on colon cancer risk among males between 1985 and 1992.  The race of participants was 
one source of differences among studies.  One study (Giovannucci et al.) did not report 
the race distribution while two studies (Longnecker et al.; White et al.) consisted of 
Caucasian individuals residing in the United States.  A fourth study (Tang et al.) 
examined colon cancer risk among Taiwanese males.   
The measurement of physical activity also differed among studies, as the time 
physical activity was measured ranged from the year prior to follow-up (Tang et al.) to 
ten years prior to follow-up (White et al., 1996).  The quantification of physical activity 
also differed among studies.  Three studies (Giovannucci et al.; White et al.; Tang et al.) 
quantified physical activity using the Compendium of Physical Activities, however, 
Giovannucci et al. reported median MET hours-per-week, while the remaining studies 
reported mean MET hours-per-week [80].  Although the mean and median are different, 
the categories of amounts of physical activity were large enough to allow for the use of 
both measures.  One additional study (Longnecker et al., 1995) quantified physical 
activity in hours per week and reported specific types of physical activity, which allowed 
for an estimation of MET hours-per-week using the Compendium.  Common physical 
activities reported for most studies of male colon cancer risk included walking, running, 
tennis, and bicycling.  Three studies (Giovannucci et al.; Longnecker et al.; Tang et al.) 




questionnaire previously developed by Taylor et al. [150].  While some studies included 
analyses of both leisure-time and occupational activity, only analyses examining the 
effect of leisure-time physical activity on colon cancer risk were included in the meta-
analyses to allow comparability among studies included in the analyses. 
 
Methodological Differences between Studies of Colon Cancer Risk among Females
Two case-control studies (White et al., 1996; Tang et al., 1999) and two cohort 
studies (Martinez et al., 1997; Calton et al., 2006) were included in the analyses of colon 
cancer risk among females, and risk was assessed between 1985 and 1998.  Again, the 
race of participants differed among studies.  While Martinez et al. did not specifically 
report a race distribution, the majority of females were likely Caucasian American 
females, as the dataset was taken from the U.S. Nurses’ Health Study.  Two other studies 
(White et al.; Calton et al.) primarily included White females, while Tang et al. examined 
Taiwanese females.   
The time span of physical activity measurement ranged from the previous year 
(Calton et al.) to ten years prior to follow-up (White et al.).  Three studies (White et al.; 
Martinez et al.; Tang et al.) directly quantified physical activity using the Compendium, 
while Calton et al. report activity in hours per week along with the typically completed 
physical activities, allowing for an estimation of the quantity of physical activity using 
the Compendium.  Typical activities reported by all studies of female colon cancer risk 




Two studies (Tang et al.; Calton et al.) used self-developed instrumentation for 
physical activity assessment, while White et al. used a questionnaire developed by Taylor 
et al., and Martinez et al. used the physical activity questionnaire from the Nurses Health 
Study developed by Wolf et al. [149].  Only leisure-time physical activities were included 
in the analyses of female colon cancer risk.   
 
Discussion of Results of Colon Cancer Meta-Analyses 
Analysis I 
 A non-statistically significant difference in the risk of developing colon cancer 
between moderate and low exercising males was found in Analysis I (Pooled Effect 
Measure = 0.817 (95% CI = 0.484-1.379), p = 0.449).  This lack of statistical significance 
was probably due to one of the studies (Tang et al.) that included an increased unadjusted 
effect measure of colon cancer for those with moderate compared to low activity (OR = 
4.286).  It is highly improbable that a greater amount of activity would be associated with 
such a large increase in colon cancer risk.  However, the Tang study included only twelve 
males in the moderate activity group and fifty-two males in the low activity group.  Each 
study was given a weight based on sample size relative to other studies included in a 
given analysis.  While Analysis I gave the Tang et al. study a weight of only 8.92%, the 
resulting effect measure of this analysis after excluding the Tang et al. study was 0.707 
(95% CI = 0.546-0.915), indicating that the unusual effect measure for this small study 
did indeed affect the overall results.  The other studies included in this analysis had lower 
effect measures that were in the direction expected for a protective effect (Giovannucci et 




Such a disparity did not exist in the analysis of the high versus low activity males 
in Analysis I.  In this group, Tang et al. found a effect measure of 0.202 (95% CI = 
0.060-0.682), while Giovannucci et al. and White et al. had effect measures of 0.527 
(95% CI = 0.364-0.760) and 0.664 (95% CI = 0.408-1.080), respectively.  The pooled 
effect measure for this meta-analysis was 0.525, and was statistically significant (p = 
.002).  While this effect measure indicated more of a protective effect for the high versus 
low activity group compared to the moderate versus low activity group, it is difficult to 
compare these results due to the presence of the unusual Tang results for the moderate 
versus low activity groups. 
 
Analysis II 
 Among females, a non-statistically significant difference for the risk of colon 
cancer was found between moderate and low activity groups (Pooled Effect Measure = 
0.872; p = 0.303).  Again, as in Analysis I for males, a statistically significant difference 
in colon cancer risk was found for high versus low activity females (Pooled Effect 
Measure = 0.673, p = 0.027).  Overall, females had a slightly smaller effect, although 
comparable, for both moderate and high amounts of activity compared to males (0.872 to 
0.817 and 0.673 to 0.524, respectively).  
 
Analysis III   
 When an additional study with Compendium-estimated activity (Longnecker et 
al.) was added to the analysis of male colon cancer risk, the difference between the 




Measure = 0.750, p = 0.174).  However, the overall risk level and level of significance 
were lower with the additional study, possibly providing further evidence that the unusual 
findings of Tang et al. study may have caused a misinterpretation of an otherwise 
potentially statistically significant reduction in colon cancer risk among moderately 
active males.  For the high versus low analysis, a statistically significant difference 
between the two groups remained (Pooled Effect Measure = 0.574, p = <0.001), similar 
to Analysis I.    
 
Analysis IV 
When the Compendium-estimated Calton et al. study was added to the analysis of 
female colon cancer risk), a nearly significant difference was seen between the moderate 
and low activity groups (Pooled Effect Measure = 0.809, p = 0.051).  The lower effect 
measure and level of significance could be due to additional subjects in the meta-analysis 
provided by the Calton et al. study.  The difference in effect measures between high and 
low activity females was no longer statistically significant in this Analysis (Pooled Effect 
Measure = 0.814, p = 0.087).  However, the weight for the Calton et al. study was 
54.93% due to a much greater number of subjects in this study compared to the others 
included in this analysis.  Because this study did not find a significant relationship 
between physical activity and colon cancer risk, results from this particular meta-analysis 







Mixed Effects Meta-Regression Model 
 No significant differences in colon cancer risk were found between moderate 
activity males and females or between high activity males and females.  However, the 
non-significant findings must be considered with the fact that a smaller number of studies 
examined the effect of physical activity on colon cancer risk by sex.  Because only three 
studies reported results of Compendium-quantified activity on colon cancer risk by sex, 
the sample size was small, resulting in an imprecise estimate.  Results from the colon 
cancer mixed effects models are presented in Appendix IV. 
 
Application of Results from Colon Cancer Analyses 
 Results from the present meta-analyses indicate that weekly leisure-time physical 
activity amounting to approximately 16 MET hours-per-week or more is associated with 
a 48% and 33% decrease in the odds of developing colon cancer among high versus low 
activity males and females, respectively, although the magnitude of this reduction varies 
between the two sexes (Effect measure = 0.524, males; Effect measure = 0.673, females) 
and is subject to the variability among individual study effect measures, as only three 
studies were included in the analyses.  These results are relevant for exercise 
programmers and specialists planning to prescribe physical activity for high-risk 
individuals.  Walking at a brisk pace of 4.0 miles-per-hour on a level firm surface for at 
least four hours weekly, bicycling at a general pace for more than two hours per week, 
running a 12 minute mile twice per week, swimming freestyle laps at a slow effort for 




while using a power cart, are examples of meeting the recommended requirement of at 
least 16 MET hours-per-week. 
 
Potential Confounding for Colon Cancer Meta-Analyses 
 Many individual studies adjusted their effect measures for potentially 
confounding factors.  Most studies adjusted for age, while typical variables in the 
multivariate-adjusted models of the original studies included age, body mass index, total 
caloric intake, smoking, total fiber intake, and alcohol consumption.  Comparisons 
between the unadjusted effect measures from the present analyses and the multivariate 
(where applicable) or age-adjusted (where applicable) effect measures from the original 
studies were reasonably similar for five of the six studies, as the percent difference 
between the estimates for these studies ranged from 0 to 31%.  However, one study (Tang 
et al.) consistently had greater percent differences between the adjusted and unadjusted 
effect measures (5% to 93% across various physical activity categorizations) [83].  Such 
differences may be due to the smaller number of subjects in this study.  Specifically, in a 
study with a small sample size, even a few individuals that are associated with 
confounding variables that could potentially influence the relationship between physical 
activity and colon cancer risk could result in a substantial difference between the 








Breast Cancer Meta-Analyses 
Methodological Differences between Studies in Breast Cancer Analyses 
 Five case-control studies (Levi et al., 1999; Matthews et al., 2001; Yang et al., 
2003; Patel et al., 2003; Bernstein et al., 2005) and two cohort studies (Thune et al., 1997; 
Rockhill et al., 1999) examined the effects of physical activity on breast cancer risk 
among combined pre- and postmenopausal females, while two additional case-control 
studies (Friedenreich et al., 2001; John et al., 2001) assessed the effect of activity on pre- 
and postmenopausal females separately.  The relationship between physical activity and 
postmenopausal breast cancer risk was assessed in two case-control studies (Carpenter et 
al., 1999; Moradi et al., 2000) and three cohort studies (Dirx et al., 2001; McTiernan et 
al., 2003; Patel et al. 2003).  Finally, Colditz et al. (2003) assessed the relationship 
between activity and premenopausal breast cancer risk.   
 Females of different races and geographic locations were included in the breast 
cancer analyses.  Specifically, two studies (McTiernan et al.; Patel et al.) primarily 
included White females from throughout the United States, and while Colditz et al. and 
Rockhill et al. did not specifically report a race distribution, the females were participants 
in the U.S. Nurses’ Health Study and most participants were likely White.  Two 
additional studies (Patel et al.; Bernstein et al.) had a majority of White females, but also 
included a substantial proportion of Black females (16% and 35%, respectively).  Patel et 
al. studied females from Los Angeles County, while Bernstein et al. studied females from 
five Surveillance, Epidemiology, and End Results (SEER) cancer registries: Los Angeles, 
Atlanta, Detroit, Seattle and Philadelphia.  Carpenter et al. included residents of Los 




residents of the San Francisco Bay Area that were primarily Latina, but also White and 
Black.  Yang et al. studied the relationship between physical activity and breast cancer 
risk among Asian American residents of Los Angeles County.   
 Some studies examined females from other countries.  Friedenreich et al. studied 
White females from Alberta, Canada, while Thune et al. studied Norwegian females, 
Moradi et al. studied Swedish females, Levi et al. studied Swiss females, and Dirx et al. 
included females from the Netherlands.  Matthews et al. examined the relationship 
between physical activity and breast cancer risk among Chinese females.  
Ten of the fifteen studies included in the meta-analyses for breast cancer risk 
directly quantified physical activity using the Compendium, whereas the five remaining 
studies provided a weekly amount of activity and description of physical activities 
(Thune et al.; Rockhill et al.; Levi et al.; Moradi et al.) or MET value (Dirx et al.) 
allowing MET hours-per-week to be estimated using the Compendium.  All of the studies 
listed above were included in Compendium-quantified and/or Compendium quantified 
and estimated meta-analyses of pre- and postmenopausal females combined.  Activities 
reported for a majority of studies included walking, jogging, bicycling, swimming 
aerobics, and calisthenics.     
 For the Compendium quantified and Compendium quantified and estimated 
analyses of pre- and postmenopausal females combined (Analyses I and III, respectively), 
the time span of physical activity measurement ranged from current (McTiernan et al.; 
Patel et al.) to lifetime (Carpenter et al.; Friedenreich et al.; Patel et al., John et al., 
Bernstein et al.).  Analysis II only included studies measuring physical activity for at least 




females (Analysis IV) was ten years (Colditz et al.) to lifetime (Friedenreich et al., John 
et al.), while the range for the analyses of postmenopausal females (Analysis V – 
Compendium quantified; Analysis VI – Compendium quantified and estimated) was 
current (Dirx et al., McTiernan et al., Patel et al.) to lifetime (Carpenter et al., 
Friedenreich et al., John et al.).  A majority of the studies in the breast cancer analyses 
used self-developed or unreported questionnaires for the assessment of physical activity 
(Thune et al.; Carpenter et al.; Levi et al.; Moradi et al.; Friedenreich et al., Matthews et 
al.; Dirx et al., McTiernan et al.; Patel et al. (cohort); Patel et al. (case-control).  Three 
studies (Yang et al.; John et al.; Bernstein et al.) used a physical activity assessment 
instrument developed by Bernstein et al (1994), while two studies (Rockhill et al., Colditz 
et al.) used the physical activity assessment questionnaire from the Nurses’ Health Study 
developed by Wolf et al [147, 148]. 
 
Results of Breast Cancer Meta-Analyses 
Analysis I 
A statistically significant difference was reported in the risk of developing breast 
cancer between moderate and low activity females (pre- and postmenopausal combined) 
in Analysis I (Pooled Effect Measure = 0.919; p = 0.008).  This indicates that females 
completing a moderate amount of activity had approximately 8% lower odds of 
developing breast cancer than women with a low amount of activity.  While a difference 
of 8% does not indicate a substantial risk reduction compared to the low activity 




a statistically significant difference for the high activity versus low activity group was 
also present (Pooled Effect Measure = 0.816, p = 0.001).   
 
Analysis II 
Analysis II excluded two studies that assessed physical activity for less than ten 
years, but still reported similar results among combined pre- and postmenopausal females 
for the moderate versus low activity group (Pooled Effect Measure = 0.890, p = 0.007).  
A result that was similar to the one found in Analysis I was reported for the high versus 
low activity group for Analysis II  (0.777, p = 0.002). 
 
Analysis III 
 While Analyses I and II only included Compendium quantified studies, Analysis 
III included studies of pre- and postmenopausal females combined that both quantified 
and estimated physical activity using the Compendium.  MET hours-per-week were 
estimated for five additional studies, allowing for a total of fifteen studies to be included 
in this meta-analysis.  The pooled effect measure for the moderate versus low activity 
groups was 0.897 and the difference was statistically significant compared to the low 
exercising group (p = 0.006).  The similarity of results for Analyses I and III suggests 
that including studies with estimated weekly MET hours-per-week did not change the 
effect size substantially for these particular breast cancer analyses.  Given the statistically 
significant difference between the moderate and low groups, it was expected that the high 
activity females would also have a statistically significant difference in the pooled effect 




and this was indeed the case.  Once again, these results were similar to the findings of 
Analysis I, suggesting that the MET hours-per-week estimations were comparable to the 
direct Compendium quantifications and did not alter the analysis. 
 
Analysis IV 
 Analysis IV was the first analysis that examined the relationship of physical 
activity on either premenopausal or postmenopausal breast cancer risk.  In this analysis, a 
meta-analysis of Compendium quantified studies of premenopausal females, the pooled 
effect measure was 0.917 (p = 0.222), indicating that a non-statistically significant 
difference existed between the moderate and low activity groups, which is consistent with 
prior research reporting no relationship between physical activity and premenopausal 
breast cancer risk.  For the high versus low premenopausal activity groups, the pooled 
effect measure was 0.820, but was not statistically significant (p = 0.251), suggesting 
little association between higher amounts of physical activity and premenopausal breast 
cancer risk.   
  
Analysis V 
 Given the findings in Analyses I through IV, one might assume that the 
statistically significant findings reported in the analyses of combined pre- and 
postmenopausal females was likely attributable to the postmenopausal females included 
in those analyses.  However, a non-statistically significant difference between the pooled 
effect measures of moderately active females and the low activity reference group was 




p = 0.090).  The result from this analysis is quite different than the result from the 
moderately active combined pre- and postmenopausal females combined in Analysis I.  A 
statistically significant difference existed between the postmenopausal high and low 
activity groups (Pooled Effect Measure = 0.847, p = 0.034).  This result was similar to 
that of pre-and postmenopausal females combined in Analysis I.   
 
Analysis VI 
When studies that could be estimated using the Compendium were included in 
addition to the directly quantified studies, the relationship between moderate physical 
activity and postmenopausal breast cancer risk remained non-statistically significant in 
this analysis (Pooled Effect Measure = 0.973, p = 0.536).  Adding more studies to this 
analysis actually made Analysis VI less significant than Analysis V.  Therefore, it may 
not be the number of females, but perhaps more heterogeneity in the measurement of 
physical activity that contributed to the differences in effect size between the two breast 
cancer meta-analyses. 
 
Mixed Effects Meta-Regression Model 
 No statistically significant differences in breast cancer risk were found between 
moderate activity pre- and postmenopausal females or between high activity pre- and 
postmenopausal females. This finding was surprising as higher amounts of physical 
activity were associated with reduced breast cancer risk in the analyses of 
postmenopausal females only, but studies of premenopausal females only did not show 




a lack of precision due to a much smaller number of studies that examined the effect of 
physical activity on breast cancer risk by menopausal status.  Because few studies 
reported results by menopausal status, the sample size was small, resulting in an 
imprecise estimate.  Results from the breast cancer mixed effects model are presented in 
Appendix IV. 
 
Application of Results from Breast Cancer Analyses 
Results from the breast cancer meta-analyses indicated that weekly leisure-time 
physical activity amounting to approximately 17 MET hours-per-week or more is likely 
associated with a 15% decrease in the odds of developing breast cancer among high 
versus low activity postmenopausal females (Effect measure = 0.847), although the 
relationship between physical activity and premenopausal breast cancer risk remains 
unclear.  For health professionals prescribing physical activity to females at a higher risk 
for developing breast cancer, walking at a brisk pace of 3.5 miles-per-hour on a level firm 
surface for approximately five hours weekly, bicycling at a general pace for just over two 
hours per week, running an 11.5 minute mile twice per week, completing four hours of 
water aerobics classes weekly, swimming freestyle laps at a slower effort for two-and-a-
half hours weekly, and completing two hours of step aerobics classes with a six to eight 








Potential of Confounding for Breast Cancer Meta-Analyses 
Comparisons between the unadjusted effect measures from the present analyses 
and the multivariate (where applicable) or age-adjusted (where applicable) effect 
measures from the original studies were reasonably similar for fourteen of the fifteen 
studies, as the percent difference between the estimates for these studies ranged from 0 to 
21%.  However, one case-control study (Patel et al.) consistently had greater percent 
differences between the multivariate-adjusted effect measure and age- and unadjusted 
effect measures, ranging from 20% to 64% [119].  This resulted in the calculated 
unadjusted effect measure being much higher than published multi-variate effect 
measure, and was one of only two effect measures that was greater than 1.0 among 
studies directly quantifying activity using the Compendium.  It cannot be determined why 
such consistent differences existed across all physical activity MET hours-per-week 
categorizations for the Patel et al. study.  The multivariate model for this study adjusted 
for many variables, including age, race, age at menarche, income, body mass index, 
family history of breast cancer, menopausal status, age at menopause, postmenopausal 
hormone use, smoking, and number of pregnancies.  These variables, along with alcohol 
use, parity, and age at first birth represented the typical variables adjusted for in studies 
included in the breast cancer analyses.  The type and number of adjusted variables were 
consistent with other studies that had substantially lower percent differences between 
unadjusted and adjusted effect measures.  Additionally, the activity categorizations in the 
Patel et al. study (0, !3, 3-6, >6-12, and >12 MET hours-per-week) were comparable 







Some of the studies included in the meta-analyses were cohort studies, while 
others were case-control studies.  The cohort studies produced incidence density ratios or 
relative risks, while the case-control studies produced odds ratios.  The different effect 
measures had to be combined in the meta-analyses.  While the incidence density ratios 
and relative risks could be approximated to the odds ratios for a uniform effect measure 
for each of the meta-analyses, a degree of error in those mathematical approximations 
was inevitably present. 
 
Demographic Differences 
Individuals included in the meta-analyses (especially females in the breast cancer 
meta-analyses) represented a wide range of demographic groups (White, Black, Hispanic, 
and Asian Americans, White Canadians, Scandinavians, and Chinese).  Despite the 
variety of demographic groups represented, effect measures were typically, but not 
always, similar across groups.  For example, the effect measures of John et al. (White, 
Black, and Hispanic Americans), Friedenreich et al. (White Canadians), Yang et al. 
(Asian Americans), and Matthews et al. (Chinese), were all similar, while Bernstein et al. 
(White and Black Americans), and some of the studies of Scandinavian females had 
effect measures that were higher.   
 




The physical activity assessment instrumentation, time span of activity 
measurement, and categorization of activity differed among studies.  Most of the studies 
used their own instrumentation to assess the various types of activities being completed 
by the subjects.  While the Compendium assists by providing a MET value for a given 
activity, regardless of how that activity was assessed, it would still be very helpful if 
studies of physical activity and cancer risk utilized a similar activity assessment 
questionnaire.    
Additionally, the present analyses only examined the effect of leisure-time 
physical activity on the risk of colon and breast cancer risk.  The effect of total physical 
activity, which is typically defined as the sum of leisure-time, occupational, and 
household activities, on cancer risk could not be assessed as most studies have not 
quantified total physical activity using the Compendium.   
 
Measurement of Physical Activity 
The length of time that physical activity was measured also varied among studies 
of colon and breast cancer risk, as the time span of measured activity ranged from current 
to lifetime activity.  While an individual’s current level of activity may be indicative of 
what that individual has completed in the past, more consistent and cumulative 
measurement of completed activity throughout the lifespan is important for assessing the 
relationship between physical activity and cancer risk.  Although the effect measures in 
breast cancer analyses I and II were similar, it would probably be most helpful if activity 




Some studies utilizing Compendium-quantified amounts of physical activity used 
MET hour-per-week ranges that likely were too large to determine the effects of 
specifically quantified physical activity on breast cancer risk.  For example, if a study had 
an odds ratio of 0.88 for the 0.1-17.59 MET hour-per-week group, that odds ratio may 
have been lower if more individuals in the group exercised closer to the 17.59 cut-off 
point, while the OR may have been higher if more individuals in the group exercised 
closer to the 0.1 cut-off point for this group, which includes individuals who are nearly, 
but not quite, completely sedentary.  Given the fact that each study utilized these different 
physical activity classifications (e.g. MET hours-per-week) of ‘low’, ‘moderate’, and 
‘high’, exact cut-points for physical activity categorizations could not be used for all 
meta-analyses.  This caused the activity cut-points between activity categories to include 
some degree of overlap.  However, when all subjects and studies were included in the 
analyses, three groups (‘low’, ‘moderate’, and ‘high’) could be compared when assessing 
the relationship between physical activity and cancer risk.    
Additionally, the analyses that also included studies for which Compendium- 
quantified physical activity were estimated rather than directly quantified were subject to 
the conditions qualifying the studies for inclusion in the meta-analyses.  Specifically, 
noting the activities mentioned in the original studies and assigning a MET value from 
the Compendium was likely to be less accurate compared to a study that directly 
quantified activity using the Compendium.  Similarly, assigning an arbitrary amount of 
activity completed during the week to accompany an activity of a given MET value 
reported in a study is likely to be less accurate than a study that directly quantified 




Potential for Confounding 
It would be desirable to have original data from each study to make a more 
complete assessment of possible confounding factors.  However, despite personalized 
requests mailed out from the University of Michigan to the original study authors, 
original data was unable to be obtained.  The unadjusted analyses that were used did not 
allow for the direct adjustment for confounding variables or the assessment of effect 
modifying variables.  Percent differences between unadjusted and age-adjusted or 
multivariate-adjusted effect measures were calculated to determine whether unadjusted 
results generally over- or overestimated differences between the high and moderate 
activity groups versus the low activity group.  As discussed earlier in this chapter, five of 
six colon cancer studies and fourteen of fifteen breast cancer studies used in their 
respective reported percent differences of 0-31% and 0-21%.  It is important to note that 
the use of the unadjusted effect measures did not bias the study results by consistently 
over- or underestimating the association of physical activity with cancer risk.  There was 
no consistent pattern of variability between the unadjusted and adjusted effect measures, 
suggesting that no consistent bias in the results either toward over- or underestimating the 
risk reduction associated with activity categories existed. 
While all of the aforementioned methodological factors could not be directly 
controlled, the most appropriate instrument for physical activity quantification was used 
(the Compendium), and the most appropriate meta-analytical procedures were used, given 
the total number of subjects and types of study in each analysis.  For the smaller colon 
cancer and premenopausal breast cancer analyses, both a fixed and random effects model 




analyses that likely had a greater amount of methodological differences, only the more 
appropriate random effects model was used.   
 It is notable that despite these methodological differences, and the apparent 
heterogeneity between studies, a rather strong and consistent relationship was found 
between high levels of activity and risk reduction for both colon cancer and breast cancer 
among postmenopausal females. 
 
Summary of Compendium-Quantified Colon and Breast Cancer Analyses 
 The analyses including studies that directly quantified leisure-time physical 
activity using the Compendium provide the most accurate estimate of the relationship 
between physical activity and the risk colon and breast cancer.  The effect measures from 
these analyses (Analyses I and II for colon cancer risk and Analyses IV and V for pre- 














Table 44.  Summary of Compendium-Quantified Analyses  
                                                          Risk         95% Confidence  
                                                                        Estimate           Interval          P-Value 
Colon Cancer Analysis I:  Males 
     Moderate
1
 Vs. Low Activity
2
                     0.817       0.484-1.379         0.449 
     High
3
 Vs. Low Activity
2
                            0.524        0.348-0.788         0.002 
Colon Cancer Analysis II:  Females 
     Moderate
4
 Vs. Low Activity
5
                     0.872       0.671-1.132         0.303 
     High
6
 Vs. Low Activity
5
                            0.673        0.474-0.956         0.027 
Breast Cancer Analysis IV: Premenopausal  
     Moderate
7
 Vs. Low Activity
8
                     0.917        0.798-1.054         0.222 
     High
9
 Vs. Low Activity
8
                            0.820        0.584-1.151         0.251 
Breast Cancer Analysis V: Postmenopausal  
     Moderate
10
 Vs. Low Activity
11
                   0.932       0.858-1.011         0.090 
     High
12
 Vs. Low Activity
11
                          0.847       0.727-0.987         0.034 
1 
0.1 to 20.0 MET hours-per-week  
2 
0 to 7.30 MET hours-per-week
 
3 
> 11.3 (median) to >20 MET hours-per-week 
4 
0.1 to 21.0 MET hours-per-week 
5 
0 to 7.30 MET hours-per-week 
6 





0 to 8.9 MET hours-per-week
 
9 






0 to 7.6 MET hours-per-week 
12 
>16.6 to >20.0 MET hours-per-week 
 
 
Substantial variability among individual studies for the categorization of ‘low’, 
‘moderate’, and ‘high’ activity in MET hours-per-week was present, and this variability 
likely impacted the effect measures of the meta-analyses.  Specifically, when lower 
amounts of activity in MET hours-per-week are included in the ‘moderate’ and ‘high’ 
activity groups, the protective effect of physical activity may be underestimated for those 
two groups in the meta-analyses.   
In Analysis I of colon cancer risk, the effect measure for high versus low activity 
males was 0.524 (95% CI = 0.348-0.788).  This effect measure represented a 48% risk 




measures from the individual studies were all less than one, but were not consistent 
among the three studies, although the test for heterogeneity was not statistically 
significant (effect measures = 0.202, 0.527, and 0.664; p-value for DerSimonian and 
Laird (D+L) Q-test of heterogeneity = 0.200).  The Tang et al. study had an unusually 
low effect measure of 0.202, but only had a study weight of 10% due to the small sample 
size in this study.  In Analysis II of colon cancer risk, the colon cancer effect measure for 
high versus low activity females was 0.673 (95% CI = 0.474-0.956).  There was a 
substantial risk reduction of 33%, which was statistically significant (p = 0.027).  The 
effect measures across studies in this meta-analysis were quite consistent (0.617, 0.741, 
0.807; p-value for D+L Q-test of heterogeneity = 0.854) despite the different sample sizes 
and only a 7% weight for the Tang et al. study. 
 For moderate versus low activity males in Analysis I, the colon cancer effect 
measure was 0.817 (95% CI = 0.484-1.379).  This risk reduction of 18% was found to be 
not statistically significant (p = 0.449).  Effect measures from the individual studies were 
not consistent (0.60, 0.79, and 4.29), although the test for heterogeneity was not 
statistically significant (p = 0.06).  The unusually high effect measure of 4.29 reported by 
Tang et al. was the only individual effect measure from this analysis that exceeded 1.0.  
Although this study had a weight of only 9%, its exclusion resulted in a combined 
estimate of 0.707 (95% CI = 0.546-0.915, p = 0.009) from the two remaining studies, 
indicating that Tang et al. did substantially influence the results of this meta-analysis.  
Moderate versus low activity females in Analysis II had a effect measure of 0.872 (95% 
CI = 0.671-1.132).  This colon cancer risk reduction of 13% was found to be non-




consistent in this meta-analysis (0.806, 0.941, 0.990; p-value for D+L Q-test of 
heterogeneity = 0.760) despite study weights ranging from 2.87% for the Tang et al. 
study up to 61.24% for the Martinez et al. study. 
In Analysis IV of breast cancer risk, the effect measure for high versus low 
activity females for premenopausal breast cancer was 0.820 (95% CI = 0.584-1.151).  
This effect measure represented an 18% risk reduction, although the result was found to 
be non-statistically significant (p = 0.251).  Only three studies met the inclusion criteria 
for this analysis, and effect measures from the individual studies showed a statistically 
significant amount of heterogeneity (0.55, 0.96, 1.00; p-value for test of heterogeneity = 
0.012).  Results from the premenopausal analyses were largely influenced by the Colditz 
et al. study, which had a study weight of approximately 60%.  The combined effect 
measure for high versus low activity females for postmenopausal cancer in Analysis V 
was 0.847 (95% CI – 0.727-0.987).  This effect measure represented a 15% breast cancer 
risk reduction, which was statistically significant (p = 0.034).  In contrast to the findings 
for premenopausal females, the effect measures for the five individual studies were more 
consistent (0.68, 070, 0.88, 0.91, 1.02), with four of the five studies having a effect 
measure of less than 1.0.  Although the effect measures for the individual studies 
appeared to be somewhat similar, statistically significant heterogeneity was present (p = 
0.012).   
 The effect measure for moderate versus low activity premenopausal females in 
Analysis IV was 0.917 (95% CI = 0.798-1.054).  This represented a breast cancer risk 
reduction of 8%.  The effect measures from the three individual studies were relatively 




was found to be non-statistically significant (p = 0.222).  The effect measure for moderate 
versus low activity postmenopausal females in Analysis V was 0.932 (95% CI = 0.858-
1.011).  This effect measure represented a 7% risk reduction, but was found to be non-
statistically significant (p = 0.090).  Results from this analysis were heavily influenced by 
the McTiernan et al. and Patel et al. studies, which had a total combined weight of 70%.  
Despite the difference in sample sizes among the five studies, the effect measures were 
relatively consistent across the five individual studies (0.79, 0.85, 0.92, 1.00, 1.04), and 
the test for heterogeneity was not statistically significant (p = 0.302).   
 With the exception of the moderate activity colon cancer analyses for males and 
females, it is encouraging that effect measures for both colon and breast cancer analyses 
were highly consistent, despite the heterogeneity in sample size and methodology.  In the 
future, more studies researching the effect of Compendium-quantified leisure-time 
physical activity on the risk of colon, premenopausal breast, and postmenopausal breast 
cancer are needed to assess more accurately the effect of physical activity on the risk of 
colon and breast cancer.  Additional methodological recommendations are detailed in the 




Sensitivity analyses can be completed to address the potential biases associated 
with unmeasured confounders.  Although all individual studies included in the meta-
analyses controlled for confounders in their analyses, it is possible that their adjusted 
estimates failed to control for important unmeasured confounders.  Typically, studies of 
the relationship between physical activity and breast cancer controlled for the effects of 




oral contraceptive use, and in some cases, postmenopausal hormone replacement therapy 
use.  Studies of the relationship between physical activity and colon cancer controlled for 
the effects of confounders such as fiber intake, body mass index, alcohol intake, and 
smoking status.  Any unmeasured confounders would have had to produce sufficient 
effects to mitigate the potentially beneficial effects of physical activity, thereby 
influencing the majority of the studies in the same direction, to greatly affect the results 
that were reported in these meta-analyses.  It is unlikely that such a consistent confounder 
was missed by all these studies.   
Another way to gauge the sensitivity of these meta-analyses is to assess the 
impact of certain studies that had potentially large effects on the overall effect measure.  
Because most studies of postmenopausal females in Analysis V had an effect size of less 
than 1.0 with the exception of McTiernan et al., it is possible that unmeasured 
confounders could have caused this unexpectedly high, unadjusted effect measure.  To 
address this, Analysis V was reanalyzed without the McTiernan study, yielding a effect 
measure of 0.815 (95% CI = 0.672-0.989).  Thus, despite the larger effect measure (1.02) 
and weight (26.30%) of the McTiernan et al. study, the protective effect of physical 
activity on postmenopausal breast cancer risk was only slightly masked by including this 
study.    
Although individual studies measured the effects of confounders on their adjusted 
effect measures, the estimates included in the meta-analyses could only be based on the 
unadjusted effect measures because original data could not be obtained.  A comparison of 




potential influence of confounders, and is reported in the ‘Results’ chapter and discussed 
earlier in this chapter. 
 
Population Attributable Fraction 
The population attributable fraction (PAF) is defined as the “proportion of disease 
cases in a population that would be prevented if an exposure were to eliminated, 
assuming the exposure to be causal” [151].  In this case, the ‘exposure’ is physical 
inactivity.  Determining the amount of risk reduction potentially associated with physical 
activity is important because activity is something that is amenable to behavior change 
and consistent completion for most people.  For postmenopausal females, a 13% 
reduction in breast cancer could be achieved, assuming that the 26% of highly active 
females from the McTiernan et al. cohort study (the only cohort study that included cases 
and non-cases, rather than person-years) is representative of the proportion of highly 
active females in the population as a whole.  The PAF was derived by estimating the 
proportion of high activity postmenopausal females in the population from the proportion 
of high activity females in the McTiernan et al. cohort study.  The calculation of the PAF 
is detailed in Appendix V. 
Because cohort studies of male and female colon cancer risk did not provide the 
number of cases and non-cases but rather person-years, the proportions of high activity 
and low plus moderate activity males were estimated based on person-years reported in 
the Giovannucci et al. study for males and the Martinez et al. study for females to 
represent the proportion of high activity males and females in the population as a whole.  




assuming the 41% of high activity males from the Giovannucci et al. cohort study is 
representative of the proportion of highly active males in the population as a whole.  For 
females, a reduction in colon cancer of approximately 33% reduction could be achieved, 
assuming the 24% of high activity females from the Martinez et al. cohort study is 
representative of the proportion of highly active females in the population. 
 
Conclusions  
 Future studies assessing the relationship between physical activity and cancer risk 
can address many of the methodological issues that currently exist.  While individual 
research studies typically report that greater amounts of physical activity are likely 
effective for reducing the risk of colon and breast cancer, the present meta-analyses 
demonstrate that some aspects of the relationship between activity and cancer risk remain 
unclear.  Specifically, high, but not moderate amounts of leisure-time physical activity 
likely reduce male and female colon cancer risk, as well as postmenopausal breast cancer 
risk.  The relationship between moderate amounts of activity and risk of postmenopausal 
breast cancer remain unclear, as does the relationship between any amount of physical 
activity and premenopausal breast cancer risk.  Finally, results from the colon and 
postmenopausal breast cancer analyses provide an initial guideline (> 16 MET hours-per-
week and > 17 MET hours-per-week, respectively) for exercise professionals prescribing 
activity to higher risk individuals. 
The issue of confounding did not appear to be a major factor affecting the results 




activity and cancer risk adjusted for the same variables to better understand the isolated 
impact of activity on the risk of colon and breast cancer.  
Based on the results from Analyses V and VI of the breast cancer meta-analyses, 
it cannot be assumed that menopausal status is the only factor responsible for the 
differences between the analyses of combined and stratified menopausal statuses.  The 
total number of individuals included in the analyses could also be important, as the 
statistically significant findings in the combined pre- and postmenopausal analyses had a 
greater number of studies and subjects compared to the stratified pre- and 
postmenopausal analyses.  
One notable problem among studies of physical activity and breast cancer is that 
many of the studies examined the effect of activity on both pre- and postmenopausal 
females combined, rather than looking at the specific relationships between activity and 
breast cancer risk separately for pre- and postmenopausal females.  Friedenreich et al. 
(2001) and John et al. (2003) were the only two studies to stratify menopausal status 
when assessing the relationship between activity and breast cancer.  While some of the 
other studies statistically adjusted for menopausal status, it would be best if all studies 
followed the method of Friedenreich and John when assessing the relationship between 
physical activity and breast cancer risk in the future.   
There are other methodological considerations that should be addressed in future 
studies.  While many studies appropriately use the Compendium to quantify an 
individual’s amount of physical activity, the instrumentation used to record the various 
activities vary among the studies.  Two physical activity assessment tools (Wolf et al., 




assessment were self-developed for individual studies.  A uniform questionnaire for 
recording physical activity for studies of activity and cancer risk would be helpful in the 
future.    
Additionally, indirectly quantifying physical activity using the Compendium may 
not be as accurate as directly quantifying activity due to a greater amount of 
heterogeneity in the measurement of physical activity.  Therefore, it is highly 
recommended that future studies assessing the relationship between physical activity and 
breast cancer risk examine pre- and postmenopausal females separately and continue to 
quantify activity using the Compendium, while measuring physical activity in a more 
consistent manner. 
 The time span for which physical activity was measured had a great amount of 
variability, ranging from current activity to lifetime activity, for both the colon and breast 
cancer analyses.  For the breast cancer analyses, it was possible to complete an additional 
analysis including only studies that measured activity for at least ten years, which 
produced results similar to the analysis that also included studies of shorter activity 
measurement time spans.  While measuring current levels of activity may be indicative of 
the amount of activity that an individual has completed in the past, future studies should 
measure activity for longer periods of time to gain a better understanding of the 
association between consistent physical activity throughout the lifespan and cancer risk, 
future studies should measure activity for longer periods of time.  
The present series of meta-analyses examining the relationship between physical 
activity and cancer of the colon and breast provided a quantitative synthesis of results 




Compendium of Physical Activities [64, 80].  Pooling numerous studies to assess the 
association of physical activity and colon cancer risk among males and females, as well 
as breast cancer risk among pre- and postmenopausal females allowed for a more 
complete understanding of the role of physical activity in reducing one’s risk of 
developing these two cancers.  While a variety of methodological issues remain 
unaddressed, results from the present analyses indicate that greater amounts of physical 
activity are likely beneficial in the reduction of colon and breast cancer risk.     
 
Future Recommendations 
The results from the present analyses provide a general framework for estimating 
the approximate amount of physical activity that may be associated with a reduction in 
colon and breast cancer risk.  Further study of the relationship between physical activity 
and the risk of colon and breast cancer is recommended, but a variety of specific 
methodological issues should be addressed in future research.  The types and amounts of 
physical activity should be assessed using a common instrument, similar to the one 
developed by Bernstein et al. (1994).  All future studies should utilize the Compendium of 
Physical Activities to quantify the MET hours-per-week of activity.  This would allow for 
a more uniform and comprehensive quantification of the amount of leisure-time physical 
activity associated with a reduction in colon and postmenopausal breast cancer risk.  A 
better understanding of the relationship between physical activity and breast cancer risk 
among premenopausal females may be established by including additional studies. 
While the specific amount of time that physical activity should be measured 




amount of activity completed over at least a ten-year period.  This would provide a more 
reasonable indication of the typical amount of activity completed throughout the lifespan 
than merely measuring ‘current’ amounts of activity.  For studies of physical activity and 
breast cancer risk, it is especially important to note the specific time-period during the 
lifespan when physical activity was measured, as activity likely has varying effects on the 
hormonal profiles of females at different time periods throughout the lifespan.  Further 
study of the specific hormonal effects of physical activity at various points throughout the 
lifespan needs to be further studied.  Also, future studies of physical activity and breast 
cancer risk should report results separately for pre- and postmenopausal females, to allow 
a better synthesis and understanding of the relationship between activity and breast 
cancer risk by menopausal status.  The potential confounding factors that are included 
should be standardized in future studies, to allow for a better understanding of the effects 
of physical activity on the risk of colon and breast cancer, after adjusting for 
confounding. 
A major limitation impacting the results of the present analyses was that each 
individual study had a different MET hour-per-week range for ‘low’, ‘moderate’, and 
‘high’ activity, causing an overlap of quantified physical activity in the combined 
analyses.  Future studies should use consistent categories of ‘low’, ‘moderate’, and ‘high’ 
activity in MET hours-per-week.  For example, if three distinct categories of ‘low’, 
‘moderate’, and ‘high’ were < 4, 4-16, and >16 MET hours-per-week across studies, the 
specific effects of ‘moderate’ and ‘high’ amounts of activity versus ‘low’ activity on the 
risk of colon and breast cancer could be better understood.  While the results of the 




colon cancer risk reduction and > 17 MET hours-per-week for postmenopausal breast 
cancer risk reduction, these levels cannot be considered to be definitive in reducing the 
risk of these two cancers.  However, these results can provide guidelines so that future 
studies can ascertain the specific amount of quantified leisure-time physical activity 
























Appendix I  
 
Calculations for Colon Cancer Analyses 
 
 
Calculation of Effect measures, Natural Logs of the Effect measures, and Standard Errors 
of the Log of Effect measures for Colon Cancer Effect measures 
 
For all Odds Ratios: 
a =  Higher Amount of Exercise; Case 
b =  Higher Amount of Exercise; Control 
c =  Lower Amount of Exercise; Case                 
d =  Lower Amount of Exercise; Control  
 
For all Relative Risks: 
r1 =  Cases in Lower Amount of Exercise 
r2 =  Cases in Higher Amount of Exercise 
T1 =  Total Person-Years of Lower Exercise Group 





Calton et al. (2006) 
 
Assumption = MET value of 8.0 for vigorous activity 
 
Moderate Vs. Low Activity (Females) 
 
r1 = 159, r2 = 34, t1 = 165069 py, t2 =  50731 py 
 
OR ~ ! = (r2*t1/r1*t2) 
! = 34 * 165069 py / 159 * .024450731 py 
! = 5612346 / 8066229 = .6958 
(ln !) = ln (.6958) = -.3627 
SE (ln !) = r1 +  r2  /  r1 !  r2  
SE (ln !) = 159+34 / 159*34  
SE (ln !) = 193 / 5406   
SE (ln !) = .0357  
SE (ln !) = .1889 
95% CI  (ln !) = -.3627 ± 1.96(.1889)  
95% CI (!) = exp (-.7329, .0075)    
95% CI (!)= (.4805, 1.01) 
 
 
High Vs. Low Activity (Females) 
 
r1 = 159, r2 = 50, t1 = 165069 py, t2 = 54525 py 
 
OR ~ ! = (r2*t1/r1*t2) 
! = 50 * 165069 py / 159 * 54525 py 
! = 8253450 / 8669475  = .9520 
(ln !) = ln (.9520) = -.0492 
SE (ln !) = r1 +  r2  /  r1 !  r2  
SE (ln !) = 159+50 / 159*50  
SE (ln !) = 209 / 7950   
SE (ln !) = .0263  
SE (ln !) = .1621 
95% CI (ln !) = -.0492 ± 1.96(.1621)  
95% CI (!) = exp (-.3669, .2685)     
95% CI (!) = (.6929, 1.3080) 
 
226 
Giovannucci et al. (1995) 
 
Moderate Vs. Low Activity (Males) 
 
r1 = 55, r2 = 88, t1 = 51660 py, t2 = 104939 py 
 
OR ~ ! = (r2*t1/r1*t2) 
! = 88 * 51660 py / 55 * 104939 py 
! = 4546080 / 5771645 = .7877 
(ln !) = ln (.7877) = -.2387 
SE (ln !) = r1 +  r2  /  r1 !  r2  
SE (ln !) = 55+88 / 55*88  
SE (ln !) = 143 / 4840   
SE (ln !) = .0296  
SE (ln !) = .1719 
95% CI (ln !)  = -.2387 ± 1.96(.1719) 
95% CI (!) = exp (-.5756, .0982)  
95% CI (!) = (.5624, 1.1032) 
 
 
High Vs. Low Activity (Males) 
 
r1 = 55, r2 = 60, t1 = 51660 py, t2 = 106955 py 
 
OR ~ ! = (r2*t1/r1*t2) 
! = 60 * 51660 py / 55 * 106955 py 
! = 3099600 / 5882525 = .5269 
(ln !) = ln (.5269) = -.6407 
SE (ln !) = r1 +  r2  /  r1 !  r2  
SE (ln !) = 55+60 / 55*60  
SE (ln !) = 115 / 3300   
SE (ln !) = .0348  
SE (ln !) = .1867 
95% CI (ln !) = -.6407 ± 1.96(.1867) 
95% CI (!) = exp (-1.01, -.2748)  
95% CI (!) = (.3642, .7597)
 
227 
Longnecker et al. (1995) 
 
(Assumption = MET value of 8 for vigorous activity) 
 
Moderate Vs. Low Activity 
 
a = 8, b = 19, c = 104, d = 141 
 
! = (a/b) / (c/d) 
! = (8/19) / (104/141) 
! = .4211 / .7376 
! = .5709 
ln (!) = ln (.5709) = -.5605 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/8 + 1/19 + 1/104 + 1/141  
SE (ln !) = .1250 + .0526 + .0096 + .0071  
SE (ln !) = .1943  
SE (ln !) = .4408 
95% CI (ln !) = -.5605 ± 1.96(.4408)  
95% CI (!) = exp (-1.4244, .3035)  
95% CI (!) = (.2406, 1.3546) 
 
 
High Vs. Low Activity 
 
a = 50, b = 101, c = 104, d = 141 
 
! = (a/b) / (c/d) 
! = (50/101) / (104/141) 
! = .4950 / .7376 
! = .6711 
ln (!) = ln (.6711) = -.3988 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/50 + 1/101 + 1/104 + 1/141  
SE (ln !) = .0200 + .0099 + .0096 + .0071  
SE (ln !) = .0466  
SE (ln !) = .2159 
95% CI (ln !) = -.3988 ± 1.96(.2159)  
95% CI (!) = exp (-.8220, .0244)  
95% CI (!) = (.4396, 1.0247) 
 
228 
Martinez et al. (1997) 
 
Moderate Vs. Low Activity (Females) 
 
r1 = 73, r2 = 65, t1 = 115,147 py, t2 =  127,204 py 
 
OR ~ ! = (r2*t1/r1*t2) 
! = 65 * 115,147 / 73 * 127,204  
! = 7,484,555 / 9,285,892 = .8060 
(ln !) = ln (.8060) = -.2157 
SE (ln !) = r1 +  r2  /  r1 !  r2  
SE (ln !) = 73+65 / 73*65  
SE (ln !) = 138 / 4745  
SE (ln !) = .0291  
SE (ln !) = .1705 
95% CI (ln !) = -.2157 ± 1.96(.1705)  
95% CI (!) = exp (-.5499, .1185)  
95% CI (!) = (.5770, 1.1258) 
 
 
High Vs. Low Activity (Females) 
 
r1 = 73, r2 = 23, t1 = 115,147 py, t2 = 58,817 py 
 
OR ~ ! = (r2*t1/r1*t2) 
! = 23 * 115,147 py / 73 * 58,817 py 
! = 2,648,381 / 4,293,641 = .6168 
(ln !) = ln (.6168) = -.4832 
SE (ln !) = r1 +  r2  /  r1 !  r2  
SE (ln !) = 73+23 / 73*23  
SE (ln !) = 96 / 1679  
SE (ln !) = 0572  
SE (ln !) = .2391 
95% CI (ln !) = -.4832 ± 1.96(.2391)  
95% CI (!) = exp (-.9518, -.0146)  






Tang et al. (1999) 
 
Moderate Vs. Low Activity (Males) 
 
a = 10, b = 2, c = 28, d = 24 
 
! = (a/b) / (c/d) 
! = (10/2) / (28/24) 
! = 5.0000 / 1.1667 
! = 4.2856 
ln (!) = ln (4.2856) = 1.4553 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) =  1/10 + 1/2 + 1/28 + 1/24  
SE (ln !) = .1000 + .5000 + .0357 + .0417  
SE (ln !) = .6774  
SE (ln !) = .8230 
95% CI (ln !) = 1.4553 ± 1.96(.8230)  
95% CI (!) = exp (-.1578, 3.0638)  
95% CI (!) = (.8540, 21.41) 
 
 
High Vs. Low Activity (Males) 
 
a = 4, b = 17, c = 28, d = 24 
 
! = (a/b) / (c/d) 
! = (4/17) / (28/24) 
! = (.2353 / 1.1667) 
! = .2017 
ln (!) = ln (.2017) = -1.6011 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/4 + 1/17 + 1/28 + 1/24  
SE (ln !) = .2500 +.0588 + .0357 + .0417  
SE (ln !) = .3862  
SE (ln !) = .6215 
95% CI (ln !) = -.1.6011 ± 1.96(.6215)  
95% CI (!) = exp (-2.8192, -.3830)  






Moderate Vs. Low Activity (Females) 
 
a = 4, b = 4, c = 17, d = 16 
 
! = (a/b) / (c/d) 
! = (4/4) / (17/16) 
! = 1.0000 / 1.0625 
! = .9412  
ln (!) = ln (1.0625) = -.0606 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/4 + 1/4 + 1/17 + 1/16  
SE (ln !) = .2500 + .2500 + .0588 + .0625  
SE (ln !) = .6213  
SE (ln !) = .7882 
95% CI (ln !) = -.0606 ± 1.96(.7882)  
95% CI (!) = exp (-1.6055, 1.4843)    
95% CI (!) = (.2008, 4.4119) 
 
 
High Vs. Low Activity (Females) 
 
a = 6, b = 7, c = 17, d = 16 
 
! = (a/b) / (c/d) 
! = (6/7) / (17/16) 
! = .8571 / 1.0625 
! = .8067 
ln (!) = ln (.8067) = -.2148 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/6 + 1/7 + 1/17 + 1/16  
SE (ln !) = .1667 + .1429 + .0588 + .0625  
SE (ln !) = .4309  
SE (ln !) = .6564 
95% CI (ln !)  = -.2148 ± 1.96(.6564)  
95% CI (!) = exp (-1.5013, 1.0717)  





White et al. (1996) 
 
Moderate Vs. Low Activity (Males) 
 
a = 85, b = 99, c = 119, d = 84 
 
! = (a/b) / (c/d) 
! = (85/99) / (119/84) 
! = .8586 / 1.4167 
! = .6061 
ln (!) = ln (.6061) = -.5008 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/85 + 1/99 + 1/119 + 1/84  
SE (ln !) = .0118 + .0101 + .0084 + .0119  
SE (ln !) = .0422  
SE (ln !) = .2054 
95% CI (ln !)  = -.5008 ± 1.96(.2054)  
95% CI (!) = exp (-.9034, -.0982)  
95% CI (!) = (.4052, .9065) 
 
 
High Vs. Low Activity (Males) 
 
a = 47, b = 50, c = 119, d = 84 
 
! = (a/b) / (c/d) 
! = (47/50) / (119/84) 
! = .9400 / 1.4167 
! = .6635 
ln (!) = ln (.6635) = -.4102 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/47 + 1/50 + 1/119 + 1/84  
SE (ln !) = .0213 + .0200 + .0084 + .0119  
SE (ln !) = .0616  
SE (ln !) = .2482 
95% CI (ln !) = -.4102 ± 1.96(.2482)  
95% CI (!) = exp (-.8967, .0763)  






Moderate Vs. Low Activity (Females) 
 
a = 80, b = 77, c = 85, d = 81 
 
! = (a/b) / (c/d) 
! = (80/77) / (85/81) 
! = 1.0390 / 1.0494 
! = .9901 
ln (!) = ln (.9901) = -.0100 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/80 + 1/77 + 1/85 + 1/81  
SE (ln !) = .0125 + .0130 + .0118 + .0123  
SE (ln !) = .0496  
SE (ln !) = .2227 
95% CI (ln !) = -.0100 ± 1.96(.2227)  
95% CI (!) = exp (-.4463, .4265)  
95% CI (!) = (.6400, 1.5319) 
 
 
High Vs. Low Activity (Females) 
 
a = 28, b = 36, c = 85, d = 81 
 
! = (a/b) / (c/d) 
! = (28/36) / (85/81) 
! = .7778 / 1.0494 
! = .7412 
ln (!) = ln (.7412) = -.2995 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/28 + 1/36 + 1/85 + 1/81  
SE (ln !) = .0357 + .0278 + .0118 + .0123  
SE (ln !) = .0876  
SE (ln !) = .2960 
95% CI (ln !) = -.2995 ± 1.96(.2960)  
95% CI (!) = exp (-.8797, .2807)  










Calculations for Breast Cancer Analyses 
 
Calculation of Effect measures, Natural Logs of the Effect measures, and Standard Errors 
of the Log of the Effect measures 
For all Odds Ratios: 
a = Higher Amount of Exercise; Case                   
b = Higher Amount of Exercise; Control  
c = Lower Amount of Exercise; Case 
d = Lower Amount of Exercise; Control 
 
For all Relative Risks: 
r1 =  Cases in Lower Amount of Exercise 
r2 =  Cases in Higher Amount of Exercise 
T1 =  Total Person-Years of Lower Exercise Group 




Bernstein et al. (2005) 
 
Premenopausal and Postmenopausal Females – Moderate Vs. Low Activity 
a = 822, b = 881, c = 2901, d = 2870 
! = (a/b) / (c/d) 
! = (822/881) / (2901/2870) 
! = .9930 / 1.0108 
! =  .9824 
ln (!) = ln (.9824) = -.0178 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/822 + 1/881 + 1/2901 + 1/2870  
SE (ln !) = .0012 + .0011 + .0003 + .0003  
SE (ln !) = .0029  
SE ln (!) = .0539 
95% CI (ln !) = -.0178 ± 1.96(.0539)  
95% CI (!) = exp (-.1234, .0878)       
95% CI (!) = (.8839, 1.0918) 
 
Premenopausal and Postmenopausal Females – High Vs. Low Activity 
a = 815, b = 898, c = 2901, d = 2870 
! = (a/b) / (c/d) 
! = (815/898) / (2901/2870) 
! = .9076 / 1.0108 
! =  .8979 
ln (!) = ln (.8979) = -.1077 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/815 + 1/898 + 1/2901 + 1/2870  
SE (ln !) = .0012 + .0011 + .0003 + .0003  
SE (ln !) = .0029  
SE ln (!) = .0539 
95% CI (ln (!)) = -.1077 ± 1.96(.0539)  
95% CI (!) = exp (-.2133, -.0021)     




Carpenter et al. (1999) 
 
Postmenopausal Females – Moderate Vs. Low Activity 
 
a = 112, b = 84, c = 923, d = 722 
! = (a/b) / (c/d) 
! = (112/84) / (923/722) 
! = 1.3333 / 1.2784 
! = 1.0429 
ln (!) = ln (1.0429) = .0420 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/112 + 1/84 + 1/923 + 1/722  
SE (ln !) = .0089 + .0119 + .0011 + .0014  
SE (ln !) = .0233  
SE ln (!) = .1526 
95% CI (ln (!)) = .0420 ± 1.96(.1526)  
95% CI (!) = exp (-.2571, .3411)      
95% CI (!) = (.7733, 1.4065) 
 
Postmenopausal Females – High Vs. Low Activity 
 
a = 88, b = 98, c = 923, d = 722 
! = (a/b) / (c/d) 
! = (88/98) / (923/722) 
! = .8980 / 1.2784 
! = .7024  
ln (!) = ln (.7024) = -.3532 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/88 + 1/98 + 1/923 + 1/722  
SE (ln !) = .0114  + .0102 + .0011 + .0014  
SE (ln !) = .0241  
SE ln (!) = .1552  
95% CI (ln !) = -.3532 ± 1.96(.1552)  
95% CI (!) = exp (-.6574, -.0490)     
95% CI (!) = (.5182, .9522) 
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Colditz et al. (2003) 
Premenopausal Females – Moderate Vs. Low Activity 
 
r1 = 305, r2 = 197, T1 = 323,600 py, T2 = 225,500 py 
OR ~ ! = (r2*T1 / r1*T2) 
! = 197 * 323,600 py / 305 * 225,500 py 
! = 63,749,200 / 68,777,500 = .9269 
(ln !) = ln (.9269) = -.0759 
SE (ln !) = r1 +  r2  /  r1 !  r2  
SE (ln !) = 305+197 / 305*197  
SE (ln !) = 502 / 60,085  
SE (ln !) = .0084  
SE (ln !) = .0914 
95% CI (ln !)  = -.0759 ± 1.96(.0914)  
95% CI (!) = exp (-.2550, .1032)       
95% CI (!) = (.7749, 1.1087) 
 
Premenopausal Females – High Vs. Low Activity 
 
r1 = 305, r2 = 347, T1 = 323,600 py, T2 = 385,000 py 
OR ~ ! = (r2*T1 / r1*T2) 
! = 347 * 323,600 py / 305 * 385,000 py 
! = 112,289,200 / 117,425,000 = .9563 
(ln !) = ln (.9563) = -.0447 
SE (ln !) = r1 +  r2  /  r1 !  r2  
SE (ln !) = 305+347 / 305*347  
SE (ln !) = 652 / 105,835  
SE (ln !) = .0616  
SE (ln !) = .0785 
95% CI (ln !)  = -.0447 ± 1.96(.0785)  
95% CI (!) = exp (-.1986, .1092)      
95% CI (!) = (.8199, 1.1154) 
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Dirx et al. (2001) 
 
(Assumption = 2 Hours of Activity Per Week at Mean MET Value) 
 
Postmenopausal Females – Moderate Vs. Low Activity 
 
r1 = 63, r2 = 178, T1 = 652 py, T2 = 1583 py 
OR ~ ! = (r2*T1 / r1*T2) 
! = 178 * 652 py / 63 * 1583 py 
! = 116,056 / 99,729 = 1.1637 
(ln !) = ln (1.1637) = .1516 
SE (ln !) = r1 +  r2  /  r1 !  r2  
SE (ln !) = 63+178 / 63*178  
SE (ln !) = 241 / 11,214  
SE (ln !) = .0215  
SE (ln !) = .1466 
95% CI (ln !) = .1516 ± 1.96(.1466)  
95% CI (!) = exp (-.1357, .4389)     
95% CI (!) = (.8731, 1.5510) 
 
Postmenopausal Females – High Vs. Low Activity 
 
r1 = 63, r2 = 187, T1 = 652 py, T2 = 1690 py 
OR ~ ! = (r2*T1 / r1*T2) 
! = 187 * 652 py / 63 * 1690 py 
! = 121,924 / 106,470 = 1.1451 
(ln !) = ln (1.1451) = .1355 
SE (ln !) = r1 +  r2  /  r1 !  r2  
SE (ln !) = 63+187 / 63*187  
SE (ln !) = 250 / 11,781  
SE (ln !) = .0212  
SE (ln !) = .1457 
95% CI (ln !) = .1355 ± 1.96(.1457)  
95% CI (!) = exp (-.1501, .4211)        
95% CI (!) = (.8606, 1.5236)
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Friedenreich et al. (2001) 
 
Premenopausal Females – Moderate Vs. Low Activity 
 
a = 216, b = 239, c = 123, d = 118 
! = (a/b) / (c/d) 
! = (216/239) / (123/118) 
! = .9038 / 1.0424 
! = .8670 
ln (!) = ln (.8670) = -.1427 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/216 + 1/239 + 1/123 + 1/118  
SE (ln !) = .0046 + .0042 + .0081 + .0085  
SE (ln !) = .0254  
SE (ln !) = .1594 
95% CI (ln !) = -.1427 ± 1.96(.1594)  
95% CI (!) = exp (-.4551, .1697)     
95% CI (!) = (.6344, 1.1849) 
 
Premenopausal Females – High Vs. Low Activity 
 
a = 123, b = 118, c = 123, d = 118 
! = (a/b) / (c/d) 
! = (123/118) / (123/118) 
! =  1.0424 / 1.0424 
! = 1.0000 
ln (!) = ln (1.0000) = 0 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/123 + 1/118 + 1/123 + 1/118  
SE (ln !) = .0081 + .0085 + .0081 + .0085  
SE (ln !) = .0332  
SE (ln !) = .1822 
95% CI (ln !) = 0 ± 1.96(.1822)  
95% CI (!) = exp (-.3571, .3571)     





Postmenopausal Females – Moderate Vs. Low Activity 
a = 364, b = 381, c = 213, d = 190 
! = (a/b) / (c/d) 
! = (364/381) / (213/190) 
! = .9554 / 1.1211 
! = .8522 
ln (!) = ln (.8522) = -.1599 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/364 + 1/381 + 1/213 + 1/190  
SE (ln !) = .0027 + .0026 + .0047 + .0053  
SE (ln !) = .0153  
SE (ln !) = .1237 
95% CI (ln !) = -.1599 ± 1.96(.1237)  
95% CI (!) = exp (-.4024, .0826)     
95% CI (!) = (.6687, 1.0861) 
 
Postmenopausal Females – High Vs. Low Activity 
 
a = 194, b = 191, c = 213, d = 190 
! = (a/b) / (c/d) 
! = (194/191) / (213/190) 
! = 1.0157 / 1.1211 
! = .9060 
ln (!) = ln (.9060) = -.0987 
SE (ln !) = 1/194 + 1/191 + 1/213 + 1/190  
SE (ln !) = .0052 + .0052 + .0047 + .0053  
SE (ln !) = .0204  
SE (ln !) = .1428 
95% CI (ln !) = -.0987 ± 1.96(.1428)    .279888 
95% CI (!) = exp (-.3786, .1812)     
95% CI (!) = (.6848, 1.1987) 
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John et al. (2003) 
Premenopausal Females - Moderate Vs. Low Activity 
 
a = 151, b = 160, c = 162, d = 161 
! = (a/b) / (c/d) 
! = (151/160) / (162/161) 
! = .944 / 1.006 
! = .938 
ln (!) = ln (.938) = -.0639 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/151+1/160+1/162+1/161  
SE (ln !) = .0066+.0063+.0062+.0062  
SE (ln !) = .0253  
SE (ln !) = .1591 
95% CI (ln !)  = -.0639 ± 1.96(.1591)  
95% CI (!) = exp (-.3757, .2479)    
95% CI (!) = (.6868, 1.2813) 
 
Premenopausal Females – High Vs. Low Activity 
 
a = 90, b = 162, c = 162, d = 161 
! = (a/b) / (c/d) 
! = (90/162) / (163/161) 
! = (.556 / 1.006) 
! = .5527 
ln (!) = ln (.5527) = -.5928 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/90+1/162+1/162+1/161  
SE (ln !) = .0111+.0062+.0062+.0062  
SE (ln !) = .0297  
SE (ln !) = .1723 
95% CI (ln !) = -.5928 ± 1.96(.1723)  
95% CI (!) = exp (-.9305, -.2551)    








Postmenopausal Females – Moderate Vs. Low Activity 
 
a = 271, b = 356, c = 343, d = 354 
! = (a/b) / (c/d) 
! = (271/356) / (343/354) 
! = .761 / .967 
! = .787 
ln (!) = ln (.787) = -.2398 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/271 + 1/356 + 1/343 + 1/354  
SE (ln !) = .0037 + .0028 + .0029 + .0028  
SE (ln !) = .0122  
SE (ln !) = .1105 
95% CI (ln !) = -.2398 ± 1.96(.1105)  
95% CI (!) = exp (-.4564, -.0232)  
95% CI (!) = (.6336, .9771) 
 
Postmenopausal Females – High Vs. Low Activity 
 
a = 233, b = 355, c = 343, d = 354 
! = (a/b) / (c/d) 
! = (233/355) / (343/354) 
! = .656 / .967 
! = .678 
ln (!) = ln (1.474) = -.3880 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/233 + 1/355 + 1/343 + 1/354  
SE (ln !) = .0043 + .0028 + .0029 + .0028  
SE (ln !) = .0128  
SE (ln !) = .1131 
95% CI (ln !) = -.3880 ± 1.96(.1131)       
95% CI (!) = exp (-.6097, -.1663)     
95% CI (!) = (.5435, .8468) 
 
242 
Levi et al. (1999) 
 
Assumption = 4 METs per week  
 
Postmenopausal Females – Moderate Vs. Low Activity 
 
a = 52, b = 110, c = 111, d = 105 
! = (a/b) / (c/d) 
! = (52/110) / (111/105) 
! = 0.4727 / 1.057 
! = 0.4472 
ln (!) = ln (0.4472) = -.8047 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) =  1/52 + 1/110 + 1/111 + 1/105  
SE (ln !) = .0192 + .0009 + .0009 + .0010  
SE (ln !) = .0220  
SE ln (!) = .1483 
95% CI (ln !) = -.8047 ± 1.96(.1483)  
95% CI (!) = exp (-1.0954, -.5140)         
95% CI (!) = (.3344, .5981) 
 
 
Postmenopausal Females – High Vs. Low Activity 
 
a = 18, b = 44, c = 111, d = 105 
! = (a/b) / (c/d) 
! = (18/44) / (111/105) 
! = 0.4091 / 1.057 
! = 0.3870 
ln (!) = ln (0.3870) = -.9493 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) =  1/18 + 1/44 + 1/111 + 1/105  
SE (ln !) = .0555 + .0227+ .0009 + .0010  
SE (ln !) = .0801  
SE ln (!) = .2830 
95% CI (ln !) = -.9493 ± 1.96(.2830)  
95% CI (!) = exp (-1.5040, -.3946)  
95% CI (!) = (.2222, .6739) 
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Matthews et al. (2001) 
Premenopausal and Postmenopausal Females – Moderate Vs. Low Activity 
a = 70, b = 96, c = 1343, d = 1360 
! = (a/b) / (c/d) 
! = (70/96) / (1343/1360) 
! = .7292 / .9875 
! =  .7384 
ln (!) = ln (.7384) = -.3032 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/70 + 1/96 + 1/1343 + 1/1360  
SE (ln !) = .0143 + .0104 + .0007 + .0007  
SE (ln !) = .0261  
SE ln (!) = .1616 
95% CI (ln !) = -.3032 ± 1.96(.1616)  
95% CI (!) = exp (-.6199, .0135)      
95% CI (!) = (0.5379, 1.0136) 
 
Premenopausal and Postmenopausal Females – High Vs. Low Activity 
a = 46, b = 97, c = 1343, d = 1360 
! = (a/b) / (c/d) 
! = (46/97) / (1343/1360) 
! = .4742 / .9875 
! =  .4802 
ln (!) = ln (.4802) = -.7335 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/46 + 1/97 + 1/1343 + 1/1360  
SE (ln !) = .0217 + .0103 + .0007 + .0007  
SE (ln !) = .0334  
SE ln (!) = .1828 
95% CI (ln !) = -.7335 ± 1.96(.1828)  
95% CI (!) = exp (-1.0918, -.3752)     
95% CI (!) = (.3356, .6872) 
 
244 
McTiernan et al. (2003) 
 
Postmenopausal Females – Moderate Vs. Low Activity 
 
a = 590, b = 23826, c = 726, d = 29200 
 
RR =  (a / (a + b)) / (c / (c + d)) 
      
RR = [590 / (590 + 23826)] / [726 / (726 + 29200)] 
RR = .0242 / .0243 
RR = 0.9959 
(ln RR) = -.0041 
SE (ln !) = 1/a -  1/(a+b)  +  1/c - 1/(c+d)  
SE (ln RR) = 1/590 - 1/(590+23826) + 1/726 - 1/(726+29200)  
SE (ln RR) = .0017 - .00004 + .0014 - .00003  
SE (ln RR) = .0030  
SE (ln RR) = .0550 
95% CI (ln RR)  = -.0041 ± 1.96(.0550)  
95% CI (RR) = exp (-.1119, .1037)       
95% CI (RR) = (.8941, 1.1093) 
 
 
Postmenopausal Females – High Vs. Low Activity 
 
a = 590, b = 23826, c = 452, d = 18576  
 
RR =  (a / (a + b)) / (c / (c + d)) 
  
RR = [590 / (590 + 23826)] / [452 / (452 + 18576)] 
RR = .0242 / .0238 
RR = 1.0168 
(ln RR) = .0167 
SE (ln RR) = 1/a -  1/(a+b)  +  1/c - 1/(c+d)  
SE (ln RR) = 1/590 - 1/(590+23826) + 1/452 - 1/(452+18576)  
SE (ln RR) = .0017 - .00004 + .0022 - .00005  
SE (ln RR) = .00381  
SE (ln RR) = .0617 
95% CI (ln RR) = .0167 ± 1.96(.0617)   .120932 
95% CI (RR) = exp (-.1042, .1376)      
95% CI (RR) = (.9010, 1.1476) 
 
245 
Moradi et al. (2000) 
 
(Assumption = MET value of 6.0) 
 
Postmenopausal Females – Moderate Vs. Low Activity 
 
a = 882, b = 800, c = 840, d = 838 
! = (a/b) / (c/d) 
! = (882/800) / (840/838) 
! = 1.1025 / 1.0024 
! = 1.1000 
ln (!) = ln (1.1000) = .0952 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) =  1/882 + 1/800 + 1/840 + 1/838  
SE (ln !) = .0011 + .0013 + .0012 + .0012  
SE (ln !) = .0048  
SE ln (!) = .0693 
95% CI (ln !) = .0952 ± 1.96(.0693)  
95% CI (!) = exp (-.0406, .2310)   .135828    
95% CI (!) = (9602, 1.2699) 
 
 
Postmenopausal Females – High Vs. Low Activity 
 
a = 812, b = 992, c = 840, d = 838 
! = (a/b) / (c/d) 
! = (812/992) / (840/838) 
! = .8185 / 1.0024 
! = .8165 
ln (!) = ln (.8165) = -.2027 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/812 + 1/992 + 1/840 + 1/838  
SE (ln !) = .0012 + .0010 + .0012 + .0012  
SE (ln !) = .0046  
SE ln (!) = .0678 
95% CI (ln !) = -.2027 ± 1.96(.0678)   .132888 
95% CI (!) = exp (-.3356, -.0698)     
95% CI (!) = (.7149, .9326) 
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Patel et al. (2003; Case-Control) 
Premenopausal and Postmenopausal Females – Moderate Vs. Low Activity 
 
a = 100, b = 111, c = 341, d = 378 
! = (a/b) / (c/d) 
! = (100/111) / (341/378) 
! = .9009 / .9021 
! = .9987 
ln (!) = ln (.9987) = -.0133 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/100 + 1/111 + 1/341 + 1/378  
SE (ln !) = .0100 + .0090 + .0029 + .0026  
SE (ln !) = .0245  
SE (ln !) = .1565 
95% CI (ln !) = -.0133 ± 1.96(.1565)       
95% CI (!) = exp (-.3200, .2934)     
95% CI (!) = (.7261, 1.3410) 
 
Premenopausal and Postmenopausal Females – High Vs. Low Activity 
 
a = 126, b = 127, c = 341, d = 378 
! = (a/b) / (c/d) 
! = (126/127) / (341/378) 
! = .9921 / .9021 
! = 1.100 
ln (!) = ln (1.100) = .0951 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/126 + 1/127 + 1/341 + 1/378  
SE (ln !) = .0079 + .0079 + .0029 + .0026  
SE (ln !) = .0213  
SE (ln !) = .1459 
95% CI (ln !) = .0951 ± 1.96(.1459)       
95% CI (!) = exp (-.1909, .3811)       




Patel et al.  (2003; Cohort) 
Postmenopausal Females – Moderate Vs. Low Activity  
 
r1 = 554, r2 = 488, T1 = 107,746 py, T2 = 102,711 py 
OR ~ ! = (r2*T1 / r1*T2) 
! = (488 * 107,746 py) / (554 * 102,711 py) 
! = 52,580,048 / 56,901,894 = 0.9240 
(ln !) = ln (0.9240) = -.0790 
SE (ln !) = (r1+r2) / (r1*r2)  
SE (ln !) = (554+488) / (554*488)  
SE (ln !) = 1042 / 270,352  
SE (ln !) = .0039  
SE (ln !) = .0621 
95% CI (ln !) = -.0790 ± 1.96(.0621)      
95% CI (!) = exp (-.2007, .0426)  
95% CI (!) = (.8181, 1.0436) 
 
Postmenopausal Females – High Vs. Low Activity 
 
r1 = 554, r2 = 352, T1 = 107,746 py, T2 = 77,641 py 
OR ~ ! = (r2*T1 / r1*T2) 
! = (352 * 107,746 py) / (554 * 77,641 py) 
! = 37,926,592 / 43,013,114 = .8817 
(ln !) = ln (.8817) = -.1259 
SE (ln !) = (r1 +  r2) / (r1 !  r2)  
SE (ln !) = 554+352 / 554*352  
SE (ln !) = 906 / 195008  
SE (ln !) = .0046  
SE (ln !) = .0682 
95% CI (ln !)  = -.1259 ± 1.96(.0682)       
95% CI (!) = exp (-.2596, .0077)      
95% CI (!) = (0.7714, 1.0078) 
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Rockhill et al. (1999) 
 
(Assumption = MET value of 4.0) 
Premenopausal  and Postmenopausal Females – Moderate Vs. Low Activity 
 
r1 = 1341, r2 = 1619, T1 = 473,595 py, T2 = 629,888 py 
OR ~ ! = (r2*T1) / (r1*T2) 
! = (1619 * 473,595 py) / (1341 * 629,888 py) 
! = 766,750,305 / 844,679,808 = .9077 
(ln !) = ln (.9077) = -.0968 
SE (ln !) = r1 +  r2  /  r1 !  r2  
SE (ln !) = 1341+1619 / 1341*1619  
SE (ln !) = 2960 / 2,171,079  
SE (ln !) = .0014  
SE (ln !) = .0369 
95% CI (ln !) = -.0968 ± 1.96(.0369)      
95% CI (!) = exp (-.1692, -.0244)     
95% CI (!) = (.8444, .9759) 
 
Premenopausal and Postmenopausal Females – High Vs. Low Activity 
 
r1 = 1341, r2 = 177 T1 = 473,595 py, T2 = 89,752 py 
OR ~ ! = (r2*T1 / r1*T2) 
! = (177 * 473,595 py) / (1341 * 89,752) py 
! = 83,826,315 / 120,357,432 = .6965 
(ln !) = ln (.6965) = -.3617 
SE (ln !) = (r1 +  r2) / (r1 !  r2 )  
SE (ln !) = (1341+177) / (1341*177)  
SE (ln !) = 1518 / 237,357  
SE (ln !) = .0064  
SE (ln !) = .0800 
95% CI (ln !) = -.3617 ± 1.96(.0800)         
95% CI (!) = exp (-.5184, -.2050)     
95% CI (!) = (.5954, .8147) 
 
249 
Thune et al. (1997) 
 
(Assumptions = Study Activity Grades from 1, 2, 3, and 4 converted to 0, <16, >16 
MET Hours/Week, respectively) 
 
Premenopausal and Postmenopausal Females – Moderate Vs. Low Activity 
 
r1 =  66, r2 = 249, t1 = 4,344, t2 = 17,232 
  
RR =  (Number of Cases High / Number of Cases High + Number of Non-Cases High) / 
    (Number of Cases Low / Number of Cases Low + Number of Non-Cases Low)  
      
RR = [249 / (249 + 17,232] / [66 / (66 + 4,344)] 
RR = .0133 / .0150 
RR = .8867 
(ln RR) = -.1203 
SE (ln !) = r1 +  r2  /  r1 !  r2  
SE (ln RR) = 66+249 / 66*249  
SE (ln RR) = 315 / 16,434  
SE (ln RR) = .1384 
95% CI (ln RR) = -.1203 ± 1.96(.1384)  
95% CI (RR) = exp (-.3916, .1510)    
95% CI (RR) = (.6760, 1.1630) 
 
Premenopausal and Postmenopausal Females – Moderate Vs. Low Activity 
 
r1 = 66, r2 = 36, t1 = 4,344, t2 = 3,683 
  
RR =  (Number of Cases High / Number of Cases High + Number of Non-Cases High) / 
    (Number of Cases Low / Number of Cases Low + Number of Non-Cases Low)  
      
RR = [36 / (36 + 3,683] / [66 / (66 + 4,344)] 
RR = .0097 / .0150 
RR = .6467 
(ln RR) = -.4359 
SE (ln !) = r1 +  r2  /  r1 !  r2  
SE (ln RR) = 66+36 / 66*36  
SE (ln RR) = 102 / 2,376  
SE (ln RR) = .2072 
95% CI (ln RR) = -.4359 ± 1.96(.2072)  
95% CI (RR)  = exp (-.8420, -.0298)    
95% CI (RR) = (.4308, .9706)
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Yang et al. (2003) 
Premenopausal and Postmenopausal Females – Moderate Vs. Low Activity 
 
a = 88, b = 135, c = 315, d = 309 
! = (a/b) / (c/d) 
! = (88/135) / (315/309) 
! =  .6519 / 1.0194 
! =  .6397 
ln (!) = ln (.6397) = -.4467 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/88 + 1/135 + 1/315 + 1/309  
SE (ln !) = .0114 + .0074 + .0032 + .0032  
SE (ln !) = .0252  
SE (ln !) = .1587 
95% CI (ln !) = -.4467 ± 1.96(.1587)  
95% CI (!) = exp (-.7577, -.1356)     
95% CI (!) = (.4687, .8732) 
 
Premenopausal and Postmenopausal Females – High Vs. Low Activity 
 
a = 81, b = 146, c = 315, d = 309 
! = (a/b) / (c/d) 
! = (81/146) / (315/309) 
! = .5548 / 1.0194 
! =  .5442 
ln (!) = ln (.5442) = .-6084 
SE (ln !) = 1/a + 1/b + 1/c + 1/d  
SE (ln !) = 1/81 + 1/146 + 1/315 + 1/309  
SE (ln !) = .0123 + .0068 + .0032 + .0032  
SE (ln !) = .0255  
SE (ln !) = .1597 
95% CI (ln !) = -.6084 ± 1.96(.1597)  
95% CI (!) = exp (-.9214, -.2954)       















Colon Cancer Analyses 
 
 The results from the Mantel-Haenszel (M-H) hand calculations and calculations 
using Stata 9.2 were similar for colon cancer analyses III and IV, as an insufficient 
number of case-control studies were present for M-H comparisons of Analyses I and II.  
The M-H results for Analysis III for males included three case-control studies 
(Longnecker et al., 1995; White et al., 1996; Tang et al., 1999) and the effect measure 
was 0.683 for moderately exercising males and .  Two studies (White et al., 1996; Tang et 
al., 1999) were also included in Analysis IV for females.  The effect measures for 
moderately and exercising females were 0.986 (hand-calculation) and 0.986 (Stata 
calculation), and 0.828 (hand-calculation) and 0.809 (Stata calculation) for highly 
exercising females.  The purpose of completing the M-H calculations was to verify that 

















Mantel-Haenszel Hand- and Stata Calculations for Colon Cancer Analyses 
 
 
Moderate Physical Activity and Colon Cancer Risk in Males  (Longnecker et al. (1995); 
White et al. (1996); Tang et al. (1999))   
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MH (OR)
 =    ___________
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               _________________________









   
 
 
T  MH  (OR)  =  [4.147 + 3.750 + 18.450]
                _____________________




T  MH  (OR)  =  [26.347]
                ________










Study              OR    [95% Conf. Interval]       % Weight 
---------------------+------------------------------------------------- 
White (1996)         |  0.606       0.405     0.906         78.90 
Tang (1999)          |  4.286       0.854    21.507          2.27 
Longnecker (1995)    |  0.571       0.241     1.354         18.83 
---------------------+------------------------------------------------- 
M-H pooled OR        |  0.683       0.482     0.967        100.00 
---------------------+------------------------------------------------- 
 
  Heterogeneity chi-squared = 5.48 (d.f. = 2) p = 0.064 
  I-squared (variation in OR attributable to heterogeneity) =  63.5% 
 
  Test of OR=1: z = 2.15; p = 0.032 
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High Physical Activity and Colon Cancer Risk in Males  (Longnecker et al. (1995); 
White et al. (1996); Tang et al. (1999))   
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MH (OR)
 =    ___________
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T  MH  (OR)  = [17.803+1.315 + 10.308]
               ________________________




T  MH  (OR)  = 29.426
                 ________
                   48.581
 
 
T  MH  (OR)  = 0.606  
 
255 
Study                    OR       [95% Conf. Interval]     % Weight 
---------------------+------------------------------------------------- 
White (1996)         |  0.664       0.408     1.079         37.51 
Tang (1999)          |  0.202       0.060     0.682         12.33 
Longnecker (1995)    |  0.671       0.440     1.025         50.16 
---------------------+------------------------------------------------- 
M-H pooled OR        |  0.610       0.449     0.829        100.00 
---------------------+------------------------------------------------- 
 
  Heterogeneity chi-squared = 3.48 (d.f. = 2) p = 0.175 
  I-squared (variation in OR attributable to heterogeneity) = 42.6% 
 
  Test of OR=1: z = 3.16; p = 0.002 
 
256 
Moderate Physical Activity and Colon Cancer Risk in Females  (White et al. (1996); 
Tang et al. (1999)) 
 
                                  
                              







     T
MH (OR)
 =    ___________


















               ________________________















               ________________








T  MH  (OR)  = [1.561+ 20.062]
               ________________




T  MH  (OR)  = 21.623
               ________








Study              OR       [95% Conf. Interval]     % Weight 
---------------------+------------------------------------------------- 
White (1996)         |  0.990       0.640     1.532         92.43 
Tang (1999)          |  0.941       0.201     4.412          7.57 
---------------------+------------------------------------------------- 
M-H pooled OR        |  0.986       0.648     1.501        100.00 
---------------------+------------------------------------------------- 
 
  Heterogeneity chi-squared = 0.00 (d.f. = 1) p = 0.951 
  I-squared (variation in OR attributable to heterogeneity) =   0.0% 
 
  Test of OR=1: z = 0.06; p = 0.949 
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High Physical Activity and Colon Cancer Risk in Females  (White et al. (1996); Tang et 
al. (1999)) 
 
                                  
                              







     T
MH (OR)
 =    ___________


















                   ______________________















                   ______________









T  MH  (OR)  =    [2.587 + 7.293]
                   ______________




T  MH  (OR)  =    [9.880]
                   __________








Study              OR       [95% Conf. Interval]     % Weight 
---------------------+------------------------------------------------- 
White (1996)         |  0.741       0.415     1.324         86.44 
Tang (1999)          |  1.240       0.342     4.487         13.56 
---------------------+------------------------------------------------- 
M-H pooled OR        |  0.809       0.477     1.370        100.00 
---------------------+------------------------------------------------- 
 
  Heterogeneity chi-squared = 0.51 (d.f. = 1) p = 0.475 
  I-squared (variation in OR attributable to heterogeneity) =   0.0% 
 
  Test of OR=1: z = 0.79; p = 0.430 
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Mantel-Haenszel Odds Ratio Comparisons for Breast Cancer Analyses 
 
The results from the M-H hand calculations and calculations using Stata 9.2 were 
similar for breast cancer analyses I, III, IV, V, and VI.  The identical case-control studies 
were included in Analyses I and II, so it was not necessary to compare M-H results for 
Analysis II.  The M-H results for Analysis I for pre- and postmenopausal females 
combined included eight case-control studies (Carpenter et al., 1999; Friedenreich et al., 
2001; Matthews et al., 2001; Yang et al., 2003; Patel et al., 2003; John et al., 2003; 
Bernstein et al., 2005).  The M-H pooled estimate was 0.880 (hand-calculation) and 0.886 
(Stata calculation) for moderately exercising females and 0.805 (hand-calculation) and 
0.803 (Stata calculation) for highly exercising females.  Small differences in the two M-H 
estimates for these analyses are likely due to rounding during the hand-calculations. 
 Nine case-control studies (Carpenter et al., 1999; Levi et al., 1999; Moradi et al., 
2000; Friedenreich et al., 2001; Matthews et al., 2001; Yang et al., 2003; Patel et al., 
2003; John et al., 2003; Bernstein et al., 2005) were included in the M-H comparisons for 
Analysis III.  For moderately exercising pre- and postmenopausal females combined, the 
M-H estimates were 0.908 (hand-calculated) and 0.914 (Stata calculated), while the 
estimates for highly exercising females were 0.801 (hand-calculated) and 0.799 (Stata 
calculated), respectively.  Two Compendium-quantified case-control studies of 
premenopausal breast cancer risk were included in the M-H estimate of Analysis IV.  
Moderately exercising females had an estimate of 0.902 (hand-calculated and Stata 
calculated), while the estimate for highly exercising females was 0.730.  Case control 
studies of postmenopausal females were included in the M-H estimates for Analysis V 
and VI.  Three studies (Carpenter et al., 1999; Friedenreich et al., 2001; John et al., 2003) 
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were included in the Analysis V estimate, and moderately exercising females had an 
estimate of 0.856 (hand-calculated) and 0.861 (Stata calculated).  Highly exercising 
females had a lower estimate of 0.742 (hand-calculated) and 0.744 (Stata calculated).  
Analysis VI’s M-H estimate included four studies (Carpenter et al., 1999; Moradi et al., 
2000; Friedenreich et al., 2001; John et al., 2003), and the pooled estimates for 
moderately exercising females were 0.977 (hand-calculated) and 0.955 (Stata calculated), 
while the highly exercising females’ estimates were 0.782 (hand-calculated) and 0.769 
(Stata calculated).  The purpose of completing the M-H calculations was to verify that the 
pooled results using Stata matched the pooled results from the hand calculations.   
 
  
Mantel-Haenszel Hand- and Stata Calculations for Breast Cancer Analyses:   
 
Moderate Physical Activity and Breast Cancer Risk - Compendium quantified physical 
activity among pre- and postmenopausal females combined; Carpenter et al. (1999); 
Friedenreich et al. (2001); Matthews et al. (2001); Yang et al. (2003); Patel et al. (2003); 
John et al. (2003); Bernstein et al. (2005) 
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MH (OR)
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T  MH  (OR)  = [42.924 + 36.621+ 60.209 + 74.384 + 32.104 +
                         40.645 + 38.345 + 72.458 + 315.646]
               ________________________________________
                 [42.114 + 42.237 + 70.691+ 90.044 + 50.207 +




T  MH  (OR)  =   713.336
                ________













        Study               OR       [95% Conf. Interval]     % Weight 
---------------------+------------------------------------------------- 
Carpenter (1999)        |  1.043       0.773     1.407          5.39 
Friedenreich-Pre (2001) |  0.867       0.634     1.185          5.41 
Friedenreich-Post(2001) |  0.938       0.687     1.281          5.23 
Matthews (2001)         |  0.826       0.665     1.026         11.53 
Yang (2003)             |  0.639       0.469     0.873          6.43 
Patel (2003)            |  0.999       0.734     1.358          5.21 
John-Pre (2003)         |  0.938       0.687     1.281          5.23 
John-Post(2003)         |  0.786       0.632     0.976         11.80 
Bernstein (2005)        |  0.923       0.828     1.028         43.77 
---------------------+------------------------------------------------- 
M-H pooled OR           |  0.886       0.825     0.953        100.00 
---------------------+------------------------------------------------- 
  Heterogeneity chi-squared = 8.36 (d.f. = 8) p = 0.400 
  I-squared (variation in OR attributable to heterogeneity) = 4.3% 
 
  Test of OR=1: z = 3.27; p = 0.001 
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High Physical Activity and Breast Cancer Risk - Compendium quantified physical 
activity among pre- and postmenopausal females combined; Carpenter et al. (1999); 
Friedenreich et al. (2001); Matthews et al. (2001); Yang et al. (2003); Patel et al. (2003); 
John et al. (2003); Bernstein et al. (2005) 
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MH (OR)
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T  MH  (OR)  = [41.828 + 30.112 + 46.777 + 21.803+ 29.411+
                         49.000 + 25.200 + 64.188 + 315.224]
               ________________________________________
                 [59.548 + 30.112 + 51.628 + 45.755 + 54.042 +




T  MH  (OR)  = 623.543
               ________
                 774.130
 
 




Study                      OR      [95% Conf. Interval]     % Weight 
---------------------+------------------------------------------------- 
Carpenter (1999)        |  0.702       0.518     0.952          6.47 
Friedenreich-Pre (2001  |  1.000       0.700     1.429          3.94 
Friedenreich-Post(2001) |  0.906       0.685     1.198          6.76 
Matthews (2001)         |  0.477       0.333     0.683          5.99 
Yang (2003)             |  0.544       0.398     0.745          7.07 
Patel (2003)            |  1.100       0.826     1.465          5.83 
John-Pre (2003)         |  0.552       0.394     0.774          5.97 
John-Post(2003)         |  0.677       0.542     0.846         12.40 
Bernstein (2005)        |  0.898       0.806     1.000         45.56 
---------------------+------------------------------------------------- 
M-H pooled OR           |  0.803       0.745     0.866        100.00 
---------------------+------------------------------------------------- 
 
  Heterogeneity chi-squared = 32.63 (d.f. = 8) p < 0.001 
  I-squared (variation in OR attributable to heterogeneity) = 75.5% 
 
  Test of OR=1: z = 5.72; p < 0.001 
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Moderate Physical Activity and Breast Cancer Risk - Compendium quantified and 
estimated physical activity among pre- and postmenopausal females combined; Carpenter 
et al. (1999); Levi et al. (1999); Moradi et al. (2000); Friedenreich et al. (2001); 
Matthews et al. (2001); Yang et al. (2003); Patel et al. (2003); John et al. (2003); 
Bernstein et al. (2005) 
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MH (OR)
 =    ___________














































               _______________________________________________________________







































































               ________________________________________







































T  MH  (OR)  =           [42.924 +14.444 + 219.975 + 36.621+ 60.209 +
                74.384 + 32.104 + 40.645 + 38.345 + 72.458 +315.646]
               ________________________________________
                      [42.114 + 32.302 + 200.000 + 42.237 + 70.691+




T  MH  (OR)  =  947.755
               _________








Study             OR      [95% Conf. Interval]     % Weight 
---------------------+------------------------------------------------- 
Carpenter (1999)        |  1.043       0.773     1.407          4.16 
Levi (1999)             |  0.447       0.293     0.683          3.19 
Moradi (2000)           |  1.100       0.961     1.259         19.73 
Friedenreich-Pre (2001) |  0.867       0.634     1.185          4.17 
Friedenreich-Post(2001) |  0.938       0.687     1.281          4.03 
Matthews (2001)         |  0.826       0.665     1.026          8.88 
Yang (2003)             |  0.639       0.469     0.873          4.95 
Patel (2003)            |  0.999       0.734     1.358          4.02 
John-Pre (2003)         |  0.938       0.687     1.281          4.03 
John-Post(2003)         |  0.786       0.632     0.976          9.10 
Bernstein (2005)        |  0.923       0.828     1.028         33.74 
---------------------+------------------------------------------------- 
M-H pooled OR           |  0.914       0.859     0.974        100.00 
---------------------+------------------------------------------------- 
 
  Heterogeneity chi-squared = 27.13 (d.f. = 10) p = 0.002 
  I-squared (variation in OR attributable to heterogeneity) = 63.1% 
 
  Test of OR=1: z = 2.78; p = 0.005 
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High Physical Activity and Breast Cancer Risk - Compendium quantified and estimated 
physical activity among pre- and postmenopausal females combined; Carpenter et al. 
(1999); Levi et al. (1999); Moradi et al. (2000); Friedenreich et al. (2001); Matthews et 
al. (2001); Yang et al. (2003); Patel et al. (2003); John et al. (2003); Bernstein et al. 
(2005) 
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T  MH  (OR)  = [41.828 + 6.799 + 195.421 + 30.112 + 46.777 + 21.803+
                       29.411+ 49.000 + 25.200 + 64.188 + 315.224]
                ______________________________________________
                 [59.548 +17.568 + 239.311+ 30.112 + 51.628 + 45.755 +




T  MH  (OR)  =   825.763
                _________








Study            OR      [95% Conf. Interval]     % Weight 
---------------------+------------------------------------------------- 
Carpenter (1999)      |  0.702       0.518     0.952          4.84 
Levi (1999)           |  0.387       0.210     0.712          1.72 
Moradi (2000)         |  0.817       0.715     0.933         23.44 
Friedenreich-Pre (2001) |  1.000       0.700     1.429          2.95 
Friedenreich-Post(2001) |  0.906       0.685     1.198          5.06 
Matthews (2001)       |  0.477       0.333     0.683          4.48 
Yang (2003)           |  0.544       0.398     0.745          5.29 
Patel (2003)          |  1.100       0.826     1.465          4.36 
John-Pre (2003)       |  0.552       0.394     0.774          4.47 
John-Post(2003)       |  0.677       0.542     0.846          9.28 
Bernstein (2005)      |  0.898       0.806     1.000         34.10 
---------------------+------------------------------------------------- 
M-H pooled OR         |  0.799       0.749     0.853        100.00 
---------------------+------------------------------------------------- 
 
  Heterogeneity chi-squared = 38.20 (d.f. = 10) p < 0.001 
  I-squared (variation in OR attributable to heterogeneity) = 73.8% 
 





Moderate Physical Activity and Breast Cancer Risk - Compendium quantified physical 
activity among premenopausal females; Friedenreich et al. (2001); John et al. (2003) 
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MH (OR)
 =    ___________
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T  MH  (OR)  = [36.621+ 38.345]
               ________________




T  MH  (OR)  =  74.966
                _______











Study                 OR    [95% Conf. Interval]     % Weight 
---------------------+------------------------------------------------- 
Friedenreich-Pre (2001) |  0.867       0.634     1.185         50.81 
John-Pre (2003)       |  0.938       0.687     1.281         49.19 
---------------------+------------------------------------------------- 
M-H pooled OR         |  0.902       0.723     1.124        100.00 
---------------------+------------------------------------------------- 
 
  Heterogeneity chi-squared = 0.12 (d.f. = 1) p = 0.727 
  I-squared (variation in OR attributable to heterogeneity) = 0.0% 
 







High Physical Activity and Breast Cancer Risk - Compendium quantified physical 
activity among premenopausal females; Friedenreich et al. (2001); John et al. (2003) 
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MH (OR)
 =    ___________


















               __________________________















               _________________









T  MH  (OR)  = [30.112 + 25.200]
               ________________




T  MH  (OR)  = 55.312
                 ______










Study               OR       [95% Conf. Interval]     % Weight 
---------------------+------------------------------------------------- 
Friedenreich-Pre (2001) |  1.000       0.700     1.429         39.75 
John-Pre (2003)     |  0.552       0.394     0.774         60.25 
---------------------+------------------------------------------------- 
M-H pooled OR         |  0.730       0.572     0.932        100.00 
---------------------+------------------------------------------------- 
 
  Heterogeneity chi-squared = 5.61 (d.f. = 1) p = 0.018 
  I-squared (variation in OR attributable to heterogeneity) = 82.2% 
 
  Test of OR=1: z = 2.53; p = 0.011 
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Moderate Physical Activity and Breast Cancer Risk - Compendium quantified physical 
activity among postmenopausal females; Carpenter et al. (1999); Friedenreich et al. 
(2001); John et al. (2003) 
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MH (OR)
 =    ___________
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T  MH  (OR)  = [42.924 + 60.209 + 72.458]
               _______________________




T  MH  (OR)  = 175.591
                _______









Study              OR      [95% Conf. Interval]     % Weight 
---------------------+------------------------------------------------- 
Carpenter (1999)     |  1.043       0.773     1.407         20.54 
Friedenreich (2001)  |  0.852       0.669     1.086         34.48 
John (2003)          |  0.786       0.632     0.976         44.98 
---------------------+------------------------------------------------- 
M-H pooled OR        |  0.861       0.747     0.993        100.00 
---------------------+------------------------------------------------- 
 
  Heterogeneity chi-squared = 2.27 (d.f. = 2) p = 0.321 
  I-squared (variation in OR attributable to heterogeneity) = 11.9% 
 




High Physical Activity and Breast Cancer Risk - Compendium quantified physical 
activity among postmenopausal females; Carpenter et al. (1999); Friedenreich et al. 
(2001); John et al. (2003) 
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MH (OR)
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T  MH  (OR)  = 41.828 + 46.777 + 64.188
               ______________________




T  MH  (OR)  = 152.793
               ________




T  MH  (OR)  = 0.742  
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Study                 OR      [95% Conf. Interval]     % Weight 
---------------------+------------------------------------------------- 
Carpenter (1999)      |  0.702       0.518     0.952         25.23 
Friedenreich-Post(2001) |  0.906       0.685     1.198         26.37 
John-Post(2003)       |  0.677       0.542     0.846         48.40 
---------------------+------------------------------------------------- 
M-H pooled OR           |  0.744       0.640     0.865        100.00 
---------------------+------------------------------------------------- 
 
  Heterogeneity chi-squared = 2.73 (d.f. = 2) p = 0.255 
  I-squared (variation in OR attributable to heterogeneity) = 26.7% 
 
  Test of OR=1: z = 3.84; p < 0.001 
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Moderate Physical Activity and Breast Cancer Risk - Compendium quantified and 
estimated physical activity among postmenopausal females; Carpenter et al. (1999); 
Moradi et al. (2000): Friedenreich et al. (2001); John et al. (2003) 
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T  MH  (OR)  =           [42.924 + 219.975 + 60.209 + 72.458]
                     _______________________________




T  MH  (OR)  =          395.566
                     _______









Study                 OR      [95% Conf. Interval]     % Weight 
---------------------+------------------------------------------------- 
Carpenter (1999)      |  1.043       0.773     1.407         10.33 
Levi (1999)           |  0.447       0.293     0.683          7.93 
Moradi (2000)         |  1.100       0.961     1.259         49.08 
Friedenreich-Post(2001) |  0.938       0.687     1.281         10.03 
John-Post(2003)       |  0.786       0.632     0.976         22.63 
---------------------+------------------------------------------------- 
M-H pooled OR         |  0.955       0.866     1.053        100.00 
---------------------+------------------------------------------------- 
 
  Heterogeneity chi-squared = 19.93 (d.f. = 4) p = 0.001 
  I-squared (variation in OR attributable to heterogeneity) = 79.9% 
 
  Test of OR=1: z = 0.92; p = 0.357 
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High Physical Activity and Breast Cancer Risk - Compendium quantified and estimated 
physical activity among postmenopausal females; Carpenter et al. (1999); Moradi et al. 
(2000): Friedenreich et al. (2001); John et al. (2003) 
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T  MH  (OR)  = [41.828 + 195.421 +  46.777 + 64.188]
                ________________________________




T  MH  (OR)  = 348.214
                 _______










           Study                   OR      [95% Conf. Interval]     % Weight 
---------------------+------------------------------------------------- 
Carpenter (1999)          |  0.702       0.518     0.952         10.91 
Levi (1999)               |  0.387       0.210     0.712          3.88 
Moradi (2000)             |  0.817       0.715     0.933         52.87 
Friedenreich-Post (2001)  |  0.906       0.685     1.198         11.41 
John-Post (2003)          |  0.677       0.542     0.846         20.93 
---------------------+------------------------------------------------- 
M-H pooled OR           |  0.769       0.697     0.848        100.00 
---------------------+------------------------------------------------- 
 
  Heterogeneity chi-squared = 8.57 (d.f. = 4) p = 0.073 
  I-squared (variation in OR attributable to heterogeneity) = 53.3% 
 








































Variance Calculation:  High Physical Activity and Breast Cancer Risk - Compendium 
quantified and estimated physical activity among pre- and postmenopausal females 
combined; Carpenter et al. (1999); Levi et al. (1999); Moradi et al. (2000); Friedenreich 
et al. (2001); Matthews et al. (2001); Yang et al. (2003); Patel et al. (2003); John et al. 
(2003); Bernstein et al. (2005) 
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                  2(825.763)
2




22.3043 + 3.0080 + 92.6047 + 15.0560 + 22.7947 + 10.7153 + 
13.4787 + 25.4074 + 11.0003 + 29.3218 + 155.5063  
    + 
[31.7539 + 7.7730 + 113.4011 + 15.0560 + 15.1589 + 22.4867 + 
24.7667 + 23.1023 + 19.9236 + 43.2869 + 171.7189]  
                                                + 
[28.1145 + 3.7906 + 102.8177 + 15.0560 + 23.9819 + 11.0880 + 
15.9326 + 23.5926 + 14.1997 + 34.8665 + 160.0131] 
     + 
[40.0256 + 9.7953 + 125.9096 + 15.0560 + 26.4693 + 23.2687 + 29.2756 + 21.4520 + 




             401.1975 + [488.4280 + 433.4532] + 545.1379  
      2(825.763)
2





     401.1975 + [488.4280 + 433.4532] + 545.1379 
     1363769.064 + 1702738.1700 + 2125959.1160 
 
=   1868.2166 
     5192466.35 
 
Estimated V MH (LN OR)  =  0.00035980 
 
Comparison of Mantel-Haenszel and STATA 95% Confidence Intervals: 
 
T MH (OR) = 0.801 
ln (T MH (OR)) = -.2219 
SE = "(V MH (LN OR) = "0.00035980  
SE = .0189 (hand-calculated) 
95% CI (ln T MH (OR)) = -.2219 ± 1.96(.0189) 
95% CI (ln T MH (OR)) = exp (-.258944, -.182356) 
95% CI (ln TMH (OR)) = (.771866, .831200) 
 
This hand-calculated 95% CI range of 0.772-0.831 compares to that of 0.749-0.853 in the 
M-H Stata output. The difference between these 95% confidence intervals is within 









Colon cancer risk among moderate versus low activity stratified males and females in 
Compendium quantified studies included in the mixed effects meta-regression model 
 
Meta-regression                             Number of studies = 6 
 
tau2 = 0.0000                
----------------------------------------------------------------------- 
logor |     exp(b)   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+--------------------------------------------------------- 




Colon cancer risk among high versus low activity stratified males and females in 
Compendium quantified studies included in the mixed effects meta-regression model 
 
Meta-regression                                 Number of studies = 6 
 
tau2   =   0.0000 
----------------------------------------------------------------------- 
logor |     exp(b)   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+--------------------------------------------------------- 





Breast cancer risk among moderate versus low activity stratified pre- and postmenopausal 
females in Compendium quantified studies included in the mixed effects meta-regression 
model 
 
Meta-regression                                  Number of studies = 8 
 
tau2 = 0.0012 
----------------------------------------------------------------------- 
logor |     exp(b)     Std. Err.    t     P>|t|   [95% Conf. Interval] 
-------------+--------------------------------------------------------- 










Breast cancer risk among high versus low activity stratified pre- and postmenopausal 




Meta-regression                                 Number of studies = 8    
 
tau2 = 0.0339 
----------------------------------------------------------------------- 
logor |       exp(b)    Std. Err.     t     P>|t|  [95% Conf. Interval] 
----------------------------------------------------------------------- 













Proportion of High Activity in Population estimated from McTiernan et al. cohort study: 
 
High Activity:   
355+14299+97+4277 
 
Low and Moderate Activity: 
355+14299+97+4277+456+17483+270+11717+351+14435+239+9391 
 
Proportion of High Activity 




Exposure = Non-High Activity  






PAF = [Px (RR-1)]  /   [Px (RR-1) + 1] 
 
PAF = [.74 (.847-1)] /  [.74 (.847-1) + 1] 
 
PAF = .74 (-0.153) /  .74 (-0.153) + 1 
 
PAF =  -.11322  /  .88678 
 
PAF = -.12768 
 


















Low and Moderate Activity (person-years): 
156,599 
 
High Activity (person-years): 
106,955 
 
Proportion of High Activity 
= .4058 
 
Exposure = Non-High Activity  





PAF = [Px (RR-1)]  /   [Px (RR-1) + 1] 
 
PAF = [.5942 (.524-1)] /  [.5942 (.524-1) + 1] 
 
PAF = .5942 (-0.476) /  .5942 (-0.476) + 1 
 
PAF =  -0.2828  /  0.7172 
 
PAF = -.3944 
 























Low and Moderate Activity (person-years): 
242,351 
 





Exposure = Non-High Activity  





PAF = [Px (RR-1)]  /   [Px (RR-1) + 1] 
 
PAF = [.7573 (.673-1)] /  [.7573 (.673-1) + 1] 
 
PAF = .7573 (-0.327) /  .7573 (-0.327) + 1 
 
PAF =  -0.2476 / 0.7524 
 
PAF = -.3291 
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